query	target	qheader	theader	fident	alnlen	mismatch	qstart	qend	tstart	tend	evalue	bits
LOKIASV2_0167_ESMFold_hypothetical_protein	4ep3-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4ep3-assembly1.cif.gz_A Crystal Structure of inactive single chain wild-type HIV-1 Protease in Complex with the substrate CA-p2	0.148	240	158	21	260	10	195	2.788E-10	326
LOKIASV2_0167_ESMFold_hypothetical_protein	4eq0-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4eq0-assembly1.cif.gz_A Crystal Structure of inactive single chain variant of HIV-1 Protease in Complex with the substrate p2-NC	0.142	243	160	21	263	10	197	1.728E-10	324
LOKIASV2_0167_ESMFold_hypothetical_protein	4eqj-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4eqj-assembly1.cif.gz_A Crystal Structure of inactive single chain variant of HIV-1 Protease in Complex with the substrate RT-RH	0.138	240	161	21	260	10	197	1.822E-10	324
LOKIASV2_0167_ESMFold_hypothetical_protein	1hvc-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1hvc-assembly1.cif.gz_A CRYSTAL STRUCTURE OF A TETHERED DIMER OF HIV-1 PROTEASE COMPLEXED WITH AN INHIBITOR	0.168	240	158	21	260	10	200	2.027E-10	318
LOKIASV2_0167_ESMFold_hypothetical_protein	4qlh-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4qlh-assembly1.cif.gz_A Crystal structure of drug resistant V82S/V1082S HIV-1 Protease	0.168	226	149	21	246	10	189	5.274E-10	311
LOKIASV2_0167_ESMFold_hypothetical_protein	3kt2-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3kt2-assembly1.cif.gz_A Crystal Structure of N88D mutant HIV-1 Protease	0.164	245	157	2	246	1	189	8.973E-10	308
LOKIASV2_0167_ESMFold_hypothetical_protein	1g6l-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1g6l-assembly1.cif.gz_A 1.9A CRYSTAL STRUCTURE OF TETHERED HIV-1 PROTEASE	0.167	226	149	21	246	10	189	9.462E-10	301
LOKIASV2_0167_ESMFold_hypothetical_protein	3dox-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3dox-assembly1.cif.gz_A X-ray structure of HIV-1 protease in situ product complex	0.162	246	158	2	247	1	190	1.447E-09	298
LOKIASV2_0167_ESMFold_hypothetical_protein	4q5m-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4q5m-assembly1.cif.gz_A D30N tethered HIV-1 protease dimer/saquinavir complex	0.160	245	158	2	246	1	189	2.739E-09	295
LOKIASV2_0167_ESMFold_hypothetical_protein	3n3i-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3n3i-assembly1.cif.gz_A Crystal Structure of G48V/C95F tethered HIV-1 Protease/Saquinavir complex	0.171	227	149	21	247	10	190	1.991E-09	293
LOKIASV2_0167_ESMFold_hypothetical_protein	3kt5-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3kt5-assembly1.cif.gz_A Crystal Structure of N88S mutant HIV-1 Protease	0.168	245	156	2	246	1	189	6.077E-09	286
LOKIASV2_0167_ESMFold_hypothetical_protein	3nxn-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3nxn-assembly1.cif.gz_A X-ray structure of ester chemical analogue 'covalent dimer' [Ile50,O-Ile50']HIV-1 protease complexed with KVS-1 inhibitor	0.177	240	156	7	246	1	190	6.758E-09	272
LOKIASV2_0167_ESMFold_hypothetical_protein	3hlo-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3hlo-assembly1.cif.gz_A Crystal structure of chemically synthesized 'covalent dimer' [Gly51/D-Ala51']HIV-1 protease	0.180	245	156	2	246	1	191	8.814E-09	268
LOKIASV2_0167_ESMFold_hypothetical_protein	3iaw-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3iaw-assembly1.cif.gz_A Crystal structure of a chemically synthesized 203 amino acid 'covalent dimer' [Gly51;Aib51']HIV-1 protease molecule complexed with MVT-101 reduced isostere inhibitor at 1.6 A resolution	0.166	227	151	21	247	10	191	1.348E-08	267
LOKIASV2_0167_ESMFold_hypothetical_protein	5kos-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5kos-assembly1.cif.gz_A Discovery of TAK-272: A Novel, Potent and Orally Active Renin In-hibitor	0.115	325	230	2	262	3	327	4.418E-09	266
LOKIASV2_0167_ESMFold_hypothetical_protein	2o40-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	2o40-assembly1.cif.gz_A Crystal Structure of a Chemically Synthesized 203 Amino Acid 'Covalent Dimer' HIV-1 Protease Molecule	0.186	226	147	21	246	10	191	1.150E-08	265
LOKIASV2_0167_ESMFold_hypothetical_protein	3ka2-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3ka2-assembly1.cif.gz_A Crystal structure of chemically synthesized 203 amino acid 'covalent dimer' [L-Ala;Gly51']HIV-1 protease molecule complexed with MVT-101 reduced isostere inhibitor at 1.4 A resolution	0.173	227	151	21	247	10	192	1.422E-08	257
LOKIASV2_0167_ESMFold_hypothetical_protein	3fsm-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3fsm-assembly1.cif.gz_A CRYSTAL STRUCTURE OF A CHEMICALLY SYNTHESIZED 203 AMINO ACID 'COVALENT DIMER' [L-Ala51,D-Ala51'] HIV-1 PROTEASE MOLECULE	0.159	262	165	2	263	1	197	1.668E-08	252
LOKIASV2_0167_ESMFold_hypothetical_protein	5vpm-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	5vpm-assembly2.cif.gz_B Crystal Structure of Human Renin in Complex with a biphenylpipderidinylcarbinol	0.116	329	230	2	262	3	331	6.758E-09	252
LOKIASV2_0167_ESMFold_hypothetical_protein	4gj6-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4gj6-assembly1.cif.gz_A Crystal structure of renin in complex with NVP-AYZ832 (compound 6a)	0.121	325	229	2	262	5	329	2.294E-08	243
LOKIASV2_0167_ESMFold_hypothetical_protein	3cms-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3cms-assembly1.cif.gz_A ENGINEERING ENZYME SUB-SITE SPECIFICITY: PREPARATION, KINETIC CHARACTERIZATION AND X-RAY ANALYSIS AT 2.0-ANGSTROMS RESOLUTION OF VAL111PHE SITE-MUTATED CALF CHYMOSIN	0.106	316	233	1	262	1	316	3.387E-09	241
LOKIASV2_0167_ESMFold_hypothetical_protein	1qrp-assembly1.cif.gz_E	LOKIASV2_0167_ESMFold_hypothetical_protein	1qrp-assembly1.cif.gz_E Human pepsin 3A in complex with a phosphonate inhibitor IVA-VAL-VAL-LEU(P)-(O)PHE-ALA-ALA-OME	0.118	320	228	3	262	3	322	1.581E-08	241
LOKIASV2_0167_ESMFold_hypothetical_protein	1ize-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1ize-assembly1.cif.gz_A Crystal structure of Aspergillus oryzae Aspartic proteinase complexed with pepstatin	0.116	319	231	1	262	1	319	1.348E-08	238
LOKIASV2_0167_ESMFold_hypothetical_protein	5sy2-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5sy2-assembly1.cif.gz_A Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors	0.114	328	231	1	262	4	331	4.577E-08	238
LOKIASV2_0167_ESMFold_hypothetical_protein	4gj6-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	4gj6-assembly2.cif.gz_B Crystal structure of renin in complex with NVP-AYZ832 (compound 6a)	0.113	324	231	2	262	6	329	3.700E-08	237
LOKIASV2_0167_ESMFold_hypothetical_protein	5sz9-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	5sz9-assembly2.cif.gz_B Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors	0.110	326	231	2	262	3	328	4.340E-08	236
LOKIASV2_0167_ESMFold_hypothetical_protein	6r6a-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	6r6a-assembly1.cif.gz_A Major aspartyl peptidase 1 from C. neoformans	0.111	341	231	2	262	1	341	4.115E-08	234
LOKIASV2_0167_ESMFold_hypothetical_protein	3f9q-assembly1.cif.gz_A-2	LOKIASV2_0167_ESMFold_hypothetical_protein	3f9q-assembly1.cif.gz_A-2 Re-refinement of uncomplexed plasmepsin II from Plasmodium falciparum.	0.102	318	234	1	262	1	318	5.464E-09	233
LOKIASV2_0167_ESMFold_hypothetical_protein	5sy3-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	5sy3-assembly2.cif.gz_B Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors	0.101	327	234	2	262	5	331	2.551E-08	233
LOKIASV2_0167_ESMFold_hypothetical_protein	3k1w-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3k1w-assembly2.cif.gz_B New Classes of Potent and Bioavailable Human Renin Inhibitors	0.109	327	232	2	262	6	332	5.660E-08	233
LOKIASV2_0167_ESMFold_hypothetical_protein	5sxn-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5sxn-assembly1.cif.gz_A Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors	0.114	328	230	2	262	5	332	7.001E-08	231
LOKIASV2_0167_ESMFold_hypothetical_protein	4cku-assembly2.cif.gz_D	LOKIASV2_0167_ESMFold_hypothetical_protein	4cku-assembly2.cif.gz_D Three dimensional structure of plasmepsin II in complex with hydroxyethylamine-based inhibitor	0.111	316	231	2	262	1	316	9.295E-09	230
LOKIASV2_0167_ESMFold_hypothetical_protein	5t4s-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5t4s-assembly1.cif.gz_A Novel Approach of Fragment-Based Lead Discovery applied to Renin Inhibitors	0.117	326	230	2	262	5	330	4.115E-08	230
LOKIASV2_0167_ESMFold_hypothetical_protein	4ybf-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4ybf-assembly1.cif.gz_A Aspartic Proteinase Sapp2 Secreted from Candida Parapsilosis at 1.25 A Resolution	0.108	317	231	3	262	4	320	5.660E-08	230
LOKIASV2_0167_ESMFold_hypothetical_protein	1rne-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1rne-assembly1.cif.gz_A THE CRYSTAL STRUCTURE OF RECOMBINANT GLYCOSYLATED HUMAN RENIN ALONE AND IN COMPLEX WITH A TRANSITION STATE ANALOG INHIBITOR	0.116	325	231	1	262	1	325	5.090E-08	229
LOKIASV2_0167_ESMFold_hypothetical_protein	5i70-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	5i70-assembly1.cif.gz_B Crystal Structure of plasmepsin IV	0.138	315	222	4	262	2	316	3.902E-08	227
LOKIASV2_0167_ESMFold_hypothetical_protein	1w6h-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1w6h-assembly2.cif.gz_B Novel plasmepsin II-inhibitor complex	0.114	316	229	3	262	3	318	1.090E-08	227
LOKIASV2_0167_ESMFold_hypothetical_protein	4gja-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	4gja-assembly2.cif.gz_B Crystal structure of renin in complex with NVP-AYL747 (compound 5)	0.114	329	231	1	262	5	333	5.969E-08	226
LOKIASV2_0167_ESMFold_hypothetical_protein	2ren-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	2ren-assembly1.cif.gz_A STRUCTURE OF RECOMBINANT HUMAN RENIN, A TARGET FOR CARDIOVASCULAR-ACTIVE DRUGS, AT 2.5 ANGSTROMS RESOLUTION	0.128	314	227	2	262	3	316	5.090E-08	225
LOKIASV2_0167_ESMFold_hypothetical_protein	1lf4-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1lf4-assembly1.cif.gz_A STRUCTURE OF PLASMEPSIN II	0.107	314	231	3	262	5	318	1.212E-08	225
LOKIASV2_0167_ESMFold_hypothetical_protein	1fq6-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1fq6-assembly1.cif.gz_A X-RAY STRUCTURE OF GLYCOL INHIBITOR PD-133,450 BOUND TO SACCHAROPEPSIN	0.097	323	235	2	262	3	325	1.855E-08	225
LOKIASV2_0167_ESMFold_hypothetical_protein	2v0z-assembly1.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	2v0z-assembly1.cif.gz_C Crystal Structure of Renin with Inhibitor 10 (Aliskiren)	0.117	329	230	2	262	6	334	1.071E-07	225
LOKIASV2_0167_ESMFold_hypothetical_protein	4cku-assembly2.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	4cku-assembly2.cif.gz_C Three dimensional structure of plasmepsin II in complex with hydroxyethylamine-based inhibitor	0.104	315	233	2	262	1	315	3.902E-08	224
LOKIASV2_0167_ESMFold_hypothetical_protein	4cku-assembly1.cif.gz_A-2	LOKIASV2_0167_ESMFold_hypothetical_protein	4cku-assembly1.cif.gz_A-2 Three dimensional structure of plasmepsin II in complex with hydroxyethylamine-based inhibitor	0.123	316	229	1	262	1	316	8.659E-08	224
LOKIASV2_0167_ESMFold_hypothetical_protein	4gj5-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	4gj5-assembly2.cif.gz_B Crystal structure of renin in complex with NVP-AMQ838 (compound 5)	0.107	322	232	2	262	6	327	8.211E-08	224
LOKIASV2_0167_ESMFold_hypothetical_protein	3vuc-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3vuc-assembly2.cif.gz_B Human renin in complex with compound 5	0.105	329	233	2	262	6	334	1.473E-07	224
LOKIASV2_0167_ESMFold_hypothetical_protein	4aa8-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4aa8-assembly1.cif.gz_A Bovine chymosin at 1.8A resolution	0.104	319	234	1	262	1	319	3.509E-08	223
LOKIASV2_0167_ESMFold_hypothetical_protein	6xcy-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	6xcy-assembly1.cif.gz_A Porcine pepsin in complex with ritonavir	0.115	321	231	1	262	1	321	2.992E-08	223
LOKIASV2_0167_ESMFold_hypothetical_protein	4y9w-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4y9w-assembly1.cif.gz_A Aspartic Proteinase Sapp2 Secreted from Candida Parapsilosis at 0.82 A Resolution.	0.110	313	232	1	262	1	313	7.001E-08	223
LOKIASV2_0167_ESMFold_hypothetical_protein	3km4-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3km4-assembly1.cif.gz_B Optimization of Orally Bioavailable Alkyl Amine Renin Inhibitors	0.131	327	226	2	262	3	329	5.660E-08	223
LOKIASV2_0167_ESMFold_hypothetical_protein	5n71-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5n71-assembly1.cif.gz_A CRYSTAL STRUCTURE OF MATURE CATHEPSIN D FROM THE TICK IXODES RICINUS (IRCD1)	0.101	329	233	3	262	5	333	2.419E-08	223
LOKIASV2_0167_ESMFold_hypothetical_protein	4pep-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4pep-assembly1.cif.gz_A THE MOLECULAR AND CRYSTAL STRUCTURES OF MONOCLINIC PORCINE PEPSIN REFINED AT 1.8 ANGSTROMS RESOLUTION	0.121	322	229	1	262	1	322	5.367E-08	222
LOKIASV2_0167_ESMFold_hypothetical_protein	5t4s-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	5t4s-assembly2.cif.gz_B Novel Approach of Fragment-Based Lead Discovery applied to Renin Inhibitors	0.111	325	232	1	262	3	327	1.015E-07	222
LOKIASV2_0167_ESMFold_hypothetical_protein	4cku-assembly2.cif.gz_E	LOKIASV2_0167_ESMFold_hypothetical_protein	4cku-assembly2.cif.gz_E Three dimensional structure of plasmepsin II in complex with hydroxyethylamine-based inhibitor	0.113	315	231	2	262	1	315	2.551E-08	221
LOKIASV2_0167_ESMFold_hypothetical_protein	8cik-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	8cik-assembly1.cif.gz_A Altai wapiti (Cervus elaphus sibiricus) chymosin at 2.2 A resolution	0.121	319	229	1	262	1	319	1.759E-08	221
LOKIASV2_0167_ESMFold_hypothetical_protein	1sme-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1sme-assembly1.cif.gz_A PLASMEPSIN II, A HEMOGLOBIN-DEGRADING ENZYME FROM PLASMODIUM FALCIPARUM, IN COMPLEX WITH PEPSTATIN A	0.115	320	229	3	262	3	322	2.175E-08	221
LOKIASV2_0167_ESMFold_hypothetical_protein	4gj5-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4gj5-assembly1.cif.gz_A Crystal structure of renin in complex with NVP-AMQ838 (compound 5)	0.116	323	230	2	262	6	328	1.015E-07	221
LOKIASV2_0167_ESMFold_hypothetical_protein	5sxn-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	5sxn-assembly2.cif.gz_B Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors	0.105	328	233	2	262	5	332	1.325E-07	221
LOKIASV2_0167_ESMFold_hypothetical_protein	6xd2-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	6xd2-assembly1.cif.gz_A Porcine pepsin in complex with darunavir	0.122	319	229	1	262	1	319	1.397E-07	220
LOKIASV2_0167_ESMFold_hypothetical_protein	1qs8-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1qs8-assembly2.cif.gz_B Crystal structure of the P. vivax aspartic proteinase plasmepsin complexed with the inhibitor pepstatin A	0.116	320	229	3	262	4	323	2.837E-08	220
LOKIASV2_0167_ESMFold_hypothetical_protein	4cku-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	4cku-assembly2.cif.gz_B Three dimensional structure of plasmepsin II in complex with hydroxyethylamine-based inhibitor	0.116	320	231	1	262	1	320	2.175E-08	219
LOKIASV2_0167_ESMFold_hypothetical_protein	4gjb-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4gjb-assembly1.cif.gz_A Crystal structure of renin in complex with NVP-BBV031 (compound 6)	0.106	326	232	2	262	6	331	2.026E-07	219
LOKIASV2_0167_ESMFold_hypothetical_protein	5n7q-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	5n7q-assembly2.cif.gz_B CRYSTAL STRUCTURE OF MATURE CATHEPSIN D FROM THE TICK IXODES RICINUS (IRCD1) IN COMPLEX WITH THE INHIBITOR PEPSTATIN A	0.098	333	235	1	262	1	333	8.211E-08	219
LOKIASV2_0167_ESMFold_hypothetical_protein	3sfc-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3sfc-assembly1.cif.gz_A Structure-Based Optimization of Potent 4- and 6-Azaindole-3-Carboxamides as Renin Inhibitors	0.116	331	230	2	262	6	336	1.473E-07	219
LOKIASV2_0167_ESMFold_hypothetical_protein	6xct-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	6xct-assembly1.cif.gz_A Porcine pepsin in complex with amprenavir	0.122	319	229	1	262	1	319	1.822E-07	218
LOKIASV2_0167_ESMFold_hypothetical_protein	1ls5-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1ls5-assembly2.cif.gz_B Crystal structure of plasmepsin IV from P. falciparum in complex with pepstatin A	0.125	322	228	1	262	1	322	8.659E-08	218
LOKIASV2_0167_ESMFold_hypothetical_protein	1hrn-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1hrn-assembly1.cif.gz_A HIGH RESOLUTION CRYSTAL STRUCTURES OF RECOMBINANT HUMAN RENIN IN COMPLEX WITH POLYHYDROXYMONOAMIDE INHIBITORS	0.129	328	226	2	262	3	330	2.506E-07	218
LOKIASV2_0167_ESMFold_hypothetical_protein	2v0z-assembly2.cif.gz_O	LOKIASV2_0167_ESMFold_hypothetical_protein	2v0z-assembly2.cif.gz_O Crystal Structure of Renin with Inhibitor 10 (Aliskiren)	0.129	327	226	2	262	6	332	1.822E-07	218
LOKIASV2_0167_ESMFold_hypothetical_protein	2g27-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	2g27-assembly1.cif.gz_A Ketopiperazine-Based Renin Inhibitors: Optimization of the "C" Ring	0.117	324	230	2	262	1	324	2.253E-07	217
LOKIASV2_0167_ESMFold_hypothetical_protein	5yic-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5yic-assembly1.cif.gz_A Crystal Structure of KNI-10333 bound Plasmepsin II (PMII) from Plasmodium falciparum	0.107	321	232	2	262	1	321	2.175E-08	217
LOKIASV2_0167_ESMFold_hypothetical_protein	1dp5-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1dp5-assembly1.cif.gz_A THE STRUCTURE OF PROTEINASE A COMPLEXED WITH A IA3 MUTANT INHIBITOR	0.112	323	229	4	262	3	325	3.509E-08	217
LOKIASV2_0167_ESMFold_hypothetical_protein	5tmk-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	5tmk-assembly2.cif.gz_B Optimization of 3,5-Disubstitued Piperidine: Discovery of Non-Peptide mimetics as an Orally Active Renin Inhibitor	0.122	324	228	2	262	3	326	9.131E-08	217
LOKIASV2_0167_ESMFold_hypothetical_protein	6i3f-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	6i3f-assembly1.cif.gz_B Crystal structure of the complex of human angiotensinogen and renin at 2.55 Angstrom	0.107	332	233	1	262	3	334	1.397E-07	217
LOKIASV2_0167_ESMFold_hypothetical_protein	5n7n-assembly3.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	5n7n-assembly3.cif.gz_C CRYSTAL STRUCTURE OF CATHEPSIN D ZYMOGEN FROM THE TICK IXODES RICINUS (IRCD1)	0.109	357	233	1	262	1	357	4.340E-08	217
LOKIASV2_0167_ESMFold_hypothetical_protein	1fmu-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1fmu-assembly1.cif.gz_A STRUCTURE OF NATIVE PROTEINASE A IN P3221 SPACE GROUP.	0.115	315	229	3	262	4	318	4.577E-08	213
LOKIASV2_0167_ESMFold_hypothetical_protein	1apt-assembly1.cif.gz_E	LOKIASV2_0167_ESMFold_hypothetical_protein	1apt-assembly1.cif.gz_E CRYSTALLOGRAPHIC ANALYSIS OF A PEPSTATIN ANALOGUE BINDING TO THE ASPARTYL PROTEINASE PENICILLOPEPSIN AT 1.8 ANGSTROMS RESOLUTION	0.102	319	234	1	262	1	319	1.015E-07	212
LOKIASV2_0167_ESMFold_hypothetical_protein	6r61-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	6r61-assembly1.cif.gz_A Major aspartyl peptidase 1 from C. neoformans in complex with Inhibitor LP258	0.115	346	230	2	262	1	346	6.638E-08	212
LOKIASV2_0167_ESMFold_hypothetical_protein	5jod-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	5jod-assembly1.cif.gz_B Structure of proplasmepsin IV from Plasmodium falciparum	0.130	324	220	9	262	46	369	2.419E-08	212
LOKIASV2_0167_ESMFold_hypothetical_protein	4cms-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4cms-assembly1.cif.gz_A X-RAY ANALYSES OF ASPARTIC PROTEINASES IV. STRUCTURE AND REFINEMENT AT 2.2 ANGSTROMS RESOLUTION OF BOVINE CHYMOSIN	0.107	316	233	1	262	1	316	1.071E-07	211
LOKIASV2_0167_ESMFold_hypothetical_protein	1uh9-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1uh9-assembly1.cif.gz_A Crystal structure of rhizopuspepsin at pH 7.0	0.112	316	230	3	262	5	320	1.822E-07	211
LOKIASV2_0167_ESMFold_hypothetical_protein	3qrv-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3qrv-assembly1.cif.gz_A Crystal structure of plasmepsin I (PMI) from Plasmodium falciparum	0.122	313	227	3	262	4	316	5.367E-08	210
LOKIASV2_0167_ESMFold_hypothetical_protein	2iko-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	2iko-assembly1.cif.gz_B Crystal Structure of Human Renin Complexed with Inhibitor	0.113	325	231	2	262	4	328	2.787E-07	210
LOKIASV2_0167_ESMFold_hypothetical_protein	3q70-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3q70-assembly1.cif.gz_A Secreted aspartic protease in complex with ritonavir	0.107	319	232	2	262	1	319	2.376E-07	210
LOKIASV2_0167_ESMFold_hypothetical_protein	1flh-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1flh-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN UROPEPSIN AT 2.45 A RESOLUTION	0.111	322	232	1	262	1	322	2.506E-07	209
LOKIASV2_0167_ESMFold_hypothetical_protein	1smr-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1smr-assembly1.cif.gz_A The 3-d structure of mouse submaxillary renin complexed with a decapeptide inhibitor ch-66 based on the 4-16 fragment of rat angiotensinogen	0.095	325	235	2	262	3	327	1.921E-07	209
LOKIASV2_0167_ESMFold_hypothetical_protein	5i70-assembly2.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5i70-assembly2.cif.gz_A Crystal Structure of plasmepsin IV	0.151	309	219	4	262	2	310	2.376E-07	208
LOKIASV2_0167_ESMFold_hypothetical_protein	5nfg-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	5nfg-assembly2.cif.gz_B Structure of recombinant cardosin B from Cynara cardunculus	0.125	318	227	3	262	7	324	9.629E-08	208
LOKIASV2_0167_ESMFold_hypothetical_protein	2qzx-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	2qzx-assembly1.cif.gz_A Secreted aspartic proteinase (Sap) 5 from Candida albicans	0.097	327	235	2	262	1	327	4.826E-08	208
LOKIASV2_0167_ESMFold_hypothetical_protein	5koq-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5koq-assembly1.cif.gz_A Discovery of TAK-272: A Novel, Potent and Orally Active Renin In-hibitor	0.113	331	232	1	262	1	331	4.263E-07	207
LOKIASV2_0167_ESMFold_hypothetical_protein	1g0v-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1g0v-assembly1.cif.gz_A THE STRUCTURE OF PROTEINASE A COMPLEXED WITH A IA3 MUTANT, MVV	0.110	325	231	2	262	1	325	1.553E-07	206
LOKIASV2_0167_ESMFold_hypothetical_protein	7agc-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	7agc-assembly1.cif.gz_A Protease Sapp1p from Candida parapsilosis in complex with KB74	0.107	325	232	2	262	1	325	1.015E-07	206
LOKIASV2_0167_ESMFold_hypothetical_protein	3qs1-assembly1.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	3qs1-assembly1.cif.gz_C Crystal structure of KNI-10006 complex of Plasmepsin I (PMI) from Plasmodium falciparum	0.123	320	229	1	262	1	320	9.131E-08	205
LOKIASV2_0167_ESMFold_hypothetical_protein	8fxq-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	8fxq-assembly1.cif.gz_A The Crystal Sturucture of Rhizopuspepsin with a bound modified peptide inhibitor generated by de novo drug design.	0.117	319	230	2	262	1	319	5.560E-07	204
LOKIASV2_0167_ESMFold_hypothetical_protein	5bwy-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5bwy-assembly1.cif.gz_A Structure of proplasmepsin II from Plasmodium falciparum, Space Group P43212	0.109	327	228	6	262	43	369	2.419E-08	204
LOKIASV2_0167_ESMFold_hypothetical_protein	7adg-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	7adg-assembly1.cif.gz_A Cocktail experiment G: fragments 216 and 338 at 90 mM concentration in complex with Endothiapepsin	0.104	327	233	2	262	1	327	4.741E-07	202
LOKIASV2_0167_ESMFold_hypothetical_protein	5sy2-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	5sy2-assembly2.cif.gz_B Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors	0.118	321	229	2	262	6	326	2.137E-07	202
LOKIASV2_0167_ESMFold_hypothetical_protein	3qvc-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3qvc-assembly1.cif.gz_A Crystal structure of histo-aspartic protease (HAP) zymogen from Plasmodium falciparum	0.093	313	224	15	262	50	362	1.071E-07	202
LOKIASV2_0167_ESMFold_hypothetical_protein	5ux4-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	5ux4-assembly2.cif.gz_B Crystal Structure of Rat Cathepsin D with (5S)-3-(5,6-dihydro-2H-pyran-3-yl)-1-fluoro- 7-(2-fluoropyridin-3-yl)spiro[chromeno[2,3- c]pyridine-5,4'-[1,3]oxazol]-2'-amine	0.100	331	233	3	262	4	334	3.833E-07	199
LOKIASV2_0167_ESMFold_hypothetical_protein	6apr-assembly1.cif.gz_E	LOKIASV2_0167_ESMFold_hypothetical_protein	6apr-assembly1.cif.gz_E STRUCTURES OF COMPLEXES OF RHIZOPUSPEPSIN WITH PEPSTATIN AND OTHER STATINE-CONTAINING INHIBITORS	0.106	316	232	3	262	5	320	8.066E-07	198
LOKIASV2_0167_ESMFold_hypothetical_protein	2anl-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	2anl-assembly2.cif.gz_B X-ray crystal structure of the aspartic protease plasmepsin 4 from the malarial parasite plasmodium malariae bound to an allophenylnorstatine based inhibitor	0.106	319	232	2	262	4	322	6.184E-07	198
LOKIASV2_0167_ESMFold_hypothetical_protein	1fmx-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1fmx-assembly2.cif.gz_B STRUCTURE OF NATIVE PROTEINASE A IN THE SPACE GROUP P21	0.107	318	231	3	262	4	321	1.728E-07	197
LOKIASV2_0167_ESMFold_hypothetical_protein	1ibq-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1ibq-assembly2.cif.gz_B ASPERGILLOPEPSIN FROM ASPERGILLUS PHOENICIS	0.131	321	226	2	262	1	321	3.447E-07	197
LOKIASV2_0167_ESMFold_hypothetical_protein	1htr-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1htr-assembly1.cif.gz_B CRYSTAL AND MOLECULAR STRUCTURES OF HUMAN PROGASTRICSIN AT 1.62 ANGSTROMS RESOLUTION	0.134	311	209	21	262	15	325	1.822E-07	197
LOKIASV2_0167_ESMFold_hypothetical_protein	6rsv-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	6rsv-assembly1.cif.gz_A Endothiapepsin in complex with 017	0.102	326	233	2	262	1	326	5.273E-07	196
LOKIASV2_0167_ESMFold_hypothetical_protein	5ux4-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5ux4-assembly1.cif.gz_A Crystal Structure of Rat Cathepsin D with (5S)-3-(5,6-dihydro-2H-pyran-3-yl)-1-fluoro- 7-(2-fluoropyridin-3-yl)spiro[chromeno[2,3- c]pyridine-5,4'-[1,3]oxazol]-2'-amine	0.098	331	235	2	262	1	331	6.184E-07	196
LOKIASV2_0167_ESMFold_hypothetical_protein	5pep-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5pep-assembly1.cif.gz_A X-RAY ANALYSES OF ASPARTIC PROTEASES. II. THREE-DIMENSIONAL STRUCTURE OF THE HEXAGONAL CRYSTAL FORM OF PORCINE PEPSIN AT 2.3 ANGSTROMS RESOLUTION	0.113	321	229	4	262	2	322	7.252E-07	195
LOKIASV2_0167_ESMFold_hypothetical_protein	5nfg-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5nfg-assembly1.cif.gz_A Structure of recombinant cardosin B from Cynara cardunculus	0.122	323	227	3	262	7	329	2.506E-07	195
LOKIASV2_0167_ESMFold_hypothetical_protein	1j71-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1j71-assembly1.cif.gz_A Structure of the extracellular aspartic proteinase from Candida tropicalis yeast.	0.104	320	233	2	262	1	320	2.643E-07	195
LOKIASV2_0167_ESMFold_hypothetical_protein	1miq-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1miq-assembly1.cif.gz_A Crystal structure of proplasmepsin from the human malarial pathogen Plasmodium vivax	0.113	324	224	9	262	45	368	6.638E-08	195
LOKIASV2_0167_ESMFold_hypothetical_protein	4yct-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4yct-assembly1.cif.gz_A Endothiapepsin in complex with fragment 216	0.101	325	234	2	262	1	325	6.521E-07	194
LOKIASV2_0167_ESMFold_hypothetical_protein	2bks-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	2bks-assembly2.cif.gz_B crystal structure of Renin-PF00074777 complex	0.114	325	230	2	262	1	325	3.447E-07	193
LOKIASV2_0167_ESMFold_hypothetical_protein	2qzw-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	2qzw-assembly2.cif.gz_B Secreted aspartic proteinase (Sap) 1 from Candida albicans	0.110	326	231	2	262	1	326	2.787E-07	193
LOKIASV2_0167_ESMFold_hypothetical_protein	6kud-assembly1.cif.gz_A-2	LOKIASV2_0167_ESMFold_hypothetical_protein	6kud-assembly1.cif.gz_A-2 Crystal structure of Plasmodium falciparum histo-aspartic protease (HAP) zymogen (Form 3)	0.100	313	222	15	262	55	367	1.129E-07	193
LOKIASV2_0167_ESMFold_hypothetical_protein	5koq-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	5koq-assembly2.cif.gz_B Discovery of TAK-272: A Novel, Potent and Orally Active Renin In-hibitor	0.116	327	230	2	262	3	329	5.000E-07	192
LOKIASV2_0167_ESMFold_hypothetical_protein	2h6s-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	2h6s-assembly1.cif.gz_A Secreted aspartic proteinase (Sap) 3 from Candida albicans	0.108	325	232	2	262	1	325	6.638E-08	192
LOKIASV2_0167_ESMFold_hypothetical_protein	1tzs-assembly1.cif.gz_A-2	LOKIASV2_0167_ESMFold_hypothetical_protein	1tzs-assembly1.cif.gz_A-2 Crystal Structure of an activation intermediate of Cathepsin E	0.126	306	211	21	262	13	318	8.970E-07	191
LOKIASV2_0167_ESMFold_hypothetical_protein	8dsr-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	8dsr-assembly2.cif.gz_B Structure of Plasmepsin X (PM10, PMX) from Plasmodium falciparum 3D7 in complex with UCB7362	0.090	324	236	3	262	4	327	1.256E-07	191
LOKIASV2_0167_ESMFold_hypothetical_protein	5mlg-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5mlg-assembly1.cif.gz_A Crystal structure of rat prorenin	0.109	314	220	15	262	45	358	6.877E-07	191
LOKIASV2_0167_ESMFold_hypothetical_protein	4aa9-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4aa9-assembly1.cif.gz_A Camel chymosin at 1.6A resolution	0.120	303	212	21	262	7	309	3.268E-07	190
LOKIASV2_0167_ESMFold_hypothetical_protein	4rld-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4rld-assembly1.cif.gz_A Crystal structure of kkf mutant of bla G 2 protein	0.102	318	234	1	262	8	325	6.184E-07	190
LOKIASV2_0167_ESMFold_hypothetical_protein	3psg-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3psg-assembly1.cif.gz_A THE HIGH RESOLUTION CRYSTAL STRUCTURE OF PORCINE PEPSINOGEN	0.123	308	217	15	262	54	361	1.921E-07	190
LOKIASV2_0167_ESMFold_hypothetical_protein	3q6y-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3q6y-assembly1.cif.gz_A Endothiapepsin in complex with a pyrrolidine based inhibitor	0.113	302	231	2	262	1	302	3.635E-07	189
LOKIASV2_0167_ESMFold_hypothetical_protein	5mkt-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5mkt-assembly1.cif.gz_A Crystal structure of mouse prorenin	0.100	323	234	2	262	1	323	8.506E-07	185
LOKIASV2_0167_ESMFold_hypothetical_protein	4amt-assembly1.cif.gz_A-2	LOKIASV2_0167_ESMFold_hypothetical_protein	4amt-assembly1.cif.gz_A-2 Crystal structure at 2.6A of human prorenin	0.133	341	225	3	262	5	345	1.109E-06	185
LOKIASV2_0167_ESMFold_hypothetical_protein	1gvt-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1gvt-assembly1.cif.gz_A Endothiapepsin complex with CP-80,794	0.102	325	233	2	262	1	325	2.596E-06	184
LOKIASV2_0167_ESMFold_hypothetical_protein	3liz-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3liz-assembly1.cif.gz_A crystal structure of bla g 2 complexed with Fab 4C3	0.104	323	228	7	262	1	323	3.268E-07	184
LOKIASV2_0167_ESMFold_hypothetical_protein	3pvk-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3pvk-assembly1.cif.gz_A Secreted aspartic protease 2 in complex with benzamidine	0.100	316	235	1	262	1	316	6.877E-07	183
LOKIASV2_0167_ESMFold_hypothetical_protein	4ehc-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4ehc-assembly1.cif.gz_A Crystal structure of the C-terminal domain of Rv0977 of Mycobacterium tuberculosis	0.086	263	237	2	261	17	279	1.301E-06	182
LOKIASV2_0167_ESMFold_hypothetical_protein	3fnt-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3fnt-assembly1.cif.gz_A Crystal structure of pepstatin A bound histo-aspartic protease (HAP) from Plasmodium falciparum	0.111	319	231	2	262	1	319	8.970E-07	182
LOKIASV2_0167_ESMFold_hypothetical_protein	1wkr-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1wkr-assembly1.cif.gz_A Crystal structure of aspartic proteinase from Irpex lacteus	0.107	327	232	2	262	3	329	3.571E-06	182
LOKIASV2_0167_ESMFold_hypothetical_protein	7nkw-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	7nkw-assembly1.cif.gz_A Endothiapepsin structure obtained at 298K after a soaking with fragment JFD03909 from a dataset collected with JUNGFRAU detector	0.102	323	233	2	262	1	323	2.213E-06	181
LOKIASV2_0167_ESMFold_hypothetical_protein	1am5-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1am5-assembly1.cif.gz_A THE CRYSTAL STRUCTURE AND PROPOSED AMINO ACID SEQUENCE OF A PEPSIN FROM ATLANTIC COD (GADUS MORHUA)	0.107	319	230	5	262	2	320	6.521E-07	180
LOKIASV2_0167_ESMFold_hypothetical_protein	3vcm-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3vcm-assembly2.cif.gz_B Crystal structure of human prorenin	0.128	310	210	21	262	12	321	3.211E-06	179
LOKIASV2_0167_ESMFold_hypothetical_protein	1eag-assembly1.cif.gz_A-2	LOKIASV2_0167_ESMFold_hypothetical_protein	1eag-assembly1.cif.gz_A-2 Secreted aspartic proteinase (SAP2) from Candida albicans complexed with A70450	0.119	324	229	2	262	1	324	6.877E-07	179
LOKIASV2_0167_ESMFold_hypothetical_protein	1avf-assembly2.cif.gz_J	LOKIASV2_0167_ESMFold_hypothetical_protein	1avf-assembly2.cif.gz_J ACTIVATION INTERMEDIATE 2 OF HUMAN GASTRICSIN FROM HUMAN STOMACH	0.135	316	221	6	262	3	318	8.970E-07	178
LOKIASV2_0167_ESMFold_hypothetical_protein	3aup-assembly1.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	3aup-assembly1.cif.gz_C Crystal structure of Basic 7S globulin from soybean	0.093	358	237	1	262	2	359	4.826E-08	178
LOKIASV2_0167_ESMFold_hypothetical_protein	6kub-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	6kub-assembly1.cif.gz_A Crystal structure of Plasmodium falciparum histo-aspartic protease (HAP) zymogen (Form 1)	0.103	311	220	17	262	64	374	2.939E-07	178
LOKIASV2_0167_ESMFold_hypothetical_protein	4pph-assembly1.cif.gz_E	LOKIASV2_0167_ESMFold_hypothetical_protein	4pph-assembly1.cif.gz_E Crystal structure of conglutin gamma, a unique basic 7S globulin from lupine seeds	0.110	368	231	3	262	4	371	1.473E-07	178
LOKIASV2_0167_ESMFold_hypothetical_protein	3emy-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3emy-assembly1.cif.gz_A Crystal structure of Trichoderma reesei aspartic proteinase complexed with pepstatin A	0.104	326	233	2	262	1	326	9.292E-06	177
LOKIASV2_0167_ESMFold_hypothetical_protein	7tbc-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	7tbc-assembly1.cif.gz_A Crystal structure of Plasmepsin X from Plasmodium falciparum in complex with WM382	0.099	332	234	2	262	1	332	2.506E-07	175
LOKIASV2_0167_ESMFold_hypothetical_protein	7tbb-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	7tbb-assembly1.cif.gz_A Crystal structure of Plasmepsin X from Plasmodium falciparum	0.091	327	237	1	262	1	327	3.268E-07	174
LOKIASV2_0167_ESMFold_hypothetical_protein	2asi-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	2asi-assembly1.cif.gz_A ASPARTIC PROTEINASE	0.132	346	226	2	262	1	346	2.643E-07	174
LOKIASV2_0167_ESMFold_hypothetical_protein	1psa-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1psa-assembly1.cif.gz_A STRUCTURE OF A PEPSIN(SLASH)RENIN INHIBITOR COMPLEX REVEALS A NOVEL CRYSTAL PACKING INDUCED BY MINOR CHEMICAL ALTERATIONS IN THE INHIBITOR	0.120	322	230	1	262	1	322	3.045E-06	173
LOKIASV2_0167_ESMFold_hypothetical_protein	4bel-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	4bel-assembly2.cif.gz_B BACE2 XAPERONE COMPLEX	0.096	321	234	3	262	6	326	1.609E-06	173
LOKIASV2_0167_ESMFold_hypothetical_protein	1avf-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1avf-assembly1.cif.gz_A ACTIVATION INTERMEDIATE 2 OF HUMAN GASTRICSIN FROM HUMAN STOMACH	0.130	303	210	21	262	14	316	1.609E-06	172
LOKIASV2_0167_ESMFold_hypothetical_protein	7tbe-assembly4.cif.gz_D	LOKIASV2_0167_ESMFold_hypothetical_protein	7tbe-assembly4.cif.gz_D Crystal structure of Plasmepsin X from Plasmodium vivax in complex with WM4	0.083	329	238	3	263	9	337	1.990E-06	172
LOKIASV2_0167_ESMFold_hypothetical_protein	1zap-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1zap-assembly1.cif.gz_A SECRETED ASPARTIC PROTEASE FROM C. ALBICANS	0.116	326	230	2	262	1	326	3.571E-06	172
LOKIASV2_0167_ESMFold_hypothetical_protein	3kyr-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3kyr-assembly2.cif.gz_B Bace-1 in complex with a norstatine type inhibitor	0.087	330	236	3	262	6	335	3.833E-07	171
LOKIASV2_0167_ESMFold_hypothetical_protein	3tpl-assembly3.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	3tpl-assembly3.cif.gz_C APO Structure of BACE1	0.080	334	238	3	262	6	339	1.447E-06	171
LOKIASV2_0167_ESMFold_hypothetical_protein	4pph-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4pph-assembly1.cif.gz_A Crystal structure of conglutin gamma, a unique basic 7S globulin from lupine seeds	0.119	368	229	2	262	3	370	9.629E-08	171
LOKIASV2_0167_ESMFold_hypothetical_protein	5kr8-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5kr8-assembly1.cif.gz_A (4~{S},6~{S})-4-[2,4-bis(fluoranyl)phenyl]-6-(3,5-dimethyl-1,2-oxazol-4-yl)-4-methyl-5,6-dihydro-1,3-thiazin-2-amine (compound 5) bound to BACE1	0.076	324	239	3	262	5	328	3.045E-06	170
LOKIASV2_0167_ESMFold_hypothetical_protein	3qvi-assembly2.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3qvi-assembly2.cif.gz_A Crystal structure of KNI-10395 bound histo-aspartic protease (HAP) from Plasmodium falciparum	0.117	302	213	21	262	16	317	1.372E-06	169
LOKIASV2_0167_ESMFold_hypothetical_protein	3aup-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3aup-assembly1.cif.gz_B Crystal structure of Basic 7S globulin from soybean	0.093	352	237	1	262	2	353	3.833E-07	169
LOKIASV2_0167_ESMFold_hypothetical_protein	4ycy-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4ycy-assembly1.cif.gz_A Endothiapepsin in complex with fragment 218	0.102	320	233	2	262	1	320	7.124E-06	167
LOKIASV2_0167_ESMFold_hypothetical_protein	3hvg-assembly3.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	3hvg-assembly3.cif.gz_C Structure of bace (beta secretase) in Complex with EV0	0.085	335	237	3	262	8	342	1.887E-06	166
LOKIASV2_0167_ESMFold_hypothetical_protein	1odx-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1odx-assembly1.cif.gz_B HIV-1 Proteinase mutant A71T, V82A	0.186	90	67	21	110	10	92	3.446E-04	165
LOKIASV2_0167_ESMFold_hypothetical_protein	3aup-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3aup-assembly1.cif.gz_A Crystal structure of Basic 7S globulin from soybean	0.095	355	236	1	262	2	356	6.184E-07	165
LOKIASV2_0167_ESMFold_hypothetical_protein	2psg-assembly1.cif.gz_A-2	LOKIASV2_0167_ESMFold_hypothetical_protein	2psg-assembly1.cif.gz_A-2 REFINED STRUCTURE OF PORCINE PEPSINOGEN AT 1.8 ANGSTROMS RESOLUTION	0.122	311	215	17	262	56	366	1.887E-06	163
LOKIASV2_0167_ESMFold_hypothetical_protein	3vlb-assembly2.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	3vlb-assembly2.cif.gz_C Crystal structure of xeg-edgp	0.082	383	238	3	262	4	386	6.877E-07	163
LOKIASV2_0167_ESMFold_hypothetical_protein	1c6y-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1c6y-assembly1.cif.gz_B ALTERNATE BINDING SITE FOR THE P1-P3 GROUP OF A CLASS OF POTENT HIV-1 PROTEASE INHIBITORS AS A RESULT OF CONCERTED STRUCTURAL CHANGE IN 80'S LOOP.	0.186	90	67	21	110	10	92	7.646E-04	162
LOKIASV2_0167_ESMFold_hypothetical_protein	3aup-assembly1.cif.gz_D	LOKIASV2_0167_ESMFold_hypothetical_protein	3aup-assembly1.cif.gz_D Crystal structure of Basic 7S globulin from soybean	0.110	345	232	1	262	2	346	1.170E-06	162
LOKIASV2_0167_ESMFold_hypothetical_protein	3kyr-assembly3.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	3kyr-assembly3.cif.gz_C Bace-1 in complex with a norstatine type inhibitor	0.089	325	235	4	262	5	329	2.596E-06	162
LOKIASV2_0167_ESMFold_hypothetical_protein	3kyr-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3kyr-assembly1.cif.gz_A Bace-1 in complex with a norstatine type inhibitor	0.087	330	236	3	262	6	335	3.571E-06	162
LOKIASV2_0167_ESMFold_hypothetical_protein	6uj0-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	6uj0-assembly1.cif.gz_A Unbound BACE2 mutant structure	0.091	336	237	1	262	1	336	3.386E-06	162
LOKIASV2_0167_ESMFold_hypothetical_protein	3hw1-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3hw1-assembly1.cif.gz_A Structure of Bace (beta secretase) in complex with ligand EV2	0.091	333	235	3	262	7	339	1.990E-06	162
LOKIASV2_0167_ESMFold_hypothetical_protein	2zji-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	2zji-assembly1.cif.gz_A Crystal structure of the human BACE1 catalytic domain in complex with N-[1-(2,6-dimethoxy-benzyl)-piperidin-4-yl]-4-mercapto-butyramide	0.078	332	239	3	262	8	339	3.766E-06	162
LOKIASV2_0167_ESMFold_hypothetical_protein	4bfb-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4bfb-assembly1.cif.gz_A BACE2 XAPERONE COMPLEX	0.100	338	233	3	262	5	342	4.657E-06	162
LOKIASV2_0167_ESMFold_hypothetical_protein	1w51-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1w51-assembly1.cif.gz_A BACE (Beta Secretase) in complex with a nanomolar non-peptidic inhibitor	0.087	339	236	3	262	5	343	7.513E-06	162
LOKIASV2_0167_ESMFold_hypothetical_protein	5qd9-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	5qd9-assembly2.cif.gz_B Crystal structure of BACE complex with BMC005	0.084	341	237	3	262	6	346	2.334E-06	162
LOKIASV2_0167_ESMFold_hypothetical_protein	3vlb-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3vlb-assembly1.cif.gz_A Crystal structure of xeg-edgp	0.080	384	238	3	262	4	387	3.099E-07	162
LOKIASV2_0167_ESMFold_hypothetical_protein	4dh6-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4dh6-assembly1.cif.gz_A Structure of Bace-1 (Beta-Secretase) in Complex with (2R)-N-((2S,3R)-1-(benzo[d][1,3]dioxol-5-yl)-3-hydroxy-4-((S)-6'-neopentyl-3',4'-dihydrospiro[cyclobutane-1,2'-pyrano[2,3-b]pyridine]-4'-ylamino)butan-2-yl)-2-methoxypropanamide	0.092	332	235	3	262	5	336	2.099E-06	161
LOKIASV2_0167_ESMFold_hypothetical_protein	2wez-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	2wez-assembly1.cif.gz_A Human BACE-1 in complex with 1-ethyl-N-((1S,2R)-2-hydroxy-3-(((3-(methyloxy)phenyl)methyl)amino)-1-(phenylmethyl)propyl)-4-(2-oxo-1- pyrrolidinyl)-1H-indole-6-carboxamide	0.095	343	236	1	262	1	343	2.596E-06	161
LOKIASV2_0167_ESMFold_hypothetical_protein	4ivs-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4ivs-assembly1.cif.gz_A Crystal structure of BACE1 with its inhibitor	0.075	336	240	3	262	7	342	1.609E-06	161
LOKIASV2_0167_ESMFold_hypothetical_protein	3tpj-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3tpj-assembly1.cif.gz_A APO structure of BACE1	0.084	338	237	3	262	8	345	6.521E-07	161
LOKIASV2_0167_ESMFold_hypothetical_protein	2aof-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	2aof-assembly1.cif.gz_A Crystal structure analysis of HIV-1 Protease mutant V82A with a substrate analog P1-P6	0.197	90	66	21	110	10	92	5.862E-04	160
LOKIASV2_0167_ESMFold_hypothetical_protein	4k4r-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4k4r-assembly1.cif.gz_A TL-3 inhibited Trp6Ala HIV Protease with 1-bromo-2-napthoic acid bound in exosite	0.186	90	67	21	110	10	92	6.875E-04	160
LOKIASV2_0167_ESMFold_hypothetical_protein	2zjh-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	2zjh-assembly1.cif.gz_A Crystal structure of the human BACE1 catalytic domain in complex with N-(1-benzyl-piperidin-4-yl)-4-mercapto-butyramide	0.092	319	235	3	262	7	325	3.211E-06	160
LOKIASV2_0167_ESMFold_hypothetical_protein	6nv7-assembly3.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	6nv7-assembly3.cif.gz_C BACE1 in complex with a macrocyclic inhibitor	0.084	338	237	3	262	6	343	2.099E-06	160
LOKIASV2_0167_ESMFold_hypothetical_protein	4azy-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4azy-assembly1.cif.gz_A Design and Synthesis of BACE1 Inhibitors with In Vivo Brain Reduction of beta-Amyloid Peptides (COMPOUND 10)	0.088	339	236	3	262	7	345	4.188E-06	160
LOKIASV2_0167_ESMFold_hypothetical_protein	3em3-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3em3-assembly1.cif.gz_B Crystal structure of amprenavir (APV) in complex with a drug resistant HIV-1 protease variant (I50L/A71V).	0.208	90	65	21	110	10	92	6.519E-04	159
LOKIASV2_0167_ESMFold_hypothetical_protein	4rvi-assembly2.cif.gz_D	LOKIASV2_0167_ESMFold_hypothetical_protein	4rvi-assembly2.cif.gz_D Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with non-peptidic inhibitor, GRL0519	0.166	90	68	21	110	10	92	6.875E-04	159
LOKIASV2_0167_ESMFold_hypothetical_protein	5ie1-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5ie1-assembly1.cif.gz_A Crystal structure of BACE1 in complex with 3-(2-amino-6-(o-tolyl)quinolin-3-yl)-N-(3,3-dimethylbutyl)propanamide	0.087	326	236	3	262	5	330	3.971E-06	159
LOKIASV2_0167_ESMFold_hypothetical_protein	7dcz-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	7dcz-assembly1.cif.gz_A Crystal Structure of BACE1 in complex with N-{3-[(4S)-2-amino-4-methyl-4H-1,3-thiazin-4-yl]-4- fluorophenyl}-5-cyanopyridine-2-carboxamide	0.095	341	234	3	262	8	348	5.760E-06	159
LOKIASV2_0167_ESMFold_hypothetical_protein	1k1t-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1k1t-assembly1.cif.gz_B Combining Mutations in HIV-1 Protease to Understand Mechanisms of Resistance	0.200	90	66	21	110	10	92	8.967E-04	158
LOKIASV2_0167_ESMFold_hypothetical_protein	3tkg-assembly2.cif.gz_D	LOKIASV2_0167_ESMFold_hypothetical_protein	3tkg-assembly2.cif.gz_D crystal structure of HIV model protease precursor/saquinavir complex	0.200	90	66	21	110	10	92	8.503E-04	158
LOKIASV2_0167_ESMFold_hypothetical_protein	3vv7-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3vv7-assembly1.cif.gz_A Crystal Structure of beta secetase in complex with 2-amino-6-((1S,2R)-2-(3'-methoxybiphenyl-3-yl)cyclopropyl)-3-methylpyrimidin-4(3H)-one	0.086	325	236	4	262	6	330	3.571E-06	158
LOKIASV2_0167_ESMFold_hypothetical_protein	4frk-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4frk-assembly1.cif.gz_A Crystal structure of BACE1 in complex with aminooxazoline xanthene 11a	0.086	334	237	3	262	5	338	6.406E-06	158
LOKIASV2_0167_ESMFold_hypothetical_protein	5dqc-assembly3.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	5dqc-assembly3.cif.gz_C Co-crystal of BACE1 with compound 0211	0.087	336	236	3	262	7	342	3.386E-06	158
LOKIASV2_0167_ESMFold_hypothetical_protein	3msj-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3msj-assembly1.cif.gz_A Structure of bace (beta secretase) in complex with inhibitor	0.079	336	239	3	262	7	342	2.887E-06	158
LOKIASV2_0167_ESMFold_hypothetical_protein	5qd0-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5qd0-assembly1.cif.gz_A Crystal structure of BACE complex withBMC006	0.084	338	237	3	262	6	343	5.179E-06	158
LOKIASV2_0167_ESMFold_hypothetical_protein	3n4l-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3n4l-assembly1.cif.gz_A BACE-1 in complex with ELN380842	0.086	339	236	4	262	5	343	1.447E-06	158
LOKIASV2_0167_ESMFold_hypothetical_protein	4d8c-assembly3.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	4d8c-assembly3.cif.gz_C Crystal Structure of Human Beta Secretase in Complex with NVP-BXD552, derived from a co-crystallization experiment	0.093	347	235	3	262	6	352	1.447E-06	158
LOKIASV2_0167_ESMFold_hypothetical_protein	3rvi-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3rvi-assembly1.cif.gz_A Structure of Bace-1 (Beta-Secretase) in Complex with 2-((2-Amino-6-o-tolylquinolin-3-yl)methyl)-N-(cyclohexylmethyl)pentanamide	0.081	334	238	3	262	5	338	9.799E-06	157
LOKIASV2_0167_ESMFold_hypothetical_protein	4d85-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4d85-assembly1.cif.gz_A Crystal Structure of Human Beta Secretase in Complex with NVP-BVI151	0.086	337	237	3	262	7	343	3.045E-06	157
LOKIASV2_0167_ESMFold_hypothetical_protein	4dqb-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	4dqb-assembly1.cif.gz_B Crystal Structure of wild-type HIV-1 Protease in Complex with DRV	0.219	90	64	21	110	10	92	6.182E-04	156
LOKIASV2_0167_ESMFold_hypothetical_protein	2p3b-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	2p3b-assembly1.cif.gz_B Crystal Structure of the subtype B wild type HIV protease complexed with TL-3 inhibitor	0.191	90	66	21	110	10	92	4.739E-04	156
LOKIASV2_0167_ESMFold_hypothetical_protein	4qj7-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	4qj7-assembly1.cif.gz_B Crystal structure of inactive HIV-1 protease variant (I50V/A71V) in complex with p1-p6 substrate variant (R452S)	0.197	90	66	21	110	10	92	9.972E-04	156
LOKIASV2_0167_ESMFold_hypothetical_protein	4dus-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4dus-assembly1.cif.gz_A Structure of Bace-1 (Beta-Secretase) in complex with N-((2S,3R)-1-(4-fluorophenyl)-3-hydroxy-4-((6'-neopentyl-3',4'-dihydrospiro[cyclobutane-1,2'-pyrano[2,3-b]pyridin]-4'-yl)amino)butan-2-yl)acetamide	0.080	330	238	3	262	5	334	7.513E-06	156
LOKIASV2_0167_ESMFold_hypothetical_protein	2zjn-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	2zjn-assembly1.cif.gz_A Crystal structure of the human BACE1 catalytic domain in complex with N-[1-(5-chloro-2-isopropoxy-3-methoxy-benzyl)-piperidin-4-yl]-2-(2-methyl-4-sulfamoyl-phenoxy)-acetamide	0.093	331	234	4	262	6	336	1.887E-06	156
LOKIASV2_0167_ESMFold_hypothetical_protein	3lhg-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3lhg-assembly1.cif.gz_A Bace1 in complex with the aminohydantoin Compound 4g	0.100	337	233	3	262	6	342	2.334E-06	156
LOKIASV2_0167_ESMFold_hypothetical_protein	6jt4-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	6jt4-assembly1.cif.gz_A Crystal Structure of BACE1 in complex with N-{3-[(4S,6S)-2-amino-4-methyl-6-(trifluoromethyl)-5,6-dihydro-4H-1,3-thiazin-4-yl]-4-fluorophenyl}-5-(fluoromethoxy)pyrazine-2-carboxamide	0.082	333	238	3	262	7	339	1.149E-05	156
LOKIASV2_0167_ESMFold_hypothetical_protein	5dqc-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5dqc-assembly1.cif.gz_A Co-crystal of BACE1 with compound 0211	0.097	336	234	3	262	6	341	3.211E-06	156
LOKIASV2_0167_ESMFold_hypothetical_protein	4fgx-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4fgx-assembly1.cif.gz_A Crystal structure of bace1 with novel inhibitor	0.075	337	240	3	262	6	342	1.790E-06	156
LOKIASV2_0167_ESMFold_hypothetical_protein	6e3z-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	6e3z-assembly1.cif.gz_A Structure of Bace-1 in complex with Ligand 8	0.087	340	236	3	262	8	347	2.887E-06	156
LOKIASV2_0167_ESMFold_hypothetical_protein	3oxx-assembly2.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	3oxx-assembly2.cif.gz_C Crystal Structure of HIV-1 I50V, A71V Protease in Complex with the Protease Inhibitor Atazanavir	0.188	90	67	21	110	10	92	8.503E-04	155
LOKIASV2_0167_ESMFold_hypothetical_protein	2qd6-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	2qd6-assembly1.cif.gz_A HIV-1 Protease Mutant I50V with potent Antiviral inhibitor GRL-98065	0.197	90	66	21	110	10	92	8.063E-04	155
LOKIASV2_0167_ESMFold_hypothetical_protein	3s43-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3s43-assembly1.cif.gz_A HIV-1 protease triple mutants V32I, I47V, V82I with antiviral drug amprenavir	0.197	90	66	21	110	10	92	8.503E-04	155
LOKIASV2_0167_ESMFold_hypothetical_protein	1mpp-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1mpp-assembly1.cif.gz_A X-RAY ANALYSES OF ASPARTIC PROTEINASES. V. STRUCTURE AND REFINEMENT AT 2.0 ANGSTROMS RESOLUTION OF THE ASPARTIC PROTEINASE FROM MUCOR PUSILLUS	0.106	347	232	2	262	1	347	4.657E-06	155
LOKIASV2_0167_ESMFold_hypothetical_protein	3zl7-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3zl7-assembly1.cif.gz_A BACE2 FYNOMER COMPLEX	0.088	332	237	2	262	1	332	6.406E-06	155
LOKIASV2_0167_ESMFold_hypothetical_protein	3dm6-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3dm6-assembly2.cif.gz_B Beta-secretase 1 complexed with statine-based inhibitor	0.096	335	234	3	262	6	340	1.790E-06	155
LOKIASV2_0167_ESMFold_hypothetical_protein	3exo-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3exo-assembly1.cif.gz_A Crystal structure of BACE1 bound to inhibitor	0.086	336	237	3	262	7	342	3.045E-06	155
LOKIASV2_0167_ESMFold_hypothetical_protein	5ezx-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5ezx-assembly1.cif.gz_A CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH {(1R,2R)-2-[(R)-2-Amino-4-(4-difluoromethoxy-phenyl)-4,5-dihydro-oxazol-4-yl]-cyclopropyl}-(5-chloro-pyridin-3-yl)-methanone	0.086	336	237	3	262	8	343	8.811E-06	155
LOKIASV2_0167_ESMFold_hypothetical_protein	3n4l-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3n4l-assembly2.cif.gz_B BACE-1 in complex with ELN380842	0.086	338	236	4	262	5	342	8.506E-07	155
LOKIASV2_0167_ESMFold_hypothetical_protein	3ekq-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3ekq-assembly1.cif.gz_B Crystal structure of inhibitor saquinavir (SQV) in complex with multi-drug resistant HIV-1 protease (L63P/V82T/I84V) (referred to as ACT in paper)	0.197	90	66	21	110	10	92	1.052E-03	154
LOKIASV2_0167_ESMFold_hypothetical_protein	2rmp-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	2rmp-assembly1.cif.gz_A RMP-pepstatin A complex	0.126	346	226	3	262	3	348	5.179E-06	154
LOKIASV2_0167_ESMFold_hypothetical_protein	3vv6-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3vv6-assembly1.cif.gz_A Crystal Structure of beta secetase in complex with 2-amino-3-methyl-6-((1S, 2R)-2-phenylcyclopropyl)pyrimidin-4(3H)-one	0.082	323	238	3	262	7	329	7.513E-06	154
LOKIASV2_0167_ESMFold_hypothetical_protein	6nv7-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	6nv7-assembly2.cif.gz_B BACE1 in complex with a macrocyclic inhibitor	0.086	332	237	3	262	7	338	3.971E-06	154
LOKIASV2_0167_ESMFold_hypothetical_protein	4k8s-assembly3.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	4k8s-assembly3.cif.gz_C Hydroxyethylamine-based inhibitors of BACE1: P1-P3 macrocyclization can improve potency, selectivity, and cell activity	0.086	335	237	3	262	6	340	5.462E-06	154
LOKIASV2_0167_ESMFold_hypothetical_protein	6nv9-assembly3.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	6nv9-assembly3.cif.gz_C BACE1 in complex with a macrocyclic inhibitor	0.093	336	235	3	262	5	340	6.756E-06	154
LOKIASV2_0167_ESMFold_hypothetical_protein	3veu-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3veu-assembly1.cif.gz_A Crystal Structure of Human Beta Secretase in Complex with NVP-AVI326	0.091	343	235	3	262	6	348	4.657E-06	154
LOKIASV2_0167_ESMFold_hypothetical_protein	3nu4-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3nu4-assembly1.cif.gz_A Crystal Structure of HIV-1 Protease Mutant V32I with Antiviral Drug Amprenavir	0.197	90	66	21	110	10	92	9.972E-04	153
LOKIASV2_0167_ESMFold_hypothetical_protein	4rce-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4rce-assembly1.cif.gz_A Crystal structure of BACE1 in complex with aminooxazoline xanthene inhibitor 2	0.088	329	236	3	262	5	333	7.923E-06	153
LOKIASV2_0167_ESMFold_hypothetical_protein	5qdc-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5qdc-assembly1.cif.gz_A Crystal structure of BACE complex with BMC019 hydrolyzed	0.089	333	236	3	262	6	338	5.760E-06	153
LOKIASV2_0167_ESMFold_hypothetical_protein	6ej3-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	6ej3-assembly1.cif.gz_A BACE1 compound 23	0.097	335	236	1	262	1	335	1.348E-05	153
LOKIASV2_0167_ESMFold_hypothetical_protein	2zjk-assembly3.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	2zjk-assembly3.cif.gz_C Crystal structure of the human BACE1 catalytic domain in complex with 4-(4-fluoro-benzyl)-piperazine-2-carboxylic acid(3-mercapto-propyl)-amide	0.081	333	238	3	262	8	340	1.149E-05	153
LOKIASV2_0167_ESMFold_hypothetical_protein	5qcq-assembly3.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	5qcq-assembly3.cif.gz_C Crystal structure of BACE complex with BMC025	0.087	340	236	3	262	6	345	7.923E-06	153
LOKIASV2_0167_ESMFold_hypothetical_protein	6dhc-assembly3.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	6dhc-assembly3.cif.gz_C X-ray structure of BACE1 in complex with a bicyclic isoxazoline carboxamide as the P3 ligand	0.095	340	234	3	262	7	346	4.416E-06	153
LOKIASV2_0167_ESMFold_hypothetical_protein	4hzt-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4hzt-assembly1.cif.gz_A Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the catalytic aspartates	0.111	342	230	3	262	7	348	1.697E-06	153
LOKIASV2_0167_ESMFold_hypothetical_protein	5qcq-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5qcq-assembly1.cif.gz_A Crystal structure of BACE complex with BMC025	0.089	334	236	3	262	6	339	6.075E-06	152
LOKIASV2_0167_ESMFold_hypothetical_protein	4rcf-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4rcf-assembly1.cif.gz_A Crystal structure of BACE1 in complex with 2-aminooxazoline 4-fluoroxanthene inhibitor 49	0.090	334	236	3	262	5	338	1.348E-05	152
LOKIASV2_0167_ESMFold_hypothetical_protein	5qd0-assembly3.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	5qd0-assembly3.cif.gz_C Crystal structure of BACE complex withBMC006	0.090	341	236	3	262	6	346	7.513E-06	152
LOKIASV2_0167_ESMFold_hypothetical_protein	6od6-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	6od6-assembly1.cif.gz_A Structure of BACE-1 in complex with Ligand 13	0.089	338	236	3	262	9	346	4.911E-06	152
LOKIASV2_0167_ESMFold_hypothetical_protein	3bva-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3bva-assembly1.cif.gz_A Cystal structure of HIV-1 Active Site Mutant D25N and p2-NC analog inhibitor	0.186	90	67	21	110	10	92	1.233E-03	151
LOKIASV2_0167_ESMFold_hypothetical_protein	3d20-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3d20-assembly1.cif.gz_A Crystal structure of HIV-1 mutant I54V and inhibitor DARUNAVIA	0.186	90	67	21	110	10	92	1.109E-03	151
LOKIASV2_0167_ESMFold_hypothetical_protein	1ff0-assembly1.cif.gz_D	LOKIASV2_0167_ESMFold_hypothetical_protein	1ff0-assembly1.cif.gz_D STRUCTURAL IMPLICATIONS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE: HIGH RESOLUTION CRYSTAL STRUCTURES OF THE MUTANT PROTEASE/SUBSTRATE ANALOG COMPLEXES.	0.200	90	66	21	110	10	92	1.696E-03	151
LOKIASV2_0167_ESMFold_hypothetical_protein	4m8x-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4m8x-assembly1.cif.gz_A GS-8374, a Novel Phosphonate-Containing Inhibitor of HIV-1 Protease, Effectively Inhibits HIV PR Mutants with Amino Acid Insertions	0.180	90	67	21	110	10	92	5.271E-04	151
LOKIASV2_0167_ESMFold_hypothetical_protein	1tcw-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1tcw-assembly1.cif.gz_B SIV PROTEASE COMPLEXED WITH INHIBITOR SB203386	0.188	90	67	21	110	10	92	1.233E-03	151
LOKIASV2_0167_ESMFold_hypothetical_protein	3vfb-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3vfb-assembly1.cif.gz_B Crystal Structure of HIV-1 Protease Mutant N88D with novel P1'-Ligands GRL-02031	0.218	86	61	21	106	10	88	1.109E-03	151
LOKIASV2_0167_ESMFold_hypothetical_protein	2zjk-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	2zjk-assembly2.cif.gz_B Crystal structure of the human BACE1 catalytic domain in complex with 4-(4-fluoro-benzyl)-piperazine-2-carboxylic acid(3-mercapto-propyl)-amide	0.095	332	234	3	262	7	338	1.090E-05	151
LOKIASV2_0167_ESMFold_hypothetical_protein	5mxd-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	5mxd-assembly2.cif.gz_B BACE-1 IN COMPLEX WITH LIGAND 32397778	0.095	322	219	20	262	18	339	7.923E-06	151
LOKIASV2_0167_ESMFold_hypothetical_protein	2xfk-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	2xfk-assembly1.cif.gz_A Human BACE-1 in complex with N-((1S,2R)-3-(((1S)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-3-(ethylamino)-5-((methylsulfonyl)(phenyl)amino)benzamide	0.096	340	236	1	262	1	340	8.355E-06	151
LOKIASV2_0167_ESMFold_hypothetical_protein	3nsh-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3nsh-assembly1.cif.gz_A BACE-1 in complex with ELN475957	0.105	336	232	3	262	6	341	2.462E-06	151
LOKIASV2_0167_ESMFold_hypothetical_protein	4i12-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4i12-assembly1.cif.gz_A Design and synthesis of thiophene dihydroisoquinolins as novel BACE-1 inhibitors	0.079	334	239	2	262	1	334	5.462E-06	151
LOKIASV2_0167_ESMFold_hypothetical_protein	2va7-assembly1.cif.gz_A-2	LOKIASV2_0167_ESMFold_hypothetical_protein	2va7-assembly1.cif.gz_A-2 X-ray crystal structure of beta secretase complexed with compound 27	0.083	340	236	5	262	4	343	7.513E-06	151
LOKIASV2_0167_ESMFold_hypothetical_protein	4j1f-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4j1f-assembly1.cif.gz_A CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4S,6S)-2-amino-4-methyl-6-trifluoromethyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide	0.091	338	235	3	262	8	345	1.149E-05	151
LOKIASV2_0167_ESMFold_hypothetical_protein	4lxk-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	4lxk-assembly2.cif.gz_B Crystal Structure of Human Beta Secretase in Complex with compound 11d	0.091	342	235	3	262	6	347	5.462E-06	151
LOKIASV2_0167_ESMFold_hypothetical_protein	2fxe-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	2fxe-assembly1.cif.gz_B X-ray crystal structure of HIV-1 protease CRM mutant complexed with atazanavir (BMS-232632)	0.200	90	66	21	110	10	92	1.696E-03	150
LOKIASV2_0167_ESMFold_hypothetical_protein	2fdp-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	2fdp-assembly2.cif.gz_B Crystal structure of beta-secretase complexed with an amino-ethylene inhibitor	0.089	333	236	3	262	6	338	6.756E-06	150
LOKIASV2_0167_ESMFold_hypothetical_protein	4zpe-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4zpe-assembly1.cif.gz_A BACE1 in complex with 4-(cyclohexylamino)-1-(3-fluorophenyl)-8-(3-isopropoxybenzyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one	0.083	335	238	3	262	7	341	7.513E-06	150
LOKIASV2_0167_ESMFold_hypothetical_protein	4zpg-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4zpg-assembly1.cif.gz_A BACE1 in complex with 8-benzyl-4-(cyclohexylamino)-1-(3-fluorophenyl)-7-methyl-1,3,8-triazaspiro[4.5]dec-3-en-2-one	0.073	335	240	3	262	7	341	3.971E-06	150
LOKIASV2_0167_ESMFold_hypothetical_protein	2zdz-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	2zdz-assembly1.cif.gz_A X-ray structure of Bace-1 in complex with compound 3.b.10	0.100	336	233	3	262	6	341	8.811E-06	150
LOKIASV2_0167_ESMFold_hypothetical_protein	4b05-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4b05-assembly1.cif.gz_A Preclinical characterization of AZD3839, a novel clinical candidate BACE1 inhibitor for the treatment of Alzheimer Disease	0.096	337	234	3	262	8	344	5.462E-06	150
LOKIASV2_0167_ESMFold_hypothetical_protein	4bfd-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4bfd-assembly1.cif.gz_A CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH CHEMICAL LIGAND	0.084	334	237	3	262	8	341	5.179E-06	150
LOKIASV2_0167_ESMFold_hypothetical_protein	2vnn-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	2vnn-assembly1.cif.gz_A Human BACE-1 in complex with 7-ethyl-N-((1S,2R)-2-hydroxy-1-(phenylmethyl)-3-(((3-(trifluoromethyl)phenyl)methyl)amino)propyl)-1- methyl-3,4-dihydro-1H-(1,2,5)thiadiazepino(3,4,5-hi)indole-9- carboxamide 2,2-dioxide	0.083	343	239	1	262	1	343	6.756E-06	150
LOKIASV2_0167_ESMFold_hypothetical_protein	3uqr-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3uqr-assembly1.cif.gz_A Crystal structure of BACE1 with its inhibitor	0.089	340	236	3	262	6	345	1.212E-05	150
LOKIASV2_0167_ESMFold_hypothetical_protein	3udk-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3udk-assembly1.cif.gz_A Crystal Structure of BACE with Compound 6	0.085	346	237	3	262	5	350	3.971E-06	150
LOKIASV2_0167_ESMFold_hypothetical_protein	2r43-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	2r43-assembly1.cif.gz_B I50V HIV-1 protease in complex with an amino decorated pyrrolidine-based inhibitor	0.186	90	67	21	110	10	92	1.696E-03	149
LOKIASV2_0167_ESMFold_hypothetical_protein	3ttp-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3ttp-assembly1.cif.gz_B Structure of multiresistant HIV-1 protease in complex with darunavir	0.200	90	66	21	110	10	92	1.233E-03	149
LOKIASV2_0167_ESMFold_hypothetical_protein	5ufz-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	5ufz-assembly1.cif.gz_B HIV-1 Protease complexed with Inhibitor: (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl [(1S,2S)-1-(1-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}cyclopropyl)-1-hydroxy-3-phenylpropan-2-yl]carbamate	0.186	90	67	21	110	10	92	1.696E-03	149
LOKIASV2_0167_ESMFold_hypothetical_protein	7d5a-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	7d5a-assembly1.cif.gz_A Crystal Structure of BACE1 in complex with N-{3-[(9S)-7-amino-2,2-difluoro-9-(prop-1-yn-1-yl)-6-oxa-8-azaspiro[3.5]non-7-en-9-yl]-4-fluorophenyl}-5-cyanopyridine-2-carboxamide	0.077	328	239	3	262	7	334	1.758E-05	149
LOKIASV2_0167_ESMFold_hypothetical_protein	3zki-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3zki-assembly1.cif.gz_A BACE2 MUTANT STRUCTURE WITH LIGAND	0.094	329	235	3	262	6	334	1.090E-05	149
LOKIASV2_0167_ESMFold_hypothetical_protein	7n4n-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	7n4n-assembly1.cif.gz_A BACE-2 in complex with ligand 36	0.092	328	235	3	262	7	334	1.667E-05	149
LOKIASV2_0167_ESMFold_hypothetical_protein	3hw1-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3hw1-assembly2.cif.gz_B Structure of Bace (beta secretase) in complex with ligand EV2	0.101	333	233	3	262	8	340	6.756E-06	149
LOKIASV2_0167_ESMFold_hypothetical_protein	1d4s-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1d4s-assembly1.cif.gz_B HIV-1 PROTEASE V82F/I84V DOUBLE MUTANT/TIPRANAVIR COMPLEX	0.175	90	68	21	110	10	92	1.696E-03	148
LOKIASV2_0167_ESMFold_hypothetical_protein	4heg-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	4heg-assembly1.cif.gz_B Crystal Structure of HIV-1 protease mutants R8Q complexed with inhibitor GRL-0519	0.197	90	66	21	110	10	92	1.372E-03	148
LOKIASV2_0167_ESMFold_hypothetical_protein	3dm6-assembly3.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	3dm6-assembly3.cif.gz_C Beta-secretase 1 complexed with statine-based inhibitor	0.093	336	235	3	262	6	341	7.923E-06	148
LOKIASV2_0167_ESMFold_hypothetical_protein	6uj1-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	6uj1-assembly1.cif.gz_A BACE2 mutant in complex with a macrocyclic compound	0.091	336	235	3	262	4	339	1.149E-05	148
LOKIASV2_0167_ESMFold_hypothetical_protein	2qu3-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	2qu3-assembly1.cif.gz_A BACE1 with Compound 2	0.081	335	238	3	262	5	339	9.799E-06	148
LOKIASV2_0167_ESMFold_hypothetical_protein	2vij-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	2vij-assembly1.cif.gz_A Human BACE-1 in complex with 3-(1,1-dioxidotetrahydro-2H-1,2-thiazin- 2-yl)-5-(ethylamino)-N-((1S,2R)-2-hydroxy-1-(phenylmethyl)-3-(1,2,3,4- tetrahydro-1-naphthalenylamino)propyl)benzamide	0.089	342	238	1	262	1	342	1.278E-05	148
LOKIASV2_0167_ESMFold_hypothetical_protein	4bfb-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	4bfb-assembly2.cif.gz_B BACE2 XAPERONE COMPLEX	0.096	338	233	4	262	6	343	9.292E-06	148
LOKIASV2_0167_ESMFold_hypothetical_protein	5tol-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5tol-assembly1.cif.gz_A CRYSTAL STRUCTURE OF BETA-SITE APP-CLEAVING ENZYME 1 COMPLEXED WITH N-(3-((4AS,7AS)-2-AMINO-4,4A,5,6-TETRAHYDRO-7AH-FURO[2,3-D][1,3]THIAZIN-7A-YL)-4-FLUOROPHENYL)-5-BROMO-2-PYRIDINECARBOXAMIDE	0.074	338	239	4	262	6	343	2.293E-05	148
LOKIASV2_0167_ESMFold_hypothetical_protein	3uqp-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3uqp-assembly1.cif.gz_A Crystal structure of Bace1 with its inhibitor	0.079	337	239	3	262	7	343	3.211E-06	148
LOKIASV2_0167_ESMFold_hypothetical_protein	4pzx-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4pzx-assembly1.cif.gz_A Synthesis, Characterization and PK/PD Studies of a Series of Spirocyclic Pyranochromene BACE1 Inhibitors	0.094	349	235	3	262	8	356	3.571E-06	148
LOKIASV2_0167_ESMFold_hypothetical_protein	1a94-assembly2.cif.gz_E	LOKIASV2_0167_ESMFold_hypothetical_protein	1a94-assembly2.cif.gz_E STRUCTURAL BASIS FOR SPECIFICITY OF RETROVIRAL PROTEASES	0.211	86	62	21	106	10	88	7.646E-04	147
LOKIASV2_0167_ESMFold_hypothetical_protein	4q1y-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	4q1y-assembly1.cif.gz_B Mutations Outside the Active Site of HIV-1 Protease Alter Enzyme Structure and Dynamic Ensemble of the Active Site to Confer Drug Resistance	0.208	90	65	21	110	10	92	1.887E-03	147
LOKIASV2_0167_ESMFold_hypothetical_protein	4rvx-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4rvx-assembly1.cif.gz_A Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with non-peptidic inhibitor, GRL079	0.170	90	68	21	110	10	92	8.503E-04	147
LOKIASV2_0167_ESMFold_hypothetical_protein	3zkg-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3zkg-assembly2.cif.gz_B BACE2 MUTANT APO STRUCTURE	0.096	314	219	20	262	15	328	1.348E-05	147
LOKIASV2_0167_ESMFold_hypothetical_protein	2ph8-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	2ph8-assembly1.cif.gz_A Crystal Structure of Human Beta Secretase Complexed with inhibitor	0.082	334	236	5	262	6	339	2.689E-05	147
LOKIASV2_0167_ESMFold_hypothetical_protein	4b0q-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4b0q-assembly1.cif.gz_A Lead Generation of BACE1 Inhibitors by Coupling Non-amidine New Warheads to a Known Binding Scaffold	0.093	341	237	1	262	1	341	7.923E-06	147
LOKIASV2_0167_ESMFold_hypothetical_protein	2zjj-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	2zjj-assembly1.cif.gz_A Crystal structure of the human BACE1 catalytic domain in complex with 4-(4-fluoro-benzyl)-piperazine-2-carboxylic acid (2-mercapto-ethyl)-amide	0.081	333	238	3	262	7	339	1.348E-05	147
LOKIASV2_0167_ESMFold_hypothetical_protein	3zlq-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3zlq-assembly1.cif.gz_B BACE2 XAPERONE COMPLEX	0.096	324	219	20	262	16	339	6.406E-06	147
LOKIASV2_0167_ESMFold_hypothetical_protein	4l7g-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4l7g-assembly1.cif.gz_A Diethylaminosulfur Trifluoride-Mediated Intramolecular Cyclization of 2-hydroxy-benzylureas to Fused Bicyclic Aminooxazoline Compounds and Evaluation of Their Biochemical Activity Against Beta-Secretase-1 (BACE1)	0.092	341	235	3	262	5	345	8.811E-06	147
LOKIASV2_0167_ESMFold_hypothetical_protein	5qct-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5qct-assembly1.cif.gz_A Crystal structure of BACE complex with BMC001	0.101	345	233	3	262	6	350	4.188E-06	147
LOKIASV2_0167_ESMFold_hypothetical_protein	3ivi-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3ivi-assembly1.cif.gz_A Design and Synthesis of Potent BACE-1 Inhibitors with Cellular Activity: Structure-Activity Relationship of P1 Substituents	0.089	345	236	3	262	6	350	6.756E-06	147
LOKIASV2_0167_ESMFold_hypothetical_protein	2j9k-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	2j9k-assembly1.cif.gz_B Atomic-resolution Crystal Structure of Chemically-Synthesized HIV-1 Protease Complexed with Inhibitor MVT-101	0.220	86	59	21	106	10	86	1.609E-03	146
LOKIASV2_0167_ESMFold_hypothetical_protein	1sip-assembly1.cif.gz_A-2	LOKIASV2_0167_ESMFold_hypothetical_protein	1sip-assembly1.cif.gz_A-2 ALTERNATIVE NATIVE FLAP CONFORMATION REVEALED BY 2.3 ANGSTROMS RESOLUTION STRUCTURE OF SIV PROTEINASE	0.214	84	60	21	104	10	86	1.301E-03	146
LOKIASV2_0167_ESMFold_hypothetical_protein	4ke1-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4ke1-assembly1.cif.gz_A Crystal structure of BACE1 in complex with hydroxyethylamine-macrocyclic inhibitor 19	0.107	320	231	3	262	5	324	7.923E-06	146
LOKIASV2_0167_ESMFold_hypothetical_protein	6jsz-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	6jsz-assembly1.cif.gz_A BACE2 xaperone complex with N-{3-[(5R)-3-amino-5-methyl-9,9-dioxo-2,9lambda6-dithia-4-azaspiro[5.5]undec-3-en-5-yl]-4-fluorophenyl}-5-(fluoromethoxy)pyrazine-2-carboxamide	0.097	316	219	20	262	16	331	1.212E-05	146
LOKIASV2_0167_ESMFold_hypothetical_protein	3fkt-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3fkt-assembly1.cif.gz_A Crystal Structure of Human Beta Secretase Complexed with Spiropiperdine Iminohydantoin Inhibitor	0.077	335	239	3	262	7	341	8.355E-06	146
LOKIASV2_0167_ESMFold_hypothetical_protein	4rcd-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4rcd-assembly1.cif.gz_A Crystal structure of BACE1 in complex with a 2-aminooxazoline 4-azaxanthene inhibitor	0.094	333	235	3	262	5	337	1.499E-05	146
LOKIASV2_0167_ESMFold_hypothetical_protein	1t6g-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1t6g-assembly1.cif.gz_A Crystal structure of the Triticum aestivum xylanase inhibitor-I in complex with aspergillus niger xylanase-I	0.094	356	236	2	262	1	356	9.799E-06	146
LOKIASV2_0167_ESMFold_hypothetical_protein	5v0n-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5v0n-assembly1.cif.gz_A BACE1 in complex with inhibitor 5g	0.082	336	238	3	262	5	340	1.667E-05	146
LOKIASV2_0167_ESMFold_hypothetical_protein	4acu-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4acu-assembly1.cif.gz_A Aminoimidazoles as BACE-1 Inhibitors. X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 14	0.088	338	236	3	262	7	344	1.758E-05	146
LOKIASV2_0167_ESMFold_hypothetical_protein	4rrs-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4rrs-assembly1.cif.gz_A 8-Tetrahydropyran-2-yl chromans: highly selective beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors	0.094	345	235	3	262	5	349	4.657E-06	146
LOKIASV2_0167_ESMFold_hypothetical_protein	2aqu-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	2aqu-assembly1.cif.gz_A Structure of HIV-1 protease bound to atazanavir	0.191	90	66	21	110	10	92	9.972E-04	145
LOKIASV2_0167_ESMFold_hypothetical_protein	1izi-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1izi-assembly1.cif.gz_B Inhibitor of HIV protease with unusual binding mode potently inhibiting multi-resistant protease mutants	0.172	90	68	21	110	10	92	9.972E-04	145
LOKIASV2_0167_ESMFold_hypothetical_protein	4bel-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4bel-assembly1.cif.gz_A BACE2 XAPERONE COMPLEX	0.101	311	218	20	262	17	327	1.278E-05	145
LOKIASV2_0167_ESMFold_hypothetical_protein	3ine-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3ine-assembly1.cif.gz_A Bace1 with the aminohydantoin Compound S-34	0.098	333	234	3	262	6	338	8.811E-06	145
LOKIASV2_0167_ESMFold_hypothetical_protein	4k9h-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	4k9h-assembly2.cif.gz_B Bace-1 inhibitor complex	0.089	333	236	3	262	6	338	1.581E-05	145
LOKIASV2_0167_ESMFold_hypothetical_protein	3u6a-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3u6a-assembly1.cif.gz_A Rational Design and Synthesis of Aminopiperazinones as Beta Secretase (BACE) Inhibitors	0.094	338	235	3	262	6	343	1.033E-05	145
LOKIASV2_0167_ESMFold_hypothetical_protein	4di2-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	4di2-assembly2.cif.gz_B Crystal structure of BACE1 in complex with hydroxyethylamine inhibitor 37	0.092	341	235	3	262	6	346	6.406E-06	145
LOKIASV2_0167_ESMFold_hypothetical_protein	4dqh-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	4dqh-assembly1.cif.gz_B Crystal Structure of (R14C/E65C) HIV-1 Protease in complex with DRV	0.193	90	66	21	110	10	92	9.972E-04	144
LOKIASV2_0167_ESMFold_hypothetical_protein	1fb7-assembly1.cif.gz_A-2	LOKIASV2_0167_ESMFold_hypothetical_protein	1fb7-assembly1.cif.gz_A-2 CRYSTAL STRUCTURE OF AN IN VIVO HIV-1 PROTEASE MUTANT IN COMPLEX WITH SAQUINAVIR: INSIGHTS INTO THE MECHANISMS OF DRUG RESISTANCE	0.186	90	67	21	110	10	92	2.098E-03	144
LOKIASV2_0167_ESMFold_hypothetical_protein	3lzv-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3lzv-assembly1.cif.gz_B Structure of Nelfinavir-resistant HIV-1 protease (D30N/N88D) in complex with Darunavir.	0.218	86	61	21	106	10	88	2.213E-03	144
LOKIASV2_0167_ESMFold_hypothetical_protein	2p3a-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	2p3a-assembly1.cif.gz_B Crystal Structure of the multi-drug resistant mutant subtype B HIV protease complexed with TL-3 inhibitor	0.191	90	66	21	110	10	92	1.109E-03	144
LOKIASV2_0167_ESMFold_hypothetical_protein	5kqf-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5kqf-assembly1.cif.gz_A (4~{S},6~{S})-4-[2,4-bis(fluoranyl)phenyl]-4-methyl-6-pyrimidin-5-yl-5,6-dihydro-1,3-thiazin-2-amine (compound 12) bound to BACE1	0.092	323	235	3	262	5	327	3.699E-05	144
LOKIASV2_0167_ESMFold_hypothetical_protein	4xkx-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4xkx-assembly1.cif.gz_A Crystal structure of BACE1 in complex with 2-aminooxazoline 3-azaxanthene inhibitor 28	0.092	328	235	3	262	5	332	1.667E-05	144
LOKIASV2_0167_ESMFold_hypothetical_protein	3rtn-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3rtn-assembly1.cif.gz_A Structure of Bace-1 (Beta-Secretase) in Complex with 3-(2-Amino-6-o-tolylquinolin-3-yl)-N-cyclohexylpropanamide	0.086	332	237	3	262	5	336	1.955E-05	144
LOKIASV2_0167_ESMFold_hypothetical_protein	6uj0-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	6uj0-assembly2.cif.gz_B Unbound BACE2 mutant structure	0.084	337	238	2	262	1	337	6.406E-06	144
LOKIASV2_0167_ESMFold_hypothetical_protein	3duy-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3duy-assembly2.cif.gz_B Crystal structure of human beta-secretase in complex with NVP-AFJ144	0.088	334	236	3	262	6	339	1.278E-05	144
LOKIASV2_0167_ESMFold_hypothetical_protein	2zhv-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	2zhv-assembly1.cif.gz_A Crystal structure of BACE1 at pH 7.0	0.086	335	237	3	262	5	339	1.348E-05	144
LOKIASV2_0167_ESMFold_hypothetical_protein	3k5f-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3k5f-assembly1.cif.gz_A Human BACE-1 COMPLEX WITH AYH011	0.105	341	232	3	262	6	346	9.799E-06	144
LOKIASV2_0167_ESMFold_hypothetical_protein	4dvf-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4dvf-assembly1.cif.gz_A Crystal structure of BACE1 with its inhibitor	0.096	338	234	3	262	5	342	1.499E-05	144
LOKIASV2_0167_ESMFold_hypothetical_protein	3rsx-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3rsx-assembly1.cif.gz_A Structure of Bace-1 (Beta-Secretase) in Complex with 6-(Thiophen-3-yl)quinolin-2-amine	0.089	340	236	3	262	5	344	1.667E-05	144
LOKIASV2_0167_ESMFold_hypothetical_protein	6ej2-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	6ej2-assembly1.cif.gz_A BACE1 compound 28	0.092	340	235	3	262	8	347	2.991E-05	144
LOKIASV2_0167_ESMFold_hypothetical_protein	3r1g-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3r1g-assembly1.cif.gz_B Structure Basis of Allosteric Inhibition of BACE1 by an Exosite-Binding Antibody	0.085	343	237	3	262	9	351	1.499E-05	144
LOKIASV2_0167_ESMFold_hypothetical_protein	4i11-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4i11-assembly1.cif.gz_A Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the catalytic aspartates.	0.108	346	231	3	262	7	352	1.090E-05	144
LOKIASV2_0167_ESMFold_hypothetical_protein	3vla-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3vla-assembly1.cif.gz_A Crystal structure of edgp	0.087	388	236	3	262	8	395	3.386E-06	144
LOKIASV2_0167_ESMFold_hypothetical_protein	1sdu-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1sdu-assembly1.cif.gz_A Crystal structures of HIV protease V82A and L90M mutants reveal changes in indinavir binding site.	0.193	90	66	21	110	10	92	1.170E-03	143
LOKIASV2_0167_ESMFold_hypothetical_protein	2rkg-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	2rkg-assembly1.cif.gz_B HIV-1 PR resistant mutant + LPV	0.180	90	68	21	110	10	93	1.301E-03	143
LOKIASV2_0167_ESMFold_hypothetical_protein	3buf-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3buf-assembly1.cif.gz_A BACE-1 complexed with compound 2	0.093	325	235	3	262	8	332	1.667E-05	143
LOKIASV2_0167_ESMFold_hypothetical_protein	3rsv-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3rsv-assembly1.cif.gz_A Structure of Bace-1 (Beta-Secretase) in complex with (R)-3-(2-amino-6-o-tolylquinolin-3-yl)-N-((R)-2,2-dimethyltetrahydro-2H-pyran-4-yl)-2-methylpropanamide	0.093	329	235	3	262	5	333	9.292E-06	143
LOKIASV2_0167_ESMFold_hypothetical_protein	3zlq-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3zlq-assembly1.cif.gz_A BACE2 XAPERONE COMPLEX	0.100	322	218	20	262	15	336	1.212E-05	143
LOKIASV2_0167_ESMFold_hypothetical_protein	3dm6-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3dm6-assembly1.cif.gz_A Beta-secretase 1 complexed with statine-based inhibitor	0.100	336	233	3	262	6	341	4.657E-06	143
LOKIASV2_0167_ESMFold_hypothetical_protein	4zpf-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4zpf-assembly1.cif.gz_A BACE1 in complex with 8-(3-((1-aminopropan-2-yl)oxy)benzyl)-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one	0.082	336	238	3	262	7	342	5.462E-06	143
LOKIASV2_0167_ESMFold_hypothetical_protein	4j17-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4j17-assembly1.cif.gz_A CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((S)-2-amino-4-difluoromethyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide	0.092	341	235	3	262	8	348	5.967E-05	143
LOKIASV2_0167_ESMFold_hypothetical_protein	1axa-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1axa-assembly1.cif.gz_B ACTIVE-SITE MOBILITY IN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE AS DEMONSTRATED BY CRYSTAL STRUCTURE OF A28S MUTANT	0.175	90	68	21	110	10	92	2.461E-03	142
LOKIASV2_0167_ESMFold_hypothetical_protein	3vv8-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3vv8-assembly1.cif.gz_A Crystal structure of beta secetase in complex with 2-amino-3-methyl-6-((1S,2R)-2-(3'-methylbiphenyl-4-yl)cyclopropyl)pyrimidin-4(3H)-one	0.098	323	234	3	262	5	327	1.581E-05	142
LOKIASV2_0167_ESMFold_hypothetical_protein	3zks-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3zks-assembly1.cif.gz_A BACE2 XAPERONE COMPLEX WITH INHIBITOR	0.106	316	216	20	262	14	329	1.033E-05	142
LOKIASV2_0167_ESMFold_hypothetical_protein	7d5b-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	7d5b-assembly1.cif.gz_A BACE2 xaperone complex with N-{3-[(5R)-3-amino-2,5-dimethyl-1,1-dioxo-5,6-dihydro-2H-1lambda6,2,4-thiadiazin-5-yl]-4-fluorophenyl}-5-fluoropyridine-2-carboxamide	0.096	332	234	3	262	7	338	2.550E-05	142
LOKIASV2_0167_ESMFold_hypothetical_protein	3in4-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3in4-assembly1.cif.gz_A Bace1 with Compound 38	0.103	338	232	3	262	6	343	8.811E-06	142
LOKIASV2_0167_ESMFold_hypothetical_protein	3tpl-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3tpl-assembly1.cif.gz_A APO Structure of BACE1	0.088	333	236	3	262	9	341	1.090E-05	142
LOKIASV2_0167_ESMFold_hypothetical_protein	3ufl-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3ufl-assembly1.cif.gz_A Discovery of Pyrrolidine-based b-Secretase Inhibitors: Lead Advancement through Conformational Design for Maintenance of Ligand Binding Efficiency	0.089	336	236	3	262	7	342	9.799E-06	142
LOKIASV2_0167_ESMFold_hypothetical_protein	2ewy-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	2ewy-assembly1.cif.gz_A Crystal structure of human BACE2 in complex with a hydroxyethylenamine transition-state inhibitor	0.100	336	229	8	262	7	342	1.955E-05	142
LOKIASV2_0167_ESMFold_hypothetical_protein	4i0h-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	4i0h-assembly2.cif.gz_B SPR and structural analysis yield insight towards mechanism of inhibition of BACE inhibitors.	0.096	338	234	3	262	6	343	9.799E-06	142
LOKIASV2_0167_ESMFold_hypothetical_protein	1ym2-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1ym2-assembly1.cif.gz_A Crystal structure of human beta secretase complexed with NVP-AUR200	0.077	329	223	20	262	17	345	1.149E-05	142
LOKIASV2_0167_ESMFold_hypothetical_protein	6jsn-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	6jsn-assembly1.cif.gz_A Crystal Structure of BACE1 in complex with N-{3-[(5R)-3-amino-5-methyl-9,9-dioxo-2,9lambda6-dithia-4-azaspiro[5.5]undec-3-en-5-yl]-4-fluorophenyl}-5-(fluoromethoxy)pyrazine-2-carboxamide	0.084	342	237	3	262	8	349	1.667E-05	142
LOKIASV2_0167_ESMFold_hypothetical_protein	3u6a-assembly3.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	3u6a-assembly3.cif.gz_C Rational Design and Synthesis of Aminopiperazinones as Beta Secretase (BACE) Inhibitors	0.088	346	236	3	262	8	353	8.811E-06	142
LOKIASV2_0167_ESMFold_hypothetical_protein	3u6a-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3u6a-assembly2.cif.gz_B Rational Design and Synthesis of Aminopiperazinones as Beta Secretase (BACE) Inhibitors	0.083	349	238	3	262	7	355	1.278E-05	142
LOKIASV2_0167_ESMFold_hypothetical_protein	4ybi-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4ybi-assembly1.cif.gz_A Crystal structure of BACE with amino thiazine inhibitor LY2811376	0.085	340	221	20	262	18	357	7.513E-06	142
LOKIASV2_0167_ESMFold_hypothetical_protein	2fgu-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	2fgu-assembly1.cif.gz_B X-ray crystal structure of HIV-1 Protease T80S variant in complex with the inhibitor saquinavir used to explore the role of invariant Thr80 in HIV-1 protease structure, function, and viral infectivity.	0.204	90	65	21	110	10	92	1.372E-03	141
LOKIASV2_0167_ESMFold_hypothetical_protein	1heg-assembly1.cif.gz_E-2	LOKIASV2_0167_ESMFold_hypothetical_protein	1heg-assembly1.cif.gz_E-2 The crystal structures at 2.2 angstroms resolution of hydroxyethylene-based inhibitors bound to human immunodeficiency virus type 1 protease show that the inhibitors are present in two distinct orientations	0.186	86	63	21	106	10	88	2.461E-03	141
LOKIASV2_0167_ESMFold_hypothetical_protein	5kr2-assembly3.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	5kr2-assembly3.cif.gz_C Protease PR5-SQV	0.184	90	67	21	110	10	92	2.098E-03	141
LOKIASV2_0167_ESMFold_hypothetical_protein	1msn-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1msn-assembly1.cif.gz_B The HIV protease (mutant Q7K L33I L63I V82F I84V) complexed with KNI-764 (an inhibitor)	0.182	90	67	21	110	10	92	1.789E-03	141
LOKIASV2_0167_ESMFold_hypothetical_protein	3wb5-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3wb5-assembly1.cif.gz_A Crystal Structure of beta secetase in complex with (6S)-2-amino-3,6-dimethyl-6-[(1R,2R)-2-phenylcyclopropyl]-3,4,5,6-tetrahydropyrimidin-4-one	0.085	327	237	3	262	5	331	2.991E-05	141
LOKIASV2_0167_ESMFold_hypothetical_protein	4j1k-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4j1k-assembly1.cif.gz_A CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4R,5R,6S)-2-amino-5-fluoro-4-methyl-6-trifluoromethyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide	0.092	330	235	3	262	8	337	3.154E-05	141
LOKIASV2_0167_ESMFold_hypothetical_protein	5i3x-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5i3x-assembly1.cif.gz_A Crystal structure of BACE1 in complex with aminoquinoline inhibitor 6	0.083	336	238	3	262	5	340	3.326E-05	141
LOKIASV2_0167_ESMFold_hypothetical_protein	3tpl-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3tpl-assembly2.cif.gz_B APO Structure of BACE1	0.074	338	240	3	262	8	345	2.418E-05	141
LOKIASV2_0167_ESMFold_hypothetical_protein	5v0n-assembly3.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	5v0n-assembly3.cif.gz_C BACE1 in complex with inhibitor 5g	0.091	344	235	3	262	5	348	1.348E-05	141
LOKIASV2_0167_ESMFold_hypothetical_protein	4cpu-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	4cpu-assembly1.cif.gz_B Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol	0.172	90	68	21	110	10	92	1.990E-03	140
LOKIASV2_0167_ESMFold_hypothetical_protein	1k1u-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1k1u-assembly1.cif.gz_B Combining Mutations in HIV-1 Protease to Understand Mechanisms of Resistance	0.197	90	66	21	110	10	92	2.461E-03	140
LOKIASV2_0167_ESMFold_hypothetical_protein	4u7q-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	4u7q-assembly1.cif.gz_B Structure of wild-type HIV protease in complex with photosensitive inhibitor PDI-6	0.206	86	62	21	106	10	88	2.461E-03	140
LOKIASV2_0167_ESMFold_hypothetical_protein	3bug-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3bug-assembly1.cif.gz_A BACE-1 complexed with compound 3	0.081	326	238	3	262	5	330	4.575E-05	140
LOKIASV2_0167_ESMFold_hypothetical_protein	3inh-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3inh-assembly1.cif.gz_A Bace1 with the aminohydantoin Compound R-58	0.096	332	234	3	262	6	337	5.462E-06	140
LOKIASV2_0167_ESMFold_hypothetical_protein	2ph6-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	2ph6-assembly1.cif.gz_A Crystal Structure of Human Beta Secretase Complexed with inhibitor	0.077	334	239	3	262	7	340	4.114E-05	140
LOKIASV2_0167_ESMFold_hypothetical_protein	3msj-assembly3.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	3msj-assembly3.cif.gz_C Structure of bace (beta secretase) in complex with inhibitor	0.084	337	237	3	262	8	344	4.825E-05	140
LOKIASV2_0167_ESMFold_hypothetical_protein	3nsh-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3nsh-assembly2.cif.gz_B BACE-1 in complex with ELN475957	0.091	339	235	3	262	6	344	1.581E-05	140
LOKIASV2_0167_ESMFold_hypothetical_protein	3zkq-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3zkq-assembly1.cif.gz_A BACE2 XAPERONE COMPLEX	0.093	327	219	20	262	18	344	1.421E-05	140
LOKIASV2_0167_ESMFold_hypothetical_protein	5qct-assembly3.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	5qct-assembly3.cif.gz_C Crystal structure of BACE complex with BMC001	0.092	345	234	4	262	5	349	1.090E-05	140
LOKIASV2_0167_ESMFold_hypothetical_protein	2avv-assembly2.cif.gz_E	LOKIASV2_0167_ESMFold_hypothetical_protein	2avv-assembly2.cif.gz_E Kinetics, stability, and structural changes in high resolution crystal structures of HIV-1 protease with drug resistant mutations L24I, I50V, and G73S	0.202	90	65	21	110	10	92	1.696E-03	139
LOKIASV2_0167_ESMFold_hypothetical_protein	4dqe-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	4dqe-assembly1.cif.gz_B Crystal Structure of (G16C/L38C) HIV-1 Protease in Complex with DRV	0.223	90	64	21	110	10	92	1.301E-03	139
LOKIASV2_0167_ESMFold_hypothetical_protein	3oxv-assembly2.cif.gz_D	LOKIASV2_0167_ESMFold_hypothetical_protein	3oxv-assembly2.cif.gz_D Crystal Structure of HIV-1 I50V, A71 Protease in Complex with the protease inhibitor amprenavir.	0.212	90	65	21	110	10	92	1.789E-03	139
LOKIASV2_0167_ESMFold_hypothetical_protein	1tsq-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1tsq-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2V SUBSTRATE VARIANT OF NC-P1 DECAMER PEPTIDE IN COMPLEX WITH V82A/D25N HIV-1 PROTEASE MUTANT	0.195	86	63	21	106	10	88	2.886E-03	139
LOKIASV2_0167_ESMFold_hypothetical_protein	2zjl-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	2zjl-assembly1.cif.gz_A Crystal structure of the human BACE1 catalytic domain in complex with N-[1-(5-bromo-2,3-dimethoxy-benzyl)-piperidin-4-yl]-4-mercapto-butyramide	0.104	307	232	3	262	7	313	1.854E-05	139
LOKIASV2_0167_ESMFold_hypothetical_protein	3zki-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3zki-assembly2.cif.gz_B BACE2 MUTANT STRUCTURE WITH LIGAND	0.094	327	235	3	262	4	330	1.421E-05	139
LOKIASV2_0167_ESMFold_hypothetical_protein	3l3a-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3l3a-assembly1.cif.gz_A Bace-1 with the aminopyridine Compound 32	0.098	333	234	3	262	6	338	1.854E-05	139
LOKIASV2_0167_ESMFold_hypothetical_protein	6nv9-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	6nv9-assembly1.cif.gz_A BACE1 in complex with a macrocyclic inhibitor	0.097	339	234	3	262	6	344	2.174E-05	139
LOKIASV2_0167_ESMFold_hypothetical_protein	3ivi-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3ivi-assembly2.cif.gz_B Design and Synthesis of Potent BACE-1 Inhibitors with Cellular Activity: Structure-Activity Relationship of P1 Substituents	0.089	343	236	3	262	6	348	1.581E-05	139
LOKIASV2_0167_ESMFold_hypothetical_protein	7b1q-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	7b1q-assembly1.cif.gz_A Crystal Structure of Human BACE-1 in Complex with Compound NB-360 (compound 54)	0.091	342	235	3	262	6	347	2.293E-05	139
LOKIASV2_0167_ESMFold_hypothetical_protein	2fdd-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	2fdd-assembly1.cif.gz_B Crystal structure of HIV protease D545701 bound with GW0385	0.170	90	68	21	110	10	92	1.789E-03	138
LOKIASV2_0167_ESMFold_hypothetical_protein	5kr0-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	5kr0-assembly1.cif.gz_B Protease E35D-APV	0.182	90	67	21	110	10	92	2.213E-03	138
LOKIASV2_0167_ESMFold_hypothetical_protein	4obg-assembly2.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	4obg-assembly2.cif.gz_C Crystal Structure of Nelfinavir-Resistant, Inactive HIV-1 Protease (D30N/N88D) in Complex with the p1-p6 substrate.	0.212	90	65	21	110	10	92	1.990E-03	138
LOKIASV2_0167_ESMFold_hypothetical_protein	2qak-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	2qak-assembly1.cif.gz_A HIV-1 PR mutant in complex with nelfinavir	0.187	90	67	21	110	10	92	1.109E-03	138
LOKIASV2_0167_ESMFold_hypothetical_protein	5t84-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	5t84-assembly1.cif.gz_B HIV-1 protease, unbound subtype B L63P construct	0.191	90	66	21	110	10	92	1.789E-03	138
LOKIASV2_0167_ESMFold_hypothetical_protein	7wcq-assembly1.cif.gz_A-2	LOKIASV2_0167_ESMFold_hypothetical_protein	7wcq-assembly1.cif.gz_A-2 Crystal structure of HIV-1 protease in complex with lactam derivative 1	0.191	90	66	21	110	10	92	1.789E-03	138
LOKIASV2_0167_ESMFold_hypothetical_protein	3ru1-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3ru1-assembly1.cif.gz_A Structure of Bace-1 (Beta-Secretase) in Complex with 3-(2-Aminoquinolin-3-yl)-N-(cyclohexylmethyl)propanamide	0.097	328	234	3	262	5	332	2.689E-05	138
LOKIASV2_0167_ESMFold_hypothetical_protein	3s7l-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3s7l-assembly1.cif.gz_A Pyrazolyl and Thienyl Aminohydantoins as Potent BACE1 Inhibitors	0.095	337	234	3	262	6	342	2.293E-05	138
LOKIASV2_0167_ESMFold_hypothetical_protein	3zkx-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3zkx-assembly1.cif.gz_A TERNARY BACE2 XAPERONE COMPLEX	0.102	325	217	20	262	15	339	1.278E-05	138
LOKIASV2_0167_ESMFold_hypothetical_protein	2xfj-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	2xfj-assembly1.cif.gz_A Human BACE-1 in complex with N-((1S,2R)-3-(((1S)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-3-(ethylamino)-5-(2-oxo-1-pyrrolidinyl)benzamide	0.105	344	234	1	262	1	344	1.348E-05	138
LOKIASV2_0167_ESMFold_hypothetical_protein	3uqr-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3uqr-assembly2.cif.gz_B Crystal structure of BACE1 with its inhibitor	0.075	337	240	3	262	6	342	2.689E-05	138
LOKIASV2_0167_ESMFold_hypothetical_protein	3ivh-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3ivh-assembly1.cif.gz_A Design and Synthesis of Potent BACE-1 Inhibitors with Cellular Activity: Structure-Activity Relationship of P1 Substituents	0.101	344	233	3	262	6	349	1.581E-05	138
LOKIASV2_0167_ESMFold_hypothetical_protein	3qi1-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3qi1-assembly1.cif.gz_A Design and synthesis of hydroxyethylamine (hea) BACE-1 inhibitors: prime side chromane-containing inhibitors	0.091	347	235	3	262	7	353	1.348E-05	138
LOKIASV2_0167_ESMFold_hypothetical_protein	5mco-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5mco-assembly1.cif.gz_A CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH ACTIVE SITE INHIBITOR GRL-8234 AND EXOSITE PEPTIDE	0.087	342	236	3	262	10	351	2.174E-05	138
LOKIASV2_0167_ESMFold_hypothetical_protein	4h3i-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4h3i-assembly1.cif.gz_A Structure of BACE Bound to 3-(5-((7aR)-2-imino-6-(3-methoxypyridin-2-yl)-3-methyl-4-oxooctahydro-1H-pyrrolo[3,4-d]pyrimidin-7a-yl)thiophen-3-yl)benzonitrile	0.084	350	235	5	262	6	355	1.033E-05	138
LOKIASV2_0167_ESMFold_hypothetical_protein	3ia9-assembly3.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3ia9-assembly3.cif.gz_B Crystal structure of a chemically synthesized [D25N]HIV-1 protease molecule complexed with MVT-101 reduced isostere inhibitor	0.188	90	66	21	110	10	91	3.970E-03	137
LOKIASV2_0167_ESMFold_hypothetical_protein	1ody-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1ody-assembly1.cif.gz_B HIV-1 PROTEASE COMPLEXED WITH AN INHIBITOR LP-130	0.182	90	67	21	110	10	92	2.333E-03	137
LOKIASV2_0167_ESMFold_hypothetical_protein	7f1g-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	7f1g-assembly1.cif.gz_A BACE2 xaperone complex with N-{3-[(4R,5R,6R)-2-amino-5-fluoro-4,6-dimethyl-5,6-dihydro-4H-1,3-thiazin-4-yl]-4-fluorophenyl}-2H,3H-[1,4]dioxino[2,3-c]pyridine-7-carboxamide	0.095	326	233	5	262	6	331	3.326E-05	137
LOKIASV2_0167_ESMFold_hypothetical_protein	3ooz-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3ooz-assembly1.cif.gz_A Bace1 in complex with the aminohydantoin Compound 102	0.097	337	234	3	262	5	341	2.418E-05	137
LOKIASV2_0167_ESMFold_hypothetical_protein	3igb-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3igb-assembly1.cif.gz_A Bace-1 with Compound 3	0.096	335	234	3	262	6	340	5.179E-06	137
LOKIASV2_0167_ESMFold_hypothetical_protein	3zov-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3zov-assembly1.cif.gz_A CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH CHEMICAL LIGAND	0.083	333	238	3	262	8	340	9.626E-05	137
LOKIASV2_0167_ESMFold_hypothetical_protein	4dpi-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4dpi-assembly1.cif.gz_A BACE-1 in complex with HEA-macrocyclic inhibitor, MV078512	0.096	339	234	3	262	5	343	3.154E-05	137
LOKIASV2_0167_ESMFold_hypothetical_protein	3ckr-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3ckr-assembly1.cif.gz_A Crystal structure of BACE-1 in complex with inhibitor	0.094	339	235	3	262	9	347	1.499E-05	137
LOKIASV2_0167_ESMFold_hypothetical_protein	4i0j-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4i0j-assembly1.cif.gz_A SPR and structural analysis yield insight towards mechanism of inhibition of BACE inhibitors	0.100	337	233	3	262	7	343	1.278E-05	137
LOKIASV2_0167_ESMFold_hypothetical_protein	6dh8-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	6dh8-assembly1.cif.gz_A Crystal structure of HIV-1 Protease NL4-3 I50V Mutant in complex with UMass6	0.182	90	67	21	110	10	92	1.887E-03	136
LOKIASV2_0167_ESMFold_hypothetical_protein	1gnm-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1gnm-assembly1.cif.gz_B HIV-1 PROTEASE MUTANT WITH VAL 82 REPLACED BY ASP (V82D) COMPLEXED WITH U89360E (INHIBITOR)	0.200	90	66	21	110	10	92	1.609E-03	136
LOKIASV2_0167_ESMFold_hypothetical_protein	2hc0-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	2hc0-assembly1.cif.gz_B Structure of HIV protease 6X mutant in complex with AB-2.	0.193	87	64	21	107	10	89	1.233E-03	136
LOKIASV2_0167_ESMFold_hypothetical_protein	2i4x-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	2i4x-assembly1.cif.gz_B HIV-1 Protease I84V, L90M with GS-8374	0.172	90	68	21	110	10	92	2.737E-03	136
LOKIASV2_0167_ESMFold_hypothetical_protein	6mk9-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	6mk9-assembly1.cif.gz_A X-ray crystal structure of darunavir-resistant-P51 HIV-1 protease in complex with GRL-121	0.144	90	70	21	110	10	92	3.570E-03	136
LOKIASV2_0167_ESMFold_hypothetical_protein	4njv-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	4njv-assembly1.cif.gz_B Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with ritonavir	0.161	90	69	21	110	10	92	2.886E-03	136
LOKIASV2_0167_ESMFold_hypothetical_protein	6opz-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	6opz-assembly1.cif.gz_B HIV-1 Protease NL4-3 I13V, G16E, V32I, L33F, K45I, M46I, I54L, A71V, L76V, V82F, I84V Mutant in complex with darunavir	0.181	84	62	21	104	10	86	1.696E-03	136
LOKIASV2_0167_ESMFold_hypothetical_protein	3spk-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3spk-assembly1.cif.gz_B Tipranavir in Complex with a Human Immunodeficiency Virus Type 1 Protease Variant	0.148	90	70	21	110	10	92	1.789E-03	136
LOKIASV2_0167_ESMFold_hypothetical_protein	5v4y-assembly1.cif.gz_A-2	LOKIASV2_0167_ESMFold_hypothetical_protein	5v4y-assembly1.cif.gz_A-2 X-ray crystal structure of wild type HIV-1 protease in complex with GRL-09510	0.191	90	66	21	110	10	92	1.990E-03	136
LOKIASV2_0167_ESMFold_hypothetical_protein	2z54-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	2z54-assembly1.cif.gz_B The Influence of I47A Mutation on Reduced Susceptibility to the Protease Inhibitor Lopinavir	0.188	86	63	21	106	10	88	1.696E-03	136
LOKIASV2_0167_ESMFold_hypothetical_protein	3s8i-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3s8i-assembly1.cif.gz_A The retroviral-like protease (RVP) domain of human DDI1	0.153	118	97	146	263	3	118	3.267E-04	136
LOKIASV2_0167_ESMFold_hypothetical_protein	5i3y-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5i3y-assembly1.cif.gz_A Crystal structure of BACE1 in complex with aminoquinoline inhibitor 9	0.100	334	233	3	262	5	338	4.114E-05	136
LOKIASV2_0167_ESMFold_hypothetical_protein	3buh-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3buh-assembly1.cif.gz_A BACE-1 complexed with compound 4	0.094	331	235	3	262	8	338	4.338E-05	136
LOKIASV2_0167_ESMFold_hypothetical_protein	4j1h-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4j1h-assembly1.cif.gz_A CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4S,6R)-2-amino-4-methyl-6-trifluoromethyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide	0.083	332	238	3	262	8	339	9.626E-05	136
LOKIASV2_0167_ESMFold_hypothetical_protein	3s7m-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3s7m-assembly1.cif.gz_A Pyrazolyl and Thienyl Aminohydantoins as Potent BACE1 Inhibitors	0.091	339	235	3	262	6	344	2.418E-05	136
LOKIASV2_0167_ESMFold_hypothetical_protein	6wny-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	6wny-assembly1.cif.gz_A Crystal structure of BACE1 in complex with (Z)-fluoro-olefin containing compound 15	0.084	344	237	3	262	5	348	3.699E-05	136
LOKIASV2_0167_ESMFold_hypothetical_protein	3nwx-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3nwx-assembly1.cif.gz_A X-ray structure of ester chemical analogue [O-Ile50,O-Ile50']HIV-1 protease complexed with KVS-1 inhibitor	0.218	86	59	21	106	10	86	3.044E-03	135
LOKIASV2_0167_ESMFold_hypothetical_protein	8esy-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	8esy-assembly1.cif.gz_A D30N mutant HIV protease in complex with benzoxaborolone analog of darunavir	0.197	90	65	21	110	10	91	3.570E-03	135
LOKIASV2_0167_ESMFold_hypothetical_protein	2hpf-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	2hpf-assembly1.cif.gz_B COMPARISON OF THE STRUCTURES OF HIV-2 PROTEASE COMPLEXES IN THREE CRYSTAL SPACE GROUPS WITH AN HIV-1 PROTEASE COMPLEX STRUCTURE	0.222	90	64	21	110	10	92	1.233E-03	135
LOKIASV2_0167_ESMFold_hypothetical_protein	2pyn-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	2pyn-assembly1.cif.gz_B HIV-1 PR mutant in complex with nelfinavir	0.187	90	67	21	110	10	92	1.372E-03	135
LOKIASV2_0167_ESMFold_hypothetical_protein	1tsu-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1tsu-assembly1.cif.gz_B CRYSTAL STRUCTURE OF DECAMER NCP1 SUBSTRATE PEPTIDE IN COMPLEX WITH WILD-TYPE D25N HIV-1 PROTEASE VARIANT	0.188	87	64	21	107	10	89	2.461E-03	135
LOKIASV2_0167_ESMFold_hypothetical_protein	3wb4-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3wb4-assembly1.cif.gz_A Crystal Structure of beta secetase in complex with 2-amino-3,6-dimethyl-6-(2-phenylethyl)-3,4,5,6-tetrahydropyrimidin-4-one	0.093	325	235	3	262	5	329	5.967E-05	135
LOKIASV2_0167_ESMFold_hypothetical_protein	1tqf-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1tqf-assembly1.cif.gz_A Crystal structure of human Beta secretase complexed with inhibitor	0.075	334	240	3	262	7	340	1.667E-05	135
LOKIASV2_0167_ESMFold_hypothetical_protein	5v0n-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	5v0n-assembly2.cif.gz_B BACE1 in complex with inhibitor 5g	0.085	337	237	3	262	6	342	5.088E-05	135
LOKIASV2_0167_ESMFold_hypothetical_protein	3nsh-assembly3.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	3nsh-assembly3.cif.gz_C BACE-1 in complex with ELN475957	0.096	342	234	3	262	6	347	1.421E-05	135
LOKIASV2_0167_ESMFold_hypothetical_protein	6nw3-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	6nw3-assembly2.cif.gz_B BACE1 in complex with a macrocyclic inhibitor	0.081	344	238	3	262	6	349	5.366E-05	135
LOKIASV2_0167_ESMFold_hypothetical_protein	6c4g-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	6c4g-assembly1.cif.gz_A Plasmepsin V from Plasmodium vivax bound to a transition state mimetic (WEHI-601)	0.117	386	231	1	263	1	386	1.758E-05	135
LOKIASV2_0167_ESMFold_hypothetical_protein	3em6-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3em6-assembly1.cif.gz_B Crystal structure of I50L/A71V mutant of hiv-1 protease in complex with inhibitor darunavir	0.188	101	67	146	246	8	90	2.786E-04	134
LOKIASV2_0167_ESMFold_hypothetical_protein	3ggu-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3ggu-assembly1.cif.gz_B HIV PR drug resistant patient's variant in complex with darunavir	0.177	90	67	21	110	10	92	1.170E-03	134
LOKIASV2_0167_ESMFold_hypothetical_protein	1rl8-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1rl8-assembly1.cif.gz_B Crystal structure of the complex of resistant strain of hiv-1 protease(v82a mutant) with ritonavir	0.187	90	67	21	110	10	92	1.301E-03	134
LOKIASV2_0167_ESMFold_hypothetical_protein	3u7s-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3u7s-assembly1.cif.gz_B HIV PR drug resistant patient's variant in complex with darunavir	0.164	90	69	21	110	10	92	4.656E-03	134
LOKIASV2_0167_ESMFold_hypothetical_protein	2iqg-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	2iqg-assembly1.cif.gz_A Crystal Structure of Hydroxyethyl Secondary Amine-based Peptidomimetic Inhibitor of Human Beta-Secretase (BACE)	0.097	338	234	3	262	6	343	2.836E-05	134
LOKIASV2_0167_ESMFold_hypothetical_protein	2qzk-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	2qzk-assembly1.cif.gz_A Crystal structure of human Beta Secretase complexed with I21	0.085	340	237	3	262	6	345	4.338E-05	134
LOKIASV2_0167_ESMFold_hypothetical_protein	1t7i-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1t7i-assembly1.cif.gz_A The structural and thermodynamic basis for the binding of TMC114, a next-generation HIV-1 protease inhibitor.	0.187	90	67	21	110	10	92	1.609E-03	133
LOKIASV2_0167_ESMFold_hypothetical_protein	5c9d-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	5c9d-assembly1.cif.gz_B Crystal structure of a retropepsin-like aspartic protease from Rickettsia conorii	0.176	122	95	2	123	5	120	5.559E-04	133
LOKIASV2_0167_ESMFold_hypothetical_protein	3inf-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3inf-assembly1.cif.gz_A Bace1 with the aminohydantoin Compound 37	0.103	336	232	3	262	6	341	9.292E-06	133
LOKIASV2_0167_ESMFold_hypothetical_protein	3rth-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3rth-assembly1.cif.gz_A Structure of Bace-1 (Beta-Secretase) in Complex with 6-(2-(3,3-Dimethylbut-1-ynyl)phenyl)quinolin-2-amine	0.090	337	235	4	262	4	340	1.033E-05	133
LOKIASV2_0167_ESMFold_hypothetical_protein	4wy6-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4wy6-assembly1.cif.gz_A Crystal structure of human BACE-1 bound to Compound 36	0.091	336	235	3	262	7	342	5.658E-05	133
LOKIASV2_0167_ESMFold_hypothetical_protein	4fco-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4fco-assembly1.cif.gz_A Crystal structure of bace1 with its inhibitor	0.084	337	237	3	262	7	343	1.758E-05	133
LOKIASV2_0167_ESMFold_hypothetical_protein	4i1c-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4i1c-assembly1.cif.gz_A Design and synthesis of thiophene dihydroisoquinolins as novel BACE-1 inhibitors	0.077	338	237	5	262	4	341	2.174E-05	133
LOKIASV2_0167_ESMFold_hypothetical_protein	2q11-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	2q11-assembly1.cif.gz_A Structure of BACE complexed to compound 1	0.091	352	235	3	262	6	357	2.174E-05	133
LOKIASV2_0167_ESMFold_hypothetical_protein	7hvp-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	7hvp-assembly1.cif.gz_B X-RAY CRYSTALLOGRAPHIC STRUCTURE OF A COMPLEX BETWEEN A SYNTHETIC PROTEASE OF HUMAN IMMUNODEFICIENCY VIRUS 1 AND A SUBSTRATE-BASED HYDROXYETHYLAMINE INHIBITOR	0.222	86	60	21	106	10	87	2.333E-03	132
LOKIASV2_0167_ESMFold_hypothetical_protein	3el9-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3el9-assembly1.cif.gz_B Crystal structure of atazanavir (ATV) in complex with a multidrug HIV-1 protease (V82T/I84V)	0.200	86	62	21	106	10	88	2.886E-03	132
LOKIASV2_0167_ESMFold_hypothetical_protein	3lzs-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3lzs-assembly1.cif.gz_B Crystal Structure of HIV-1 CRF01_AE Protease in Complex with Darunavir	0.193	90	66	21	110	10	92	2.595E-03	132
LOKIASV2_0167_ESMFold_hypothetical_protein	7m9p-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	7m9p-assembly1.cif.gz_A HIV-1 Protease (I84V) in Complex with LR3-55	0.172	90	68	21	110	10	92	3.044E-03	132
LOKIASV2_0167_ESMFold_hypothetical_protein	6oou-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	6oou-assembly1.cif.gz_A Crystal structure of HIV-1 Protease NL4-3 L89V Mutant in complex with darunavir	0.200	87	63	21	107	10	89	3.044E-03	132
LOKIASV2_0167_ESMFold_hypothetical_protein	4q1x-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	4q1x-assembly1.cif.gz_B Mutations Outside the Active Site of HIV-1 Protease Alter Enzyme Structure and Dynamic Ensemble of the Active Site to Confer Drug Resistance	0.207	101	65	146	246	8	90	3.832E-04	132
LOKIASV2_0167_ESMFold_hypothetical_protein	2qhc-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	2qhc-assembly1.cif.gz_B The Influence of I47A Mutation on Reduced Susceptibility to the Protease Inhibitor Lopinavir	0.191	90	66	21	110	10	92	2.737E-03	132
LOKIASV2_0167_ESMFold_hypothetical_protein	4frj-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4frj-assembly1.cif.gz_A Crystal structure of BACE1 in complex with aminooxazoline xanthene 9l	0.098	338	234	3	262	5	342	6.636E-05	132
LOKIASV2_0167_ESMFold_hypothetical_protein	5he7-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5he7-assembly1.cif.gz_A BACE-1 in complex with (4aR,7aS)-7a-(2,4-difluorophenyl)-6-(5-fluoro-4-methoxy-6-methylpyrimidin-2-yl)-2-imino-3-methyloctahydro-4H-pyrrolo[3,4-d]pyrimidin-4-one	0.086	336	221	20	262	18	353	1.581E-05	132
LOKIASV2_0167_ESMFold_hypothetical_protein	2zhr-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	2zhr-assembly2.cif.gz_B Crystal structure of BACE1 in complex with OM99-2 at pH 5.0	0.091	339	220	20	262	16	354	3.154E-05	132
LOKIASV2_0167_ESMFold_hypothetical_protein	4i0d-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4i0d-assembly1.cif.gz_A Design and Synthesis of Thiophene Dihydroisoquinolins as Novel BACE-1 Inhibitors	0.097	327	219	20	262	16	342	1.090E-05	132
LOKIASV2_0167_ESMFold_hypothetical_protein	1qdm-assembly3.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	1qdm-assembly3.cif.gz_C CRYSTAL STRUCTURE OF PROPHYTEPSIN, A ZYMOGEN OF A BARLEY VACUOLAR ASPARTIC PROTEINASE.	0.092	423	236	2	262	1	423	6.519E-04	132
LOKIASV2_0167_ESMFold_hypothetical_protein	3bxr-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3bxr-assembly1.cif.gz_B Crystal Structures Of Highly Constrained Substrate And Hydrolysis Products Bound To HIV-1 Protease. Implications For Catalytic Mechanism	0.204	90	64	21	110	10	91	2.886E-03	131
LOKIASV2_0167_ESMFold_hypothetical_protein	6o54-assembly1.cif.gz_X	LOKIASV2_0167_ESMFold_hypothetical_protein	6o54-assembly1.cif.gz_X Crystal Structure of multi-drug resistant HIV-1 protease PR-S17 (D25N)	0.170	87	66	21	107	10	89	3.570E-03	131
LOKIASV2_0167_ESMFold_hypothetical_protein	6oot-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	6oot-assembly1.cif.gz_B HIV-1 Protease NL4-3 L89V, L90M Mutant in complex with darunavir	0.200	87	63	21	107	10	89	3.044E-03	131
LOKIASV2_0167_ESMFold_hypothetical_protein	3oud-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3oud-assembly1.cif.gz_B MDR769 HIV-1 protease complexed with CA/p2 hepta-peptide	0.164	84	64	21	104	10	86	2.737E-03	131
LOKIASV2_0167_ESMFold_hypothetical_protein	3t3c-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3t3c-assembly1.cif.gz_B Structure of HIV PR resistant patient derived mutant (comprising 22 mutations) in complex with DRV	0.191	90	66	21	110	10	92	2.595E-03	131
LOKIASV2_0167_ESMFold_hypothetical_protein	2qu2-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	2qu2-assembly1.cif.gz_A BACE1 with Compound 1	0.083	339	238	3	262	6	344	1.758E-05	131
LOKIASV2_0167_ESMFold_hypothetical_protein	3tpr-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3tpr-assembly1.cif.gz_A Crystal structure of BACE1 complexed with an inhibitor	0.089	333	236	3	262	5	337	4.575E-05	131
LOKIASV2_0167_ESMFold_hypothetical_protein	3hd8-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3hd8-assembly1.cif.gz_A Crystal structure of the Triticum aestivum xylanase inhibitor-IIA in complex with bacillus subtilis xylanase	0.101	353	234	3	263	4	356	1.033E-05	131
LOKIASV2_0167_ESMFold_hypothetical_protein	2p83-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	2p83-assembly2.cif.gz_B Potent and selective isophthalamide S2 hydroxyethylamine inhibitor of BACE1	0.104	335	232	3	262	6	340	2.293E-05	131
LOKIASV2_0167_ESMFold_hypothetical_protein	6oos-assembly2.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	6oos-assembly2.cif.gz_C HIV-1 Protease NL4-3 L90M Mutant in complex with darunavir	0.191	90	66	21	110	10	92	3.210E-03	130
LOKIASV2_0167_ESMFold_hypothetical_protein	2p3d-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	2p3d-assembly1.cif.gz_B Crystal Structure of the multi-drug resistant mutant subtype F HIV protease complexed with TL-3 inhibitor	0.195	84	61	21	104	10	86	3.210E-03	130
LOKIASV2_0167_ESMFold_hypothetical_protein	7bgu-assembly2.cif.gz_D	LOKIASV2_0167_ESMFold_hypothetical_protein	7bgu-assembly2.cif.gz_D Mason-Pfizer Monkey Virus Protease mutant C7A/D26N/C106A in complex with peptidomimetic inhibitor	0.175	87	71	21	107	11	97	5.460E-03	130
LOKIASV2_0167_ESMFold_hypothetical_protein	5c9b-assembly1.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	5c9b-assembly1.cif.gz_C Crystal structure of a retropepsin-like aspartic protease from Rickettsia conorii	0.193	123	90	2	124	7	119	4.041E-04	130
LOKIASV2_0167_ESMFold_hypothetical_protein	7d5u-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	7d5u-assembly1.cif.gz_A BACE2 xaperone complex with N-{3-[(9S)-7-amino-2,2-difluoro-9-(prop-1-yn-1-yl)-6-oxa-8-azaspiro[3.5]non-7-en-9-yl]-4-fluorophenyl}-5-cyanopyridine-2-carboxamide	0.091	335	235	3	262	5	339	7.380E-05	130
LOKIASV2_0167_ESMFold_hypothetical_protein	5clm-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5clm-assembly1.cif.gz_A 1,4-Oxazine BACE1 inhibitors	0.086	341	237	3	262	5	345	2.836E-05	130
LOKIASV2_0167_ESMFold_hypothetical_protein	7mas-assembly2.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	7mas-assembly2.cif.gz_C Drug Resistant HIV-1 Protease (L10F, M46I, I50V, F53L, L63P, G73S) in Complex with DRV	0.228	90	63	21	110	10	92	1.789E-03	129
LOKIASV2_0167_ESMFold_hypothetical_protein	7n6v-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	7n6v-assembly1.cif.gz_B Crystal structure of HIV-1 Protease multiple mutants PRS17 with Revertant mutation V48G bound to inhibitor Amprenavir	0.170	90	68	21	110	10	92	3.570E-03	129
LOKIASV2_0167_ESMFold_hypothetical_protein	6opu-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	6opu-assembly1.cif.gz_A HIV-1 Protease NL4-3 K45I, M46I, V82F, I84V Mutant in complex with darunavir	0.180	90	67	21	110	10	92	3.385E-03	129
LOKIASV2_0167_ESMFold_hypothetical_protein	4q1w-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	4q1w-assembly1.cif.gz_B Mutations Outside the Active Site of HIV-1 Protease Alter Enzyme Structure and Dynamic Ensemble of the Active Site to Confer Drug Resistance	0.177	107	72	140	246	2	90	4.998E-04	129
LOKIASV2_0167_ESMFold_hypothetical_protein	5c9b-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5c9b-assembly1.cif.gz_A Crystal structure of a retropepsin-like aspartic protease from Rickettsia conorii	0.198	123	91	2	124	7	121	4.739E-04	129
LOKIASV2_0167_ESMFold_hypothetical_protein	5c9b-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	5c9b-assembly1.cif.gz_B Crystal structure of a retropepsin-like aspartic protease from Rickettsia conorii	0.206	123	91	2	124	7	122	4.041E-04	129
LOKIASV2_0167_ESMFold_hypothetical_protein	4j1c-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4j1c-assembly1.cif.gz_A CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((S)-2-amino-5,5-difluoro-4-fluoromethyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide	0.098	334	233	4	262	7	340	1.553E-04	129
LOKIASV2_0167_ESMFold_hypothetical_protein	4i0h-assembly3.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	4i0h-assembly3.cif.gz_C SPR and structural analysis yield insight towards mechanism of inhibition of BACE inhibitors.	0.118	340	228	3	262	6	345	4.575E-05	129
LOKIASV2_0167_ESMFold_hypothetical_protein	2q64-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	2q64-assembly1.cif.gz_B HIV-1 PR mutant in complex with nelfinavir	0.200	84	61	21	104	10	86	1.887E-03	128
LOKIASV2_0167_ESMFold_hypothetical_protein	3zkg-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3zkg-assembly1.cif.gz_A BACE2 MUTANT APO STRUCTURE	0.107	317	216	20	262	17	333	9.626E-05	128
LOKIASV2_0167_ESMFold_hypothetical_protein	5f01-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5f01-assembly1.cif.gz_A CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH (1SR,2SR)-2-((R)-2-amino-5,5-difluoro-4-methyl-5,6-dihydro-4H-1,3-oxazin-4-yl)-N-(3-chloroquinolin-8-yl)cyclopropanecarboxamide	0.110	346	231	3	262	8	353	2.836E-05	128
LOKIASV2_0167_ESMFold_hypothetical_protein	3skg-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3skg-assembly1.cif.gz_A Crystal structure of beta-site app-cleaving enzyme 1 (BACE-WT) complex with (2S)-2-((3R)-3-acetamido-3-isobutyl-2-oxo-1-pyrrolidinyl)-N-((1S,2R)-1-(3,5-difluorobenzyl)-2-hydroxy-2-(1,2,3,4-tetrahydro-3-isoquinolinyl)ethyl)-4-phenylbutanamide	0.083	341	222	20	262	16	356	3.699E-05	128
LOKIASV2_0167_ESMFold_hypothetical_protein	4r95-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4r95-assembly1.cif.gz_A BACE-1 in complex with 2-(((1R,3S)-3-(((R)-4-(2-cyclohexylethyl)-2-iminio-1-methyl-5-oxoimidazolidin-4-yl)methyl)cyclohexyl)amino)quinolin-1-ium	0.074	350	238	5	262	6	355	2.991E-05	128
LOKIASV2_0167_ESMFold_hypothetical_protein	3dcr-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3dcr-assembly1.cif.gz_B X-ray structure of HIV-1 protease and hydrated form of ketomethylene isostere inhibitor	0.206	90	64	21	110	10	91	6.073E-03	127
LOKIASV2_0167_ESMFold_hypothetical_protein	3hbo-assembly3.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3hbo-assembly3.cif.gz_B Crystal structure of chemically synthesized [D-Ala51/51']HIV-1 protease	0.211	90	64	21	110	10	91	9.289E-03	127
LOKIASV2_0167_ESMFold_hypothetical_protein	1k2c-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1k2c-assembly1.cif.gz_B Combining Mutations in HIV-1 Protease to Understand Mechanisms of Resistance	0.197	90	66	21	110	10	92	2.737E-03	127
LOKIASV2_0167_ESMFold_hypothetical_protein	1odw-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1odw-assembly1.cif.gz_B Native HIV-1 Proteinase	0.198	101	66	146	246	8	90	7.250E-04	127
LOKIASV2_0167_ESMFold_hypothetical_protein	3s56-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3s56-assembly1.cif.gz_B HIV-1 protease triple mutants V32I, I47V, V82I with antiviral drug saquinavir	0.207	101	65	146	246	8	90	6.182E-04	127
LOKIASV2_0167_ESMFold_hypothetical_protein	5c9f-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	5c9f-assembly1.cif.gz_B Crystal structure of a retropepsin-like aspartic protease from Rickettsia conorii	0.190	123	90	2	124	7	118	1.052E-03	127
LOKIASV2_0167_ESMFold_hypothetical_protein	4rgh-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4rgh-assembly1.cif.gz_A Human DNA Damage-Inducible Protein: From Protein Chemistry and 3D Structure to Deciphering its Cellular Role	0.164	119	98	146	263	4	122	3.446E-04	127
LOKIASV2_0167_ESMFold_hypothetical_protein	3ixk-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3ixk-assembly1.cif.gz_A Potent beta-secretase 1 inhibitor	0.086	337	237	3	262	6	342	4.338E-05	127
LOKIASV2_0167_ESMFold_hypothetical_protein	7d2x-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	7d2x-assembly1.cif.gz_A Crystal Structure of BACE1 in complex with N-{3-[(4R)-2-amino-4-(prop-1-yn-1-yl)-5,6-dihydro-4H-1,3-oxazin-4-yl]-4-fluorophenyl}-5-cyanopyridine-2-carboxamide	0.099	338	233	3	262	7	344	5.366E-05	127
LOKIASV2_0167_ESMFold_hypothetical_protein	5hdv-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5hdv-assembly1.cif.gz_A BACE-1 incomplex with (7aR)-7a-(5-cyanothiophen-2-yl)-6-(5-fluoro-4-methoxy-6-methylpyrimidin-2-yl)-3-methyl-4-oxooctahydro-2H-pyrrolo[3,4-d]pyrimidin-2-iminium	0.082	335	222	20	262	18	352	1.955E-05	127
LOKIASV2_0167_ESMFold_hypothetical_protein	1qdm-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1qdm-assembly2.cif.gz_B CRYSTAL STRUCTURE OF PROPHYTEPSIN, A ZYMOGEN OF A BARLEY VACUOLAR ASPARTIC PROTEINASE.	0.102	426	233	2	262	1	426	1.071E-04	127
LOKIASV2_0167_ESMFold_hypothetical_protein	3nyg-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3nyg-assembly1.cif.gz_A X-ray structure of ester chemical analogue [O-Gly51,O-Gly51']HIV-1 protease complexed with MVT-101 inhibitor	0.197	90	64	21	110	10	90	2.737E-03	126
LOKIASV2_0167_ESMFold_hypothetical_protein	3upj-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3upj-assembly1.cif.gz_B HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 PROTEASE MUTANT WITH LYS 57 REPLACED BY LEU (K57L) COMPLEX WITH U096333 [4-HYDROXY-3-[1-(PHENYL)PROPYL]-7-METHOXYCOUMARIN]	0.222	90	64	21	110	8	90	2.333E-03	126
LOKIASV2_0167_ESMFold_hypothetical_protein	1gnn-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1gnn-assembly1.cif.gz_B HIV-1 PROTEASE MUTANT WITH VAL 82 REPLACED BY ASN (V82N) COMPLEXED WITH U89360E (INHIBITOR)	0.221	90	64	21	110	10	92	1.372E-03	126
LOKIASV2_0167_ESMFold_hypothetical_protein	4qgi-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	4qgi-assembly1.cif.gz_B X-ray crystal structure of HIV-1 protease variant G48T/L89M in complex with Saquinavir	0.198	101	66	146	246	8	90	1.109E-03	126
LOKIASV2_0167_ESMFold_hypothetical_protein	2ze1-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	2ze1-assembly1.cif.gz_A X-ray structure of Bace-1 in complex with compound 6g	0.098	331	234	3	262	5	335	8.208E-05	126
LOKIASV2_0167_ESMFold_hypothetical_protein	3hd8-assembly2.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	3hd8-assembly2.cif.gz_C Crystal structure of the Triticum aestivum xylanase inhibitor-IIA in complex with bacillus subtilis xylanase	0.093	352	236	3	263	4	355	3.901E-05	126
LOKIASV2_0167_ESMFold_hypothetical_protein	2viz-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	2viz-assembly1.cif.gz_A Human BACE-1 in complex with N-((1S,2R)-3-(((1S)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-3-(2-oxo- 1-pyrrolidinyl)-5-(propyloxy)benzamide	0.095	328	219	20	262	14	341	4.825E-05	126
LOKIASV2_0167_ESMFold_hypothetical_protein	4i0h-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4i0h-assembly1.cif.gz_A SPR and structural analysis yield insight towards mechanism of inhibition of BACE inhibitors.	0.100	338	233	3	262	6	343	2.418E-05	126
LOKIASV2_0167_ESMFold_hypothetical_protein	2oah-assembly1.cif.gz_A-2	LOKIASV2_0167_ESMFold_hypothetical_protein	2oah-assembly1.cif.gz_A-2 Crystal Structure of Human Beta Secretase Complexed with inhibitor	0.077	340	237	5	262	8	347	4.338E-05	126
LOKIASV2_0167_ESMFold_hypothetical_protein	4j0t-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4j0t-assembly1.cif.gz_A CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Ethoxy-pyridine-2-carboxylic acid [3-((R)-2-amino-5,5-difluoro-4-methyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide	0.105	343	232	3	262	8	350	2.991E-05	126
LOKIASV2_0167_ESMFold_hypothetical_protein	7ry7-assembly1.cif.gz_A-2	LOKIASV2_0167_ESMFold_hypothetical_protein	7ry7-assembly1.cif.gz_A-2 Structure of Plasmepsin X (PM10, PMX) from Plasmodium falciparum 3D7	0.096	300	219	20	262	126	425	6.293E-05	126
LOKIASV2_0167_ESMFold_hypothetical_protein	1a9m-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1a9m-assembly1.cif.gz_B G48H MUTANT OF HIV-1 PROTEASE IN COMPLEX WITH A PEPTIDIC INHIBITOR U-89360E	0.198	101	66	146	246	8	90	9.972E-04	125
LOKIASV2_0167_ESMFold_hypothetical_protein	6opv-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	6opv-assembly1.cif.gz_A HIV-1 Protease NL4-3 I13V, G16E, V32I, L33F, K45I, M46I, V82F, I84V Mutant in complex with darunavir	0.188	86	63	21	106	10	88	4.910E-03	125
LOKIASV2_0167_ESMFold_hypothetical_protein	3u71-assembly1.cif.gz_A-2	LOKIASV2_0167_ESMFold_hypothetical_protein	3u71-assembly1.cif.gz_A-2 Crystal Structure Analysis of South African wild type HIV-1 Subtype C Protease	0.204	84	60	21	104	10	86	2.886E-03	125
LOKIASV2_0167_ESMFold_hypothetical_protein	3el0-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3el0-assembly1.cif.gz_B Crystal structure of the inhibitor Nelfinavir (NFV) in complex with a multi-drug resistant HIV-1 protease variant (L10I/G48V/I54V/V64I/V82A) (Refer: FLAP+ in citation)	0.198	101	66	146	246	8	90	5.862E-04	124
LOKIASV2_0167_ESMFold_hypothetical_protein	2g69-assembly1.cif.gz_A-2	LOKIASV2_0167_ESMFold_hypothetical_protein	2g69-assembly1.cif.gz_A-2 Structure of Unliganded HIV-1 Protease F53L Mutant	0.206	86	62	21	106	10	88	1.696E-03	124
LOKIASV2_0167_ESMFold_hypothetical_protein	1hwr-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1hwr-assembly1.cif.gz_A MOLECULAR RECOGNITION OF CYCLIC UREA HIV PROTEASE INHIBITORS	0.186	107	72	140	246	2	90	7.646E-04	124
LOKIASV2_0167_ESMFold_hypothetical_protein	2sam-assembly1.cif.gz_A-2	LOKIASV2_0167_ESMFold_hypothetical_protein	2sam-assembly1.cif.gz_A-2 STRUCTURE OF THE PROTEASE FROM SIMIAN IMMUNODEFICIENCY VIRUS: COMPLEX WITH AN IRREVERSIBLE NON-PEPTIDE INHIBITOR	0.244	90	62	21	110	10	92	2.737E-03	124
LOKIASV2_0167_ESMFold_hypothetical_protein	5t1u-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5t1u-assembly1.cif.gz_A Aminomethyl-Derived Beta Secretase (BACE1) Inhibitors: Engaging Gly230 without an Anilide Functionality	0.087	343	236	3	262	7	349	4.338E-05	124
LOKIASV2_0167_ESMFold_hypothetical_protein	3ou4-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3ou4-assembly1.cif.gz_B MDR769 HIV-1 protease complexed with TF/PR hepta-peptide	0.186	84	62	21	104	10	86	5.178E-03	123
LOKIASV2_0167_ESMFold_hypothetical_protein	4z50-assembly2.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	4z50-assembly2.cif.gz_C Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical Isolate PR20D25N with Tucked Flap	0.162	86	65	21	106	10	88	6.753E-03	123
LOKIASV2_0167_ESMFold_hypothetical_protein	6uj1-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	6uj1-assembly2.cif.gz_B BACE2 mutant in complex with a macrocyclic compound	0.090	319	220	20	262	16	334	1.129E-04	123
LOKIASV2_0167_ESMFold_hypothetical_protein	5cop-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	5cop-assembly1.cif.gz_B X-ray crystal structure of wild type HIV-1 protease in complex with GRL-097	0.172	90	68	21	110	10	92	7.511E-03	122
LOKIASV2_0167_ESMFold_hypothetical_protein	3ixo-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3ixo-assembly1.cif.gz_B Crystal Structure of uncomplexed HIV_1 Protease Subtype A	0.202	90	65	21	110	10	92	6.404E-03	122
LOKIASV2_0167_ESMFold_hypothetical_protein	3jw2-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3jw2-assembly1.cif.gz_B HIV-1 Protease Mutant G86S with DARUNAVIR	0.188	101	67	146	246	8	90	8.063E-04	122
LOKIASV2_0167_ESMFold_hypothetical_protein	1meu-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1meu-assembly1.cif.gz_B HIV-1 MUTANT (V82F, I84V) PROTEASE COMPLEXED WITH DMP323	0.168	101	68	146	246	8	90	2.595E-03	122
LOKIASV2_0167_ESMFold_hypothetical_protein	1tcx-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1tcx-assembly1.cif.gz_B HIV TRIPLE MUTANT PROTEASE COMPLEXED WITH INHIBITOR SB203386	0.207	101	65	146	246	8	90	1.170E-03	122
LOKIASV2_0167_ESMFold_hypothetical_protein	5fiv-assembly1.cif.gz_A-2	LOKIASV2_0167_ESMFold_hypothetical_protein	5fiv-assembly1.cif.gz_A-2 STRUCTURAL STUDIES OF HIV AND FIV PROTEASES COMPLEXED WITH AN EFFICIENT INHIBITOR OF FIV PR	0.176	97	74	146	242	9	99	8.967E-04	122
LOKIASV2_0167_ESMFold_hypothetical_protein	5c9f-assembly1.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	5c9f-assembly1.cif.gz_C Crystal structure of a retropepsin-like aspartic protease from Rickettsia conorii	0.198	123	95	2	124	7	126	9.972E-04	122
LOKIASV2_0167_ESMFold_hypothetical_protein	3l38-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3l38-assembly1.cif.gz_A Bace1 in complex with the aminopyridine Compound 44	0.095	333	234	3	262	6	338	3.326E-05	122
LOKIASV2_0167_ESMFold_hypothetical_protein	6i45-assembly1.cif.gz_A-2	LOKIASV2_0167_ESMFold_hypothetical_protein	6i45-assembly1.cif.gz_A-2 Crystal structure of I13V/I62V/V77I South African HIV-1 subtype C protease containing a D25A mutation	0.181	84	62	21	104	10	86	3.570E-03	121
LOKIASV2_0167_ESMFold_hypothetical_protein	3nu9-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3nu9-assembly1.cif.gz_B Crystal Structure of HIV-1 Protease Mutant I84V with Antiviral Drug Amprenavir	0.177	107	72	140	246	2	90	9.972E-04	121
LOKIASV2_0167_ESMFold_hypothetical_protein	2p3c-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	2p3c-assembly1.cif.gz_B Crystal Structure of the subtype F wild type HIV protease complexed with TL-3 inhibitor	0.172	84	63	21	104	10	86	6.073E-03	121
LOKIASV2_0167_ESMFold_hypothetical_protein	2q3k-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	2q3k-assembly1.cif.gz_A Crystal Structure of Lysine Sulfonamide Inhibitor Reveals the Displacement of the Conserved Flap Water Molecule in HIV-1 Protease	0.198	101	66	146	246	8	90	1.170E-03	121
LOKIASV2_0167_ESMFold_hypothetical_protein	2r5p-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	2r5p-assembly1.cif.gz_B Crystal Structure Analysis of HIV-1 Subtype C Protease Complexed with Indinavir	0.198	101	66	146	246	8	90	8.967E-04	121
LOKIASV2_0167_ESMFold_hypothetical_protein	3l5d-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3l5d-assembly1.cif.gz_A Structure of BACE Bound to SCH723873	0.086	337	221	20	262	18	354	6.636E-05	121
LOKIASV2_0167_ESMFold_hypothetical_protein	7o0g-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	7o0g-assembly1.cif.gz_A Structure of the foamy viral protease-reverse transcriptase in complex with RNA/DNA hybrid.	0.161	99	67	148	246	5	85	3.764E-03	121
LOKIASV2_0167_ESMFold_hypothetical_protein	1z1r-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1z1r-assembly1.cif.gz_A HIV-1 protease complexed with Macrocyclic peptidomimetic inhibitor 2	0.223	90	63	21	110	10	91	6.073E-03	120
LOKIASV2_0167_ESMFold_hypothetical_protein	2mip-assembly2.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	2mip-assembly2.cif.gz_C CRYSTAL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) TYPE 2 PROTEASE IN COMPLEX WITH A REDUCED AMIDE INHIBITOR AND COMPARISON WITH HIV-1 PROTEASE STRUCTURES	0.222	90	64	21	110	10	92	5.178E-03	120
LOKIASV2_0167_ESMFold_hypothetical_protein	6opt-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	6opt-assembly1.cif.gz_A HIV-1 Protease NL4-3 V82F, I84V Mutant in complex with darunavir	0.188	101	67	146	246	8	90	1.233E-03	120
LOKIASV2_0167_ESMFold_hypothetical_protein	1z8c-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1z8c-assembly1.cif.gz_B Crystal structure of the complex of mutant HIV-1 protease (l63P, A71V, V82T, I84V) with a hydroxyethylamine peptidomimetic inhibitor BOC-PHE-PSI[R-CH(OH)CH2NH]-PHE-GLU-PHE-NH2	0.177	107	72	140	246	2	90	1.233E-03	120
LOKIASV2_0167_ESMFold_hypothetical_protein	6pz4-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	6pz4-assembly1.cif.gz_A co-crystal structure of BACE with inhibitor AM-6494	0.100	344	233	3	262	5	348	6.293E-05	120
LOKIASV2_0167_ESMFold_hypothetical_protein	4j0z-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4j0z-assembly1.cif.gz_A CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4S,5R)-2-amino-5-fluoro-4-fluoromethyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide	0.111	343	230	3	262	8	350	6.998E-05	120
LOKIASV2_0167_ESMFold_hypothetical_protein	5b18-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	5b18-assembly1.cif.gz_B Crystal Structure of a Darunavir Resistant HIV-1 Protease	0.144	90	70	21	110	10	92	1.149E-02	119
LOKIASV2_0167_ESMFold_hypothetical_protein	4obk-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	4obk-assembly1.cif.gz_B Crystal structure of inactive HIV-1 protease in complex with the P1-P6 substrate variant (L449F/S451N)	0.188	101	67	146	246	8	90	1.301E-03	119
LOKIASV2_0167_ESMFold_hypothetical_protein	6ogv-assembly1.cif.gz_A-2	LOKIASV2_0167_ESMFold_hypothetical_protein	6ogv-assembly1.cif.gz_A-2 X-ray crystal structure of darunavir-resistant HIV-1 protease (P30) in apo state	0.198	101	66	146	246	8	90	1.233E-03	119
LOKIASV2_0167_ESMFold_hypothetical_protein	4qj9-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4qj9-assembly1.cif.gz_A Crystal structure of inactive HIV-1 protease in complex with p1-p6 substrate variant (R452S)	0.188	101	67	146	246	8	90	1.372E-03	119
LOKIASV2_0167_ESMFold_hypothetical_protein	6fiv-assembly1.cif.gz_A-2	LOKIASV2_0167_ESMFold_hypothetical_protein	6fiv-assembly1.cif.gz_A-2 STRUCTURAL STUDIES OF HIV AND FIV PROTEASES COMPLEXED WITH AN EFFICIENT INHIBITOR OF FIV PR	0.165	104	81	139	242	2	99	8.063E-04	119
LOKIASV2_0167_ESMFold_hypothetical_protein	2hs2-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	2hs2-assembly1.cif.gz_B Crystal structure of M46L mutant of HIV-1 protease complexed with TMC114 (darunavir)	0.198	101	66	146	246	8	90	1.233E-03	118
LOKIASV2_0167_ESMFold_hypothetical_protein	4npt-assembly1.cif.gz_A-2	LOKIASV2_0167_ESMFold_hypothetical_protein	4npt-assembly1.cif.gz_A-2 Crystal Structure of HIV-1 Protease Multiple Mutant P51 Complexed with Darunavir	0.149	84	65	21	104	10	86	5.460E-03	118
LOKIASV2_0167_ESMFold_hypothetical_protein	1zpk-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1zpk-assembly1.cif.gz_B Crystal structure of the complex of mutant HIV-1 protease (A71V, V82T, I84V) with a hydroxyethylamine peptidomimetic inhibitor BOC-PHE-PSI[R-CH(OH)CH2NH]-PHE-GLU-PHE-NH2	0.188	101	67	146	246	8	90	1.372E-03	118
LOKIASV2_0167_ESMFold_hypothetical_protein	1b11-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1b11-assembly1.cif.gz_A STRUCTURE OF FELINE IMMUNODEFICIENCY VIRUS PROTEASE COMPLEXED WITH TL-3-093	0.162	106	83	137	242	1	100	7.250E-04	118
LOKIASV2_0167_ESMFold_hypothetical_protein	2i1a-assembly2.cif.gz_D	LOKIASV2_0167_ESMFold_hypothetical_protein	2i1a-assembly2.cif.gz_D A Retroviral Protease-Like Domain in the Eukaryotic Protein Ddi1	0.146	118	90	146	263	3	108	1.525E-03	118
LOKIASV2_0167_ESMFold_hypothetical_protein	5c9f-assembly1.cif.gz_D	LOKIASV2_0167_ESMFold_hypothetical_protein	5c9f-assembly1.cif.gz_D Crystal structure of a retropepsin-like aspartic protease from Rickettsia conorii	0.188	123	91	2	124	7	119	2.333E-03	118
LOKIASV2_0167_ESMFold_hypothetical_protein	1az5-assembly1.cif.gz_A-2	LOKIASV2_0167_ESMFold_hypothetical_protein	1az5-assembly1.cif.gz_A-2 UNLIGANDED SIV PROTEASE STRUCTURE IN AN "OPEN" CONFORMATION	0.190	84	58	21	104	10	82	8.353E-03	117
LOKIASV2_0167_ESMFold_hypothetical_protein	4dqf-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4dqf-assembly1.cif.gz_A Crystal Structure of (G16A/L38A) HIV-1 Protease in Complex with DRV	0.198	101	64	146	246	8	88	1.301E-03	117
LOKIASV2_0167_ESMFold_hypothetical_protein	4dqf-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	4dqf-assembly1.cif.gz_B Crystal Structure of (G16A/L38A) HIV-1 Protease in Complex with DRV	0.198	101	66	146	246	8	90	1.609E-03	117
LOKIASV2_0167_ESMFold_hypothetical_protein	2fxd-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	2fxd-assembly1.cif.gz_B X-ray crystal structure of HIV-1 protease IRM mutant complexed with atazanavir (BMS-232632)	0.178	101	67	146	246	8	90	1.233E-03	117
LOKIASV2_0167_ESMFold_hypothetical_protein	1hvs-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1hvs-assembly1.cif.gz_B STRUCTURAL BASIS OF DRUG RESISTANCE FOR THE V82A MUTANT OF HIV-1 PROTEASE: BACKBONE FLEXIBILITY AND SUBSITE REPACKING	0.186	107	72	140	246	2	90	1.887E-03	117
LOKIASV2_0167_ESMFold_hypothetical_protein	1k2b-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1k2b-assembly1.cif.gz_B Combining Mutations in HIV-1 Protease to Understand Mechanisms of Resistance	0.188	101	67	146	246	8	90	1.789E-03	117
LOKIASV2_0167_ESMFold_hypothetical_protein	3mws-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3mws-assembly1.cif.gz_B Crystal Structure of Group N HIV-1 Protease	0.173	86	65	21	106	10	88	4.186E-03	117
LOKIASV2_0167_ESMFold_hypothetical_protein	3r0y-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3r0y-assembly1.cif.gz_A Crystal Structures of Multidrug-resistant HIV-1 Protease in Complex with Mechanism-Based Aspartyl Protease Inhibitors	0.186	84	62	21	104	10	86	9.289E-03	117
LOKIASV2_0167_ESMFold_hypothetical_protein	2hb2-assembly1.cif.gz_A-2	LOKIASV2_0167_ESMFold_hypothetical_protein	2hb2-assembly1.cif.gz_A-2 Structure of HIV protease 6X mutant in apo form	0.207	101	63	146	246	8	88	1.696E-03	116
LOKIASV2_0167_ESMFold_hypothetical_protein	2fgv-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	2fgv-assembly1.cif.gz_B X-ray crystal structure of HIV-1 Protease T80N variant in complex with the inhibitor saquinavir used to explore the role of invariant Thr80 in HIV-1 protease structure, function, and viral infectivity.	0.188	101	67	146	246	8	90	2.333E-03	116
LOKIASV2_0167_ESMFold_hypothetical_protein	1mtb-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1mtb-assembly1.cif.gz_B Viability of a drug-resistant HIV-1 protease mutant: structural insights for better antiviral therapy	0.178	101	67	146	246	8	90	2.213E-03	116
LOKIASV2_0167_ESMFold_hypothetical_protein	7bgu-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	7bgu-assembly1.cif.gz_A Mason-Pfizer Monkey Virus Protease mutant C7A/D26N/C106A in complex with peptidomimetic inhibitor	0.164	87	70	21	107	11	95	1.667E-02	116
LOKIASV2_0167_ESMFold_hypothetical_protein	3l5c-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3l5c-assembly1.cif.gz_A Structure of BACE Bound to SCH723871	0.083	350	236	5	262	6	355	1.129E-04	116
LOKIASV2_0167_ESMFold_hypothetical_protein	1aid-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1aid-assembly1.cif.gz_B STRUCTURE OF A NON-PEPTIDE INHIBITOR COMPLEXED WITH HIV-1 PROTEASE: DEVELOPING A CYCLE OF STRUCTURE-BASED DRUG DESIGN	0.188	101	67	146	246	8	90	1.696E-03	115
LOKIASV2_0167_ESMFold_hypothetical_protein	2avo-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	2avo-assembly1.cif.gz_B Kinetics, stability, and structural changes in high resolution crystal structures of HIV-1 protease with drug resistant mutations L24I, I50V, AND G73S	0.198	101	66	146	246	8	90	2.098E-03	115
LOKIASV2_0167_ESMFold_hypothetical_protein	2b7z-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	2b7z-assembly1.cif.gz_A Structure of HIV-1 protease mutant bound to indinavir	0.177	90	67	21	110	10	92	7.920E-03	115
LOKIASV2_0167_ESMFold_hypothetical_protein	3bc4-assembly1.cif.gz_A-2	LOKIASV2_0167_ESMFold_hypothetical_protein	3bc4-assembly1.cif.gz_A-2 I84V HIV-1 protease in complex with a pyrrolidine diester	0.188	101	67	146	246	8	90	1.696E-03	115
LOKIASV2_0167_ESMFold_hypothetical_protein	3d3t-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3d3t-assembly1.cif.gz_B Crystal Structure of HIV-1 CRF01_AE in complex with the substrate p1-p6	0.182	90	67	21	110	10	92	1.149E-02	115
LOKIASV2_0167_ESMFold_hypothetical_protein	6dh5-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	6dh5-assembly1.cif.gz_B Crystal structure of HIV-1 Protease NL4-3 V82I Mutant in complex with UMass6	0.198	101	66	146	246	8	90	1.990E-03	115
LOKIASV2_0167_ESMFold_hypothetical_protein	1ytg-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1ytg-assembly1.cif.gz_A SIV PROTEASE CRYSTALLIZED WITH PEPTIDE PRODUCT	0.177	107	72	140	246	2	90	1.990E-03	115
LOKIASV2_0167_ESMFold_hypothetical_protein	3s8i-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3s8i-assembly1.cif.gz_B The retroviral-like protease (RVP) domain of human DDI1	0.140	118	95	146	263	5	115	6.182E-04	115
LOKIASV2_0167_ESMFold_hypothetical_protein	3l5c-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3l5c-assembly2.cif.gz_B Structure of BACE Bound to SCH723871	0.099	339	218	20	262	18	356	5.967E-05	115
LOKIASV2_0167_ESMFold_hypothetical_protein	4ejk-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4ejk-assembly1.cif.gz_A HIV Protease (PR) dimer in closed form with pepstatin in active site and fragment 1F1-N in the outside/top of flap	0.198	101	66	146	246	8	90	1.990E-03	114
LOKIASV2_0167_ESMFold_hypothetical_protein	6opw-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	6opw-assembly1.cif.gz_A HIV-1 Protease NL4-3 I13V, G16E, V32I, L33F, K45I, M46I, A71V, V82F, I84V Mutant in complex with darunavir	0.188	101	67	146	246	8	90	2.333E-03	114
LOKIASV2_0167_ESMFold_hypothetical_protein	3oy4-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3oy4-assembly1.cif.gz_B Crystal Structure of HIV-1 L76V Protease in Complex with the Protease Inhibitor Darunavir.	0.198	101	66	146	246	8	90	2.098E-03	114
LOKIASV2_0167_ESMFold_hypothetical_protein	2b60-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	2b60-assembly1.cif.gz_B Structure of HIV-1 protease mutant bound to Ritonavir	0.198	101	66	146	246	8	90	1.990E-03	113
LOKIASV2_0167_ESMFold_hypothetical_protein	3cyw-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3cyw-assembly1.cif.gz_B Effect of Flap Mutations on Structure of HIV-1 Protease and Inhibition by Saquinavir and Darunavir	0.195	97	63	146	242	8	86	1.109E-03	113
LOKIASV2_0167_ESMFold_hypothetical_protein	2f80-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	2f80-assembly1.cif.gz_B HIV-1 Protease mutant D30N complexed with inhibitor TMC114	0.195	97	63	146	242	8	86	1.170E-03	113
LOKIASV2_0167_ESMFold_hypothetical_protein	2fle-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	2fle-assembly1.cif.gz_B Structural analysis of asymmetric inhibitor bound to the HIV-1 Protease V82A mutant	0.198	101	66	146	246	8	90	2.886E-03	113
LOKIASV2_0167_ESMFold_hypothetical_protein	2pym-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	2pym-assembly1.cif.gz_B HIV-1 PR mutant in complex with nelfinavir	0.231	90	63	21	110	10	92	4.910E-03	113
LOKIASV2_0167_ESMFold_hypothetical_protein	1bdq-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1bdq-assembly1.cif.gz_B HIV-1 (2:31-37, 47, 82) PROTEASE COMPLEXED WITH INHIBITOR SB203386	0.196	107	71	140	246	2	90	2.461E-03	112
LOKIASV2_0167_ESMFold_hypothetical_protein	1bdr-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1bdr-assembly1.cif.gz_B HIV-1 (2: 31, 33-37) PROTEASE COMPLEXED WITH INHIBITOR SB203386	0.186	107	72	140	246	2	90	1.887E-03	112
LOKIASV2_0167_ESMFold_hypothetical_protein	1bv7-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1bv7-assembly1.cif.gz_B COUNTERACTING HIV-1 PROTEASE DRUG RESISTANCE: STRUCTURAL ANALYSIS OF MUTANT PROTEASES COMPLEXED WITH XV638 AND SD146, CYCLIC UREA AMIDES WITH BROAD SPECIFICITIES	0.198	101	66	146	246	8	90	2.737E-03	112
LOKIASV2_0167_ESMFold_hypothetical_protein	7map-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	7map-assembly1.cif.gz_A Drug Resistant HIV-1 Protease (L10I, V32I, L33F, K45I, M46I, I50V, A71V, V82I, I84V) in Complex with DRV	0.198	101	66	146	246	8	90	2.737E-03	112
LOKIASV2_0167_ESMFold_hypothetical_protein	7mar-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	7mar-assembly2.cif.gz_B Drug Resistant HIV-1 Protease (L10F, M46I, I47V, I50V, F53L, L63P, I72V, G73S, V82I, I85V) in Complex with DRV	0.207	101	65	146	246	8	90	2.886E-03	112
LOKIASV2_0167_ESMFold_hypothetical_protein	2o4n-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	2o4n-assembly1.cif.gz_B Crystal Structure of HIV-1 Protease (TRM Mutant) in Complex with Tipranavir	0.178	101	67	146	246	8	90	2.595E-03	112
LOKIASV2_0167_ESMFold_hypothetical_protein	5yrs-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5yrs-assembly1.cif.gz_A X-ray Snapshot of HIV-1 Protease in Action: Observation of Tetrahedral Intermediate and Its SIHB with Catalytic Aspartate	0.187	90	67	21	110	10	92	1.089E-02	112
LOKIASV2_0167_ESMFold_hypothetical_protein	6opy-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	6opy-assembly1.cif.gz_B HIV-1 Protease NL4-3 I13V, G16E, V32I, L33F, K45I, M46I, A71V, L76V, V82F, I84V Mutant in complex with darunavir	0.188	101	67	146	246	8	90	2.886E-03	111
LOKIASV2_0167_ESMFold_hypothetical_protein	3oqd-assembly1.cif.gz_A-2	LOKIASV2_0167_ESMFold_hypothetical_protein	3oqd-assembly1.cif.gz_A-2 Crystal Structures of Multidrug-Resistant Clinical Isolate 769 HIV-1 Protease Variants	0.175	97	64	146	242	8	86	1.372E-03	111
LOKIASV2_0167_ESMFold_hypothetical_protein	2hah-assembly1.cif.gz_A-2	LOKIASV2_0167_ESMFold_hypothetical_protein	2hah-assembly1.cif.gz_A-2 The structure of FIV 12S protease in complex with TL-3	0.194	97	73	146	242	9	99	1.170E-03	111
LOKIASV2_0167_ESMFold_hypothetical_protein	2fiv-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	2fiv-assembly1.cif.gz_A Crystal structure of feline immunodeficiency virus protease complexed with a substrate	0.155	104	82	139	242	3	100	1.609E-03	111
LOKIASV2_0167_ESMFold_hypothetical_protein	4j0p-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4j0p-assembly1.cif.gz_A CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((S)-2-amino-4-methyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide	0.105	339	231	4	262	7	345	1.473E-04	111
LOKIASV2_0167_ESMFold_hypothetical_protein	5w5w-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5w5w-assembly1.cif.gz_A HIV Protease (PR) in open form with Mg2+ in active site and HIVE-9 in eye site	0.198	101	66	146	246	8	90	2.595E-03	110
LOKIASV2_0167_ESMFold_hypothetical_protein	5yoj-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	5yoj-assembly1.cif.gz_B Structure of A17 HIV-1 Protease in Complex with Inhibitor KNI-1657	0.206	97	62	146	242	8	86	1.525E-03	110
LOKIASV2_0167_ESMFold_hypothetical_protein	5c9b-assembly1.cif.gz_D	LOKIASV2_0167_ESMFold_hypothetical_protein	5c9b-assembly1.cif.gz_D Crystal structure of a retropepsin-like aspartic protease from Rickettsia conorii	0.177	123	85	2	124	7	110	2.333E-03	110
LOKIASV2_0167_ESMFold_hypothetical_protein	2az9-assembly1.cif.gz_A-2	LOKIASV2_0167_ESMFold_hypothetical_protein	2az9-assembly1.cif.gz_A-2 HIV-1 Protease NL4-3 1X mutant	0.186	107	72	140	246	2	90	3.570E-03	109
LOKIASV2_0167_ESMFold_hypothetical_protein	3lzu-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3lzu-assembly1.cif.gz_A Crystal Structure of a Nelfinavir Resistant HIV-1 CRF01_AE Protease variant (N88S) in Complex with the Protease Inhibitor Darunavir.	0.177	107	72	140	246	2	90	2.213E-03	109
LOKIASV2_0167_ESMFold_hypothetical_protein	3pwm-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3pwm-assembly1.cif.gz_B HIV-1 Protease Mutant L76V with Darunavir	0.195	97	63	146	242	8	86	1.789E-03	109
LOKIASV2_0167_ESMFold_hypothetical_protein	3el4-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3el4-assembly1.cif.gz_B Crystal structure of inhibitor saquinavir (SQV) complexed with the multidrug HIV-1 protease variant L63P/V82T/I84V	0.188	101	67	146	246	8	90	3.970E-03	108
LOKIASV2_0167_ESMFold_hypothetical_protein	4nkk-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4nkk-assembly1.cif.gz_A Crystal structure of a multi-drug resistant clinical isolate-769 HIV-1 protease variant that is resistant to the dimerization inhibitory activity of TLF-PafF	0.175	97	64	146	242	8	86	2.333E-03	108
LOKIASV2_0167_ESMFold_hypothetical_protein	4npu-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	4npu-assembly1.cif.gz_B Crystal Structure of HIV-1 Protease Multiple Mutant P51	0.188	101	67	146	246	8	90	2.886E-03	108
LOKIASV2_0167_ESMFold_hypothetical_protein	3uhl-assembly2.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	3uhl-assembly2.cif.gz_C Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical Isolate PR20 in Complex with p2-NC substrate analog	0.185	107	72	140	246	2	90	3.044E-03	108
LOKIASV2_0167_ESMFold_hypothetical_protein	2o4l-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	2o4l-assembly1.cif.gz_B Crystal Structure of HIV-1 Protease (Q7K, I50V) in Complex with Tipranavir	0.195	97	63	146	242	8	86	2.098E-03	107
LOKIASV2_0167_ESMFold_hypothetical_protein	2j9j-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	2j9j-assembly1.cif.gz_B Atomic-resolution Crystal Structure of Chemically-Synthesized HIV-1 Protease Complexed with Inhibitor JG-365	0.250	84	56	21	104	10	84	1.212E-02	106
LOKIASV2_0167_ESMFold_hypothetical_protein	7n6x-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	7n6x-assembly1.cif.gz_A Crystal structure of HIV-1 Protease multiple mutants PRS17 bound to inhibitor Amprenavir	0.195	97	63	146	242	8	86	1.525E-03	106
LOKIASV2_0167_ESMFold_hypothetical_protein	6opx-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	6opx-assembly1.cif.gz_A HIV-1 Protease NL4-3 I13V, G16E, V32I, L33F, K45I, M46I, L76V, V82F, I84V Mutant in complex with darunavir	0.188	101	67	146	246	8	90	4.186E-03	106
LOKIASV2_0167_ESMFold_hypothetical_protein	3oqa-assembly1.cif.gz_A-2	LOKIASV2_0167_ESMFold_hypothetical_protein	3oqa-assembly1.cif.gz_A-2 Crystal Structures of Multidrug-Resistant Clinical Isolate 769 HIV-1 Protease Variants	0.171	99	66	146	244	8	88	2.595E-03	106
LOKIASV2_0167_ESMFold_hypothetical_protein	2i1a-assembly2.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	2i1a-assembly2.cif.gz_C A Retroviral Protease-Like Domain in the Eukaryotic Protein Ddi1	0.145	127	86	137	263	4	105	2.333E-03	106
LOKIASV2_0167_ESMFold_hypothetical_protein	4he9-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	4he9-assembly1.cif.gz_B Crystal Structure of HIV-1 protease mutants I54M complexed with inhibitor GRL-0519	0.195	97	63	146	242	8	86	2.333E-03	105
LOKIASV2_0167_ESMFold_hypothetical_protein	7maq-assembly2.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	7maq-assembly2.cif.gz_A Drug Resistant HIV-1 Protease (L10F, V32I, L33F, K45I, A71V, V82I, I84V) in Complex with DRV	0.188	101	67	146	246	8	90	4.186E-03	105
LOKIASV2_0167_ESMFold_hypothetical_protein	1tw7-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1tw7-assembly1.cif.gz_B Wide Open 1.3A Structure of a Multi-drug Resistant HIV-1 Protease Represents a Novel Drug Target	0.175	97	64	146	242	8	86	2.461E-03	105
LOKIASV2_0167_ESMFold_hypothetical_protein	1yti-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1yti-assembly1.cif.gz_A SIV PROTEASE CRYSTALLIZED WITH PEPTIDE PRODUCT	0.225	90	64	21	110	10	92	9.796E-03	105
LOKIASV2_0167_ESMFold_hypothetical_protein	5c9d-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5c9d-assembly1.cif.gz_A Crystal structure of a retropepsin-like aspartic protease from Rickettsia conorii	0.148	127	95	1	127	1	113	4.186E-03	105
LOKIASV2_0167_ESMFold_hypothetical_protein	5yq8-assembly2.cif.gz_D	LOKIASV2_0167_ESMFold_hypothetical_protein	5yq8-assembly2.cif.gz_D Crystal structure of retroviral protease-like domain of Ddi1 from Leishmania major	0.155	118	98	146	263	4	120	5.758E-03	105
LOKIASV2_0167_ESMFold_hypothetical_protein	4z2z-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	4z2z-assembly1.cif.gz_B New crystal structure of yeast Ddi1 aspartyl protease reveals substrate engagement mode	0.154	126	97	138	263	16	131	2.333E-03	105
LOKIASV2_0167_ESMFold_hypothetical_protein	1sh9-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1sh9-assembly1.cif.gz_B Comparing the Accumulation of Active Site and Non-active Site Mutations in the HIV-1 Protease	0.188	101	67	146	246	8	90	5.758E-03	104
LOKIASV2_0167_ESMFold_hypothetical_protein	4yoa-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4yoa-assembly1.cif.gz_A Crsystal structure HIV-1 Protease MDR769 L33F Complexed with darunavir	0.175	97	64	146	242	8	86	2.737E-03	104
LOKIASV2_0167_ESMFold_hypothetical_protein	6s1v-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	6s1v-assembly1.cif.gz_A Crystal structure of dimeric M-PMV protease D26N mutant in complex with inhibitor	0.152	87	69	21	107	11	92	1.347E-02	104
LOKIASV2_0167_ESMFold_hypothetical_protein	2azb-assembly1.cif.gz_A-2	LOKIASV2_0167_ESMFold_hypothetical_protein	2azb-assembly1.cif.gz_A-2 HIV-1 Protease NL4-3 3X mutant in complex with inhibitor, TL-3	0.198	101	64	146	246	8	88	6.073E-03	103
LOKIASV2_0167_ESMFold_hypothetical_protein	1aaq-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1aaq-assembly1.cif.gz_B HYDROXYETHYLENE ISOSTERE INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS-1 PROTEASE: STRUCTURE-ACTIVITY ANALYSIS USING ENZYME KINETICS, X-RAY CRYSTALLOGRAPHY, AND INFECTED T-CELL ASSAYS	0.184	103	69	140	242	2	86	3.044E-03	103
LOKIASV2_0167_ESMFold_hypothetical_protein	3jvy-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3jvy-assembly1.cif.gz_B HIV-1 Protease Mutant G86A with DARUNAVIR	0.185	97	64	146	242	8	86	3.385E-03	103
LOKIASV2_0167_ESMFold_hypothetical_protein	3vf5-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3vf5-assembly1.cif.gz_B Crystal Structure of HIV-1 Protease Mutant I47V with novel P1'-Ligands GRL-02031	0.195	97	63	146	242	8	86	3.385E-03	103
LOKIASV2_0167_ESMFold_hypothetical_protein	1bdl-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1bdl-assembly1.cif.gz_B HIV-1 (2:31-37) PROTEASE COMPLEXED WITH INHIBITOR SB203386	0.196	107	71	140	246	2	90	5.460E-03	102
LOKIASV2_0167_ESMFold_hypothetical_protein	2i1a-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	2i1a-assembly1.cif.gz_B A Retroviral Protease-Like Domain in the Eukaryotic Protein Ddi1	0.170	118	85	146	263	5	108	8.809E-03	102
LOKIASV2_0167_ESMFold_hypothetical_protein	6o5a-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	6o5a-assembly1.cif.gz_A Crystal Structure of multi-drug resistant HIV-1 protease PR-S17 with a substrate analog p2-NC in P61	0.184	103	69	140	242	2	86	2.886E-03	101
LOKIASV2_0167_ESMFold_hypothetical_protein	6p9b-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	6p9b-assembly1.cif.gz_B HIV-1 Protease multiple drug resistant mutant PRS5B with Amprenavir	0.188	101	67	146	246	8	90	7.122E-03	101
LOKIASV2_0167_ESMFold_hypothetical_protein	3ogq-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3ogq-assembly1.cif.gz_A Crystal Structure of 6s-98S FIV Protease with Lopinavir bound	0.166	97	75	146	242	9	99	6.753E-03	101
LOKIASV2_0167_ESMFold_hypothetical_protein	5ys4-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5ys4-assembly1.cif.gz_A Crystal structure of retroviral protease-like domain of Ddi1 from Leishmania major	0.142	127	93	137	263	6	114	2.886E-03	101
LOKIASV2_0167_ESMFold_hypothetical_protein	4obz-assembly1.cif.gz_D	LOKIASV2_0167_ESMFold_hypothetical_protein	4obz-assembly1.cif.gz_D Structure of Cathepsin D with inhibitor 2-(3,4-dimethoxyphenyl)-N-[N-(4-methylbenzyl)carbamimidoyl]acetamide	0.115	175	134	111	262	59	233	2.213E-03	100
LOKIASV2_0167_ESMFold_hypothetical_protein	1bv9-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1bv9-assembly1.cif.gz_A HIV-1 PROTEASE (I84V) COMPLEXED WITH XV638 OF DUPONT PHARMACEUTICALS	0.188	101	67	146	246	8	90	9.289E-03	99
LOKIASV2_0167_ESMFold_hypothetical_protein	5ys4-assembly1.cif.gz_D	LOKIASV2_0167_ESMFold_hypothetical_protein	5ys4-assembly1.cif.gz_D Crystal structure of retroviral protease-like domain of Ddi1 from Leishmania major	0.123	127	94	137	263	2	109	2.213E-03	99
LOKIASV2_0167_ESMFold_hypothetical_protein	5ys4-assembly3.cif.gz_F	LOKIASV2_0167_ESMFold_hypothetical_protein	5ys4-assembly3.cif.gz_F Crystal structure of retroviral protease-like domain of Ddi1 from Leishmania major	0.147	127	94	137	263	2	112	4.186E-03	99
LOKIASV2_0167_ESMFold_hypothetical_protein	5ys4-assembly2.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	5ys4-assembly2.cif.gz_C Crystal structure of retroviral protease-like domain of Ddi1 from Leishmania major	0.117	118	93	146	263	6	111	3.570E-03	99
LOKIASV2_0167_ESMFold_hypothetical_protein	4rgh-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	4rgh-assembly1.cif.gz_B Human DNA Damage-Inducible Protein: From Protein Chemistry and 3D Structure to Deciphering its Cellular Role	0.125	118	95	146	263	5	113	4.656E-03	99
LOKIASV2_0167_ESMFold_hypothetical_protein	7sjx-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	7sjx-assembly1.cif.gz_B Cryo-EM Structure of the PR-RT components of the HIV-1 Pol Polyprotein	0.188	101	67	146	246	8	90	6.753E-03	98
LOKIASV2_0167_ESMFold_hypothetical_protein	7bgt-assembly2.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	7bgt-assembly2.cif.gz_C Mason-Pfizer Monkey Virus Protease mutant C7A/D26N/C106A in complex with peptidomimetic inhibitor	0.166	87	68	21	107	11	93	3.153E-02	96
LOKIASV2_0167_ESMFold_hypothetical_protein	5ys4-assembly3.cif.gz_E	LOKIASV2_0167_ESMFold_hypothetical_protein	5ys4-assembly3.cif.gz_E Crystal structure of retroviral protease-like domain of Ddi1 from Leishmania major	0.142	127	88	137	263	3	106	5.178E-03	96
LOKIASV2_0167_ESMFold_hypothetical_protein	7efy-assembly1.cif.gz_A-2	LOKIASV2_0167_ESMFold_hypothetical_protein	7efy-assembly1.cif.gz_A-2 Crystal structure of retroviral protease-like domain of Ddi1 from Cryptosporidium hominis	0.188	127	88	137	263	2	110	4.656E-03	96
LOKIASV2_0167_ESMFold_hypothetical_protein	2je4-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	2je4-assembly1.cif.gz_B Atomic-resolution crystal structure of chemically-synthesized HIV-1 protease in complex with JG-365	0.198	101	65	146	246	8	89	1.421E-02	95
LOKIASV2_0167_ESMFold_hypothetical_protein	6s1v-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	6s1v-assembly1.cif.gz_B Crystal structure of dimeric M-PMV protease D26N mutant in complex with inhibitor	0.175	87	68	21	107	11	94	3.507E-02	95
LOKIASV2_0167_ESMFold_hypothetical_protein	6s1u-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	6s1u-assembly1.cif.gz_B Crystal structure of dimeric M-PMV protease C7A/D26N/C106A mutant in complex with inhibitor	0.152	89	72	19	107	9	94	3.153E-02	95
LOKIASV2_0167_ESMFold_hypothetical_protein	7d66-assembly2.cif.gz_L	LOKIASV2_0167_ESMFold_hypothetical_protein	7d66-assembly2.cif.gz_L Crystal structure of retroviral protease-like domain of Ddi1 from Toxoplasma gondii	0.141	118	98	146	263	3	117	8.353E-03	95
LOKIASV2_0167_ESMFold_hypothetical_protein	7d66-assembly2.cif.gz_K	LOKIASV2_0167_ESMFold_hypothetical_protein	7d66-assembly2.cif.gz_K Crystal structure of retroviral protease-like domain of Ddi1 from Toxoplasma gondii	0.154	119	94	21	132	5	123	1.757E-02	95
LOKIASV2_0167_ESMFold_hypothetical_protein	7sjx-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	7sjx-assembly1.cif.gz_A Cryo-EM Structure of the PR-RT components of the HIV-1 Pol Polyprotein	0.188	101	67	146	246	8	90	1.033E-02	95
LOKIASV2_0167_ESMFold_hypothetical_protein	7bgu-assembly2.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	7bgu-assembly2.cif.gz_C Mason-Pfizer Monkey Virus Protease mutant C7A/D26N/C106A in complex with peptidomimetic inhibitor	0.150	87	70	21	107	11	93	3.698E-02	93
LOKIASV2_0167_ESMFold_hypothetical_protein	8dci-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	8dci-assembly1.cif.gz_B Crystal Structure of a highly resistant HIV-1 protease Clinical isolate PR10x (inhibitor-free)	0.195	97	63	146	242	8	86	7.920E-03	92
LOKIASV2_0167_ESMFold_hypothetical_protein	7d66-assembly2.cif.gz_I	LOKIASV2_0167_ESMFold_hypothetical_protein	7d66-assembly2.cif.gz_I Crystal structure of retroviral protease-like domain of Ddi1 from Toxoplasma gondii	0.139	118	100	146	263	2	118	8.809E-03	91
LOKIASV2_0167_ESMFold_hypothetical_protein	7d66-assembly1.cif.gz_F	LOKIASV2_0167_ESMFold_hypothetical_protein	7d66-assembly1.cif.gz_F Crystal structure of retroviral protease-like domain of Ddi1 from Toxoplasma gondii	0.143	118	96	146	263	3	115	6.753E-03	89
LOKIASV2_0167_ESMFold_hypothetical_protein	6s1u-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	6s1u-assembly1.cif.gz_A Crystal structure of dimeric M-PMV protease C7A/D26N/C106A mutant in complex with inhibitor	0.161	87	68	21	107	11	92	4.112E-02	87
LOKIASV2_0167_ESMFold_hypothetical_protein	7d66-assembly2.cif.gz_G	LOKIASV2_0167_ESMFold_hypothetical_protein	7d66-assembly2.cif.gz_G Crystal structure of retroviral protease-like domain of Ddi1 from Toxoplasma gondii	0.126	118	97	146	263	3	114	9.796E-03	87
LOKIASV2_0167_ESMFold_hypothetical_protein	4z2z-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4z2z-assembly1.cif.gz_A New crystal structure of yeast Ddi1 aspartyl protease reveals substrate engagement mode	0.139	118	90	146	263	13	117	1.421E-02	87
LOKIASV2_0167_ESMFold_hypothetical_protein	1fmb-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1fmb-assembly1.cif.gz_A EIAV PROTEASE COMPLEXED WITH THE INHIBITOR HBY-793	0.184	101	71	146	246	8	95	5.364E-02	86
LOKIASV2_0167_ESMFold_hypothetical_protein	6s1w-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	6s1w-assembly1.cif.gz_B Crystal structure of dimeric M-PMV protease D26N mutant	0.161	87	72	21	107	11	97	4.112E-02	86
LOKIASV2_0167_ESMFold_hypothetical_protein	2i1a-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	2i1a-assembly1.cif.gz_A A Retroviral Protease-Like Domain in the Eukaryotic Protein Ddi1	0.140	118	89	146	263	4	108	3.153E-02	86
LOKIASV2_0167_ESMFold_hypothetical_protein	7d66-assembly2.cif.gz_H	LOKIASV2_0167_ESMFold_hypothetical_protein	7d66-assembly2.cif.gz_H Crystal structure of retroviral protease-like domain of Ddi1 from Toxoplasma gondii	0.143	116	93	148	263	4	113	1.421E-02	85
LOKIASV2_0167_ESMFold_hypothetical_protein	7d66-assembly2.cif.gz_J	LOKIASV2_0167_ESMFold_hypothetical_protein	7d66-assembly2.cif.gz_J Crystal structure of retroviral protease-like domain of Ddi1 from Toxoplasma gondii	0.137	118	96	146	263	3	114	1.580E-02	85
LOKIASV2_0167_ESMFold_hypothetical_protein	7d66-assembly1.cif.gz_E	LOKIASV2_0167_ESMFold_hypothetical_protein	7d66-assembly1.cif.gz_E Crystal structure of retroviral protease-like domain of Ddi1 from Toxoplasma gondii	0.129	118	91	146	263	3	107	3.698E-02	80
LOKIASV2_0167_ESMFold_hypothetical_protein	7d66-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	7d66-assembly1.cif.gz_B Crystal structure of retroviral protease-like domain of Ddi1 from Toxoplasma gondii	0.140	118	95	146	263	3	114	2.549E-02	79
LOKIASV2_0167_ESMFold_hypothetical_protein	1lyb-assembly3.cif.gz_D	LOKIASV2_0167_ESMFold_hypothetical_protein	1lyb-assembly3.cif.gz_D CRYSTAL STRUCTURES OF NATIVE AND INHIBITED FORMS OF HUMAN CATHEPSIN D: IMPLICATIONS FOR LYSOSOMAL TARGETING AND DRUG DESIGN	0.121	183	136	107	262	55	237	1.347E-02	77
LOKIASV2_0167_ESMFold_hypothetical_protein	2hvp-assembly1.cif.gz_A-2	LOKIASV2_0167_ESMFold_hypothetical_protein	2hvp-assembly1.cif.gz_A-2 THREE-DIMENSIONAL STRUCTURE OF ASPARTYL PROTEASE FROM HUMAN IMMUNODEFICIENCY VIRUS HIV-1	0.174	84	63	21	104	5	81	8.653E-02	72
LOKIASV2_0167_ESMFold_hypothetical_protein	1b5f-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1b5f-assembly1.cif.gz_A NATIVE CARDOSIN A FROM CYNARA CARDUNCULUS L.	0.129	213	173	3	215	4	203	1.149E-02	64
LOKIASV2_0167_ESMFold_hypothetical_protein	6s1w-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	6s1w-assembly1.cif.gz_A Crystal structure of dimeric M-PMV protease D26N mutant	0.108	97	66	146	242	9	83	1.637E-01	49
LOKIASV2_0167_ESMFold_hypothetical_protein	3sqf-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3sqf-assembly2.cif.gz_B Crystal structure of monomeric M-PMV retroviral protease	0.086	95	76	148	242	3	86	1.324E-01	48
LOKIASV2_0167_ESMFold_hypothetical_protein	6ywy-assembly1.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	6ywy-assembly1.cif.gz_C The structure of the mitoribosome from Neurospora crassa with bound tRNA at the P-site	0.217	23	17	183	205	50	72	7.120E+00	34
LOKIASV2_0167_ESMFold_hypothetical_protein	7pkt-assembly1.cif.gz_b	LOKIASV2_0167_ESMFold_hypothetical_protein	7pkt-assembly1.cif.gz_b Large subunit of the Chlamydomonas reinhardtii mitoribosome	0.125	24	20	183	206	55	78	8.350E+00	33
LOKIASV2_0167_ESMFold_hypothetical_protein	5udf-assembly1.cif.gz_D	LOKIASV2_0167_ESMFold_hypothetical_protein	5udf-assembly1.cif.gz_D Structure of the N-terminal domain of lipoprotein-releasing system transmembrane protein LolE from Acinetobacter baumannii	0.083	107	91	3	102	42	148	1.051E+00	31
LOKIASV2_0167_ESMFold_hypothetical_protein	4ce4-assembly1.cif.gz_E	LOKIASV2_0167_ESMFold_hypothetical_protein	4ce4-assembly1.cif.gz_E 39S large subunit of the porcine mitochondrial ribosome	0.153	26	21	183	208	5	30	8.806E+00	31
LOKIASV2_0167_ESMFold_hypothetical_protein	3r42-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3r42-assembly1.cif.gz_A Crystal structure of the yeast vps23 UEV domain in complex with a vps27 PSDP peptide	0.162	42	33	181	222	39	78	2.333E+00	29
LOKIASV2_0167_ESMFold_hypothetical_protein	5udf-assembly1.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	5udf-assembly1.cif.gz_C Structure of the N-terminal domain of lipoprotein-releasing system transmembrane protein LolE from Acinetobacter baumannii	0.082	109	91	3	102	42	150	1.608E+00	29
LOKIASV2_0167_ESMFold_hypothetical_protein	5n77-assembly1.cif.gz_E	LOKIASV2_0167_ESMFold_hypothetical_protein	5n77-assembly1.cif.gz_E Crystal structure of the cytosolic domain of the CorA magnesium channel from Escherichia coli in complex with magnesium	0.100	50	38	183	232	73	115	3.043E+00	28
LOKIASV2_0167_ESMFold_hypothetical_protein	5yzp-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5yzp-assembly1.cif.gz_A Crystal structure of p204 HINa domain	0.092	238	163	1	238	14	193	9.125E-02	27
LOKIASV2_0167_ESMFold_hypothetical_protein	5n78-assembly1.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	5n78-assembly1.cif.gz_C Crystal structure of the cytosolic domain of the CorA Mg2+ channel from Escherichia coli in complex with magnesium and cobalt hexammine	0.116	43	31	183	225	73	108	4.185E+00	27
LOKIASV2_0167_ESMFold_hypothetical_protein	5ly5-assembly1.cif.gz_A-2	LOKIASV2_0167_ESMFold_hypothetical_protein	5ly5-assembly1.cif.gz_A-2 Arcadin-1 from Pyrobaculum calidifontis	0.061	81	64	183	263	8	76	1.371E+00	26
LOKIASV2_0167_ESMFold_hypothetical_protein	5n78-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5n78-assembly1.cif.gz_A Crystal structure of the cytosolic domain of the CorA Mg2+ channel from Escherichia coli in complex with magnesium and cobalt hexammine	0.100	50	38	183	232	73	115	3.968E+00	26
LOKIASV2_0167_ESMFold_hypothetical_protein	3luq-assembly1.cif.gz_D	LOKIASV2_0167_ESMFold_hypothetical_protein	3luq-assembly1.cif.gz_D The Crystal Structure of a PAS Domain from a Sensory Box Histidine Kinase Regulator from Geobacter sulfurreducens to 2.5A	0.131	38	29	173	206	56	93	8.806E+00	24
LOKIASV2_0167_ESMFold_hypothetical_protein	6qsa-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	6qsa-assembly1.cif.gz_A Cryogenic temperature structure of blue light-irradiated AtPhot2LOV2 recorded after an accumulated dose of 48 kGy	0.170	40	29	171	206	48	87	8.806E+00	24
LOKIASV2_0167_ESMFold_hypothetical_protein	1m4q-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1m4q-assembly1.cif.gz_A STRUCTURE OF THE TSG101 UEV DOMAIN IN COMPLEX WITH A HIV-1 PTAP "LATE DOMAIN" PEPTIDE, CNS ENSEMBLE	0.101	55	49	174	228	26	80	7.508E+00	23
LOKIASV2_0167_ESMFold_hypothetical_protein	8b6h-assembly1.cif.gz_DR	LOKIASV2_0167_ESMFold_hypothetical_protein	8b6h-assembly1.cif.gz_DR Cryo-EM structure of cytochrome c oxidase dimer (complex IV) from respiratory supercomplex of Tetrahymena thermophila	0.111	45	29	70	103	178	222	8.350E+00	22
LOKIASV2_0167_ESMFold_hypothetical_protein	6wle-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	6wle-assembly1.cif.gz_B Crystal structure of the Zeitlupe light-state mimic G46A	0.100	49	40	171	215	65	113	8.806E+00	21
LOKIASV2_0167_ESMFold_hypothetical_protein	5nwm-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5nwm-assembly1.cif.gz_A Insight into the molecular recognition mechanism of the coactivator NCoA1 by STAT6	0.042	47	41	174	220	62	105	7.120E+00	21
LOKIASV2_0167_ESMFold_hypothetical_protein	8t08-assembly1.cif.gz_f	LOKIASV2_0167_ESMFold_hypothetical_protein	8t08-assembly1.cif.gz_f Preholo-Proteasome from Pre1-1 Pre4-1 Double Mutant	0.080	77	62	148	224	32	99	2.736E+00	21
LOKIASV2_0167_ESMFold_hypothetical_protein	7tbn-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	7tbn-assembly2.cif.gz_B LOV2-DARPIN fusion : D11	0.138	62	49	171	228	56	117	8.350E+00	21
LOKIASV2_0167_ESMFold_hypothetical_protein	3u96-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3u96-assembly1.cif.gz_A Crystal Structure of YopHQ357F(Catalytic Domain, Residues 163-468) in complex with pNCS	0.123	70	50	170	227	99	168	4.185E+00	20
LOKIASV2_0167_ESMFold_hypothetical_protein	6j6u-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	6j6u-assembly1.cif.gz_B Rat PTPRZ D1-D2 domain	0.097	78	55	181	242	374	451	3.384E+00	20
LOKIASV2_0167_ESMFold_hypothetical_protein	3tqy-assembly1.cif.gz_D	LOKIASV2_0167_ESMFold_hypothetical_protein	3tqy-assembly1.cif.gz_D Structure of a single-stranded DNA-binding protein (ssb), from Coxiella burnetii	0.142	89	67	2	80	8	96	2.212E+00	19
LOKIASV2_0167_ESMFold_hypothetical_protein	5z7d-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5z7d-assembly1.cif.gz_A p204HINab-dsDNA complex structure	0.091	264	235	1	259	14	277	4.040E-01	19
LOKIASV2_0167_ESMFold_hypothetical_protein	1ae3-assembly1.cif.gz_A-2	LOKIASV2_0167_ESMFold_hypothetical_protein	1ae3-assembly1.cif.gz_A-2 MUTANT R82C OF GENE V PROTEIN (SINGLE-STRANDED DNA BINDING PROTEIN)	0.103	58	43	182	239	12	60	5.459E+00	18
LOKIASV2_0167_ESMFold_hypothetical_protein	1vqe-assembly1.cif.gz_A-2	LOKIASV2_0167_ESMFold_hypothetical_protein	1vqe-assembly1.cif.gz_A-2 GENE V PROTEIN MUTANT WITH VAL 35 REPLACED BY ILE 35 AND ILE 47 REPLACED BY MET 47 (V35I, I47M)	0.121	41	32	182	222	12	48	9.286E+00	18
LOKIASV2_0167_ESMFold_hypothetical_protein	2oq0-assembly4.cif.gz_D	LOKIASV2_0167_ESMFold_hypothetical_protein	2oq0-assembly4.cif.gz_D Crystal Structure of the First HIN-200 Domain of Interferon-Inducible Protein 16	0.091	237	161	2	238	6	183	1.109E+00	18
LOKIASV2_0167_ESMFold_hypothetical_protein	3clo-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3clo-assembly1.cif.gz_B Crystal structure of putative transcriptional regulator containing a LuxR DNA binding domain (NP_811094.1) from Bacteroides thetaiotaomicron VPI-5482 at 2.04 A resolution	0.090	90	76	174	263	105	188	8.806E+00	18
LOKIASV2_0167_ESMFold_hypothetical_protein	1vqh-assembly1.cif.gz_A-2	LOKIASV2_0167_ESMFold_hypothetical_protein	1vqh-assembly1.cif.gz_A-2 GENE V PROTEIN MUTANT WITH ILE 47 REPLACED BY MET 47 (I47M)	0.097	41	33	182	222	12	48	9.793E+00	17
LOKIASV2_0167_ESMFold_hypothetical_protein	1vqj-assembly1.cif.gz_A-2	LOKIASV2_0167_ESMFold_hypothetical_protein	1vqj-assembly1.cif.gz_A-2 GENE V PROTEIN MUTANT WITH VAL 35 REPLACED BY ILE 35 (V35I)	0.146	41	31	182	222	12	48	9.793E+00	17
LOKIASV2_0167_ESMFold_hypothetical_protein	6cqk-assembly3.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	6cqk-assembly3.cif.gz_C Crystal Structure of mitochondrial single-stranded DNA binding proteins from S. cerevisiae, Rim1 (Form1)	0.090	96	74	2	97	7	88	3.968E+00	17
LOKIASV2_0167_ESMFold_hypothetical_protein	7qf4-assembly1.cif.gz_AAA	LOKIASV2_0167_ESMFold_hypothetical_protein	7qf4-assembly1.cif.gz_AAA Structure of the R57Q mutant of miniSOG expressed in E. coli in LB medium enriched with riboflavin	0.126	84	51	148	206	4	87	8.350E+00	17
LOKIASV2_0167_ESMFold_hypothetical_protein	6lm2-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	6lm2-assembly1.cif.gz_A Crystal structure of Zinc binding protein ZinT from E. coli	0.083	78	53	148	225	83	141	9.793E+00	17
LOKIASV2_0167_ESMFold_hypothetical_protein	8x70-assembly4.cif.gz_D	LOKIASV2_0167_ESMFold_hypothetical_protein	8x70-assembly4.cif.gz_D The Crystal Structure of IFI16 from Biortus.	0.080	224	161	2	225	14	189	1.696E+00	17
LOKIASV2_0167_ESMFold_hypothetical_protein	7uw8-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	7uw8-assembly1.cif.gz_A Drosophila melanogaster setdb1-tuor domain	0.081	86	52	137	222	11	68	6.402E+00	17
LOKIASV2_0167_ESMFold_hypothetical_protein	1kaw-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1kaw-assembly1.cif.gz_A STRUCTURE OF SINGLE STRANDED DNA BINDING PROTEIN (SSB)	0.160	71	50	2	72	8	67	4.908E+00	16
LOKIASV2_0167_ESMFold_hypothetical_protein	4x2x-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4x2x-assembly1.cif.gz_A Crystal structure of the Murine Norovirus NS6 protease (inactive C139A mutant) with a C-terminal extension to include residues P1 prime - P4 prime of NS7	0.067	103	83	121	223	54	143	5.176E+00	16
LOKIASV2_0167_ESMFold_hypothetical_protein	1txl-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1txl-assembly1.cif.gz_A Crystal structure of metal-binding protein yodA from E. coli, Pfam DUF149	0.084	92	77	148	239	86	170	7.918E+00	16
LOKIASV2_0167_ESMFold_hypothetical_protein	4qgu-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	4qgu-assembly1.cif.gz_B protein domain complex with ssDNA	0.078	238	164	1	238	13	191	2.098E+00	16
LOKIASV2_0167_ESMFold_hypothetical_protein	2oq0-assembly3.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	2oq0-assembly3.cif.gz_C Crystal Structure of the First HIN-200 Domain of Interferon-Inducible Protein 16	0.095	237	167	2	238	8	192	1.608E+00	16
LOKIASV2_0167_ESMFold_hypothetical_protein	7uve-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	7uve-assembly1.cif.gz_A Drosophila melanogaster setdb1-tuor domain with peptide H3K9me2K14ac	0.081	86	52	137	222	11	68	7.508E+00	16
LOKIASV2_0167_ESMFold_hypothetical_protein	6pzj-assembly1.cif.gz_A-2	LOKIASV2_0167_ESMFold_hypothetical_protein	6pzj-assembly1.cif.gz_A-2 Structure of the N-terminal domain (residues 43-304) of Methyl-accepting chemotaxis protein from Leptospira interrogans serogroup Icterohaemorrhagiae serovar Copenhageni (strain Fiocruz L1-130)	0.080	120	103	112	231	64	176	7.918E+00	16
LOKIASV2_0167_ESMFold_hypothetical_protein	4aw8-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4aw8-assembly1.cif.gz_A X-ray structure of ZinT from Salmonella enterica in complex with zinc ion and PEG	0.117	103	73	154	256	90	173	6.071E+00	15
LOKIASV2_0167_ESMFold_hypothetical_protein	5aq6-assembly1.cif.gz_A-2	LOKIASV2_0167_ESMFold_hypothetical_protein	5aq6-assembly1.cif.gz_A-2 Structure of E. coli ZinT at 1.79 Angstrom	0.086	79	66	183	261	102	174	7.120E+00	15
LOKIASV2_0167_ESMFold_hypothetical_protein	7bu9-assembly2.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	7bu9-assembly2.cif.gz_C Crystal Structure of Spindlin1-H3(K4me3-K9me2) complex	0.081	202	164	46	224	2	203	2.736E+00	15
LOKIASV2_0167_ESMFold_hypothetical_protein	2a84-assembly1.cif.gz_A-2	LOKIASV2_0167_ESMFold_hypothetical_protein	2a84-assembly1.cif.gz_A-2 Crystal structure of A Pantothenate synthetase complexed with ATP	0.070	54	49	174	227	224	277	8.806E+00	15
LOKIASV2_0167_ESMFold_hypothetical_protein	6j6u-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	6j6u-assembly1.cif.gz_A Rat PTPRZ D1-D2 domain	0.075	78	56	181	242	395	472	9.793E+00	15
LOKIASV2_0167_ESMFold_hypothetical_protein	1hv1-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	1hv1-assembly1.cif.gz_A DISSECTING ELECTROSTATIC INTERACTIONS AND THE PH-DEPENDENT ACTIVITY OF A FAMILY 11 GLYCOSIDASE	0.077	205	129	53	257	8	148	2.885E+00	14
LOKIASV2_0167_ESMFold_hypothetical_protein	2nlk-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	2nlk-assembly1.cif.gz_A Crystal structure of D1 and D2 catalytic domains of human Protein Tyrosine Phosphatase Gamma (D1+D2 PTPRG)	0.090	82	57	181	244	414	495	6.402E+00	14
LOKIASV2_0167_ESMFold_hypothetical_protein	6rm3-assembly1.cif.gz_SX0	LOKIASV2_0167_ESMFold_hypothetical_protein	6rm3-assembly1.cif.gz_SX0 Evolutionary compaction and adaptation visualized by the structure of the dormant microsporidian ribosome	0.108	81	66	183	263	46	120	9.286E+00	13
LOKIASV2_0167_ESMFold_hypothetical_protein	4igx-assembly4.cif.gz_D	LOKIASV2_0167_ESMFold_hypothetical_protein	4igx-assembly4.cif.gz_D Crystal structure of kirola (Act d 11) - triclinic form	0.088	90	80	173	262	25	113	7.120E+00	13
LOKIASV2_0167_ESMFold_hypothetical_protein	4x2w-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4x2w-assembly1.cif.gz_A Crystal structure of the Murine Norovirus NS6 protease (inactive C139A mutant) with a C-terminal extension to include residues P1 prime - P2 prime of NS7	0.070	126	104	111	223	21	146	6.402E+00	13
LOKIASV2_0167_ESMFold_hypothetical_protein	8x70-assembly3.cif.gz_C	LOKIASV2_0167_ESMFold_hypothetical_protein	8x70-assembly3.cif.gz_C The Crystal Structure of IFI16 from Biortus.	0.081	238	163	1	238	13	190	4.654E+00	13
LOKIASV2_0167_ESMFold_hypothetical_protein	4h75-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	4h75-assembly1.cif.gz_A Crystal structure of human Spindlin1 in complex with a histone H3K4(me3) peptide	0.083	193	160	46	220	3	195	3.209E+00	13
LOKIASV2_0167_ESMFold_hypothetical_protein	1jly-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1jly-assembly1.cif.gz_B CRYSTAL STRUCTURE OF AMARANTHUS CAUDATUS AGGLUTININ	0.068	258	235	6	263	45	297	2.736E+00	13
LOKIASV2_0167_ESMFold_hypothetical_protein	8c5z-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	8c5z-assembly1.cif.gz_A RPA tetrameric supercomplex with AROD-OB-1	0.066	229	181	3	231	76	270	3.384E+00	13
LOKIASV2_0167_ESMFold_hypothetical_protein	6e8a-assembly1.cif.gz_A-3	LOKIASV2_0167_ESMFold_hypothetical_protein	6e8a-assembly1.cif.gz_A-3 Crystal structure of DcrB from Salmonella enterica at 1.92 Angstroms resolution	0.079	188	103	44	231	21	133	6.402E+00	12
LOKIASV2_0167_ESMFold_hypothetical_protein	5ec5-assembly2.cif.gz_S	LOKIASV2_0167_ESMFold_hypothetical_protein	5ec5-assembly2.cif.gz_S Crystal structure of lysenin pore	0.107	197	170	66	262	89	279	6.402E+00	12
LOKIASV2_0167_ESMFold_hypothetical_protein	7stb-assembly1.cif.gz_F	LOKIASV2_0167_ESMFold_hypothetical_protein	7stb-assembly1.cif.gz_F Closed state of Rad24-RFC:9-1-1 bound to a 5' ss/dsDNA junction	0.086	166	142	4	159	29	194	3.568E+00	12
LOKIASV2_0167_ESMFold_hypothetical_protein	4zqd-assembly2.cif.gz_D	LOKIASV2_0167_ESMFold_hypothetical_protein	4zqd-assembly2.cif.gz_D Crystal Structure of the Heterodimeric HIF-2a:ARNT Complex with the Benzoxadiazole Antagonist 0X3	0.080	163	132	58	220	122	265	7.120E+00	12
LOKIASV2_0167_ESMFold_hypothetical_protein	7zi4-assembly1.cif.gz_D	LOKIASV2_0167_ESMFold_hypothetical_protein	7zi4-assembly1.cif.gz_D Cryo-EM structure of the human INO80 complex bound to a WT nucleosome	0.085	128	70	136	263	115	191	8.806E+00	12
LOKIASV2_0167_ESMFold_hypothetical_protein	3uj4-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3uj4-assembly1.cif.gz_A Crystal structure of the apo-inositol 1,4,5-trisphosphate receptor	0.072	105	94	122	223	206	310	8.806E+00	12
LOKIASV2_0167_ESMFold_hypothetical_protein	5y5w-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	5y5w-assembly1.cif.gz_A Crystal structure of human Spindlin1 in complex with a histone H4K20(me3) peptide	0.075	191	156	51	220	18	208	6.751E+00	11
LOKIASV2_0167_ESMFold_hypothetical_protein	8oej-assembly1.cif.gz_D	LOKIASV2_0167_ESMFold_hypothetical_protein	8oej-assembly1.cif.gz_D Extended RPA-DNA nucleoprotein filament	0.089	230	161	2	231	22	199	3.043E+00	11
LOKIASV2_0167_ESMFold_hypothetical_protein	8oel-assembly1.cif.gz_D	LOKIASV2_0167_ESMFold_hypothetical_protein	8oel-assembly1.cif.gz_D Condensed RPA-DNA nucleoprotein filament	0.096	230	164	2	231	22	203	3.384E+00	11
LOKIASV2_0167_ESMFold_hypothetical_protein	4zqd-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	4zqd-assembly1.cif.gz_B Crystal Structure of the Heterodimeric HIF-2a:ARNT Complex with the Benzoxadiazole Antagonist 0X3	0.084	155	118	66	220	135	264	9.793E+00	11
LOKIASV2_0167_ESMFold_hypothetical_protein	3p8a-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	3p8a-assembly1.cif.gz_A Crystal Structure of a hypothetical protein from Staphylococcus aureus	0.070	222	179	4	225	25	217	4.908E+00	10
LOKIASV2_0167_ESMFold_hypothetical_protein	5ec5-assembly1.cif.gz_I	LOKIASV2_0167_ESMFold_hypothetical_protein	5ec5-assembly1.cif.gz_I Crystal structure of lysenin pore	0.107	198	165	66	263	84	269	8.350E+00	10
LOKIASV2_0167_ESMFold_hypothetical_protein	5ec5-assembly2.cif.gz_O	LOKIASV2_0167_ESMFold_hypothetical_protein	5ec5-assembly2.cif.gz_O Crystal structure of lysenin pore	0.114	197	172	66	262	91	285	9.793E+00	10
LOKIASV2_0167_ESMFold_hypothetical_protein	3p8a-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3p8a-assembly2.cif.gz_B Crystal Structure of a hypothetical protein from Staphylococcus aureus	0.063	222	182	4	225	24	218	8.806E+00	9
LOKIASV2_0167_ESMFold_hypothetical_protein	3uj4-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	3uj4-assembly2.cif.gz_B Crystal structure of the apo-inositol 1,4,5-trisphosphate receptor	0.062	154	136	70	223	166	311	9.286E+00	9
LOKIASV2_0167_ESMFold_hypothetical_protein	6h1p-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	6h1p-assembly1.cif.gz_A Cold-adapted beta-D-galactosidase from Arthrobacter sp. 32cB - data collected at room temperature	0.120	228	190	4	220	584	811	3.763E+00	9
LOKIASV2_0167_ESMFold_hypothetical_protein	6se8-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	6se8-assembly1.cif.gz_A Cold-adapted beta-D-galactosidase from Arthrobacter sp. 32cB mutant E441Q	0.094	227	195	5	220	597	823	3.968E+00	9
LOKIASV2_0167_ESMFold_hypothetical_protein	7t3p-assembly1.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	7t3p-assembly1.cif.gz_B IP3 and ATP bound type 3 IP3 receptor in the pre-active A state	0.090	223	176	70	263	168	390	8.806E+00	9
LOKIASV2_0167_ESMFold_hypothetical_protein	1xcr-assembly2.cif.gz_B	LOKIASV2_0167_ESMFold_hypothetical_protein	1xcr-assembly2.cif.gz_B Crystal Structure of Longer Splice Variant of PTD012 from Homo sapiens reveals a novel Zinc-containing fold	0.103	260	177	3	262	92	289	9.286E+00	8
LOKIASV2_0167_ESMFold_hypothetical_protein	6zjp-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	6zjp-assembly1.cif.gz_A Cold-adapted beta-D-galactosidase from Arthrobacter sp. 32cB mutant E517Q	0.099	227	194	5	220	585	811	6.751E+00	8
LOKIASV2_0167_ESMFold_hypothetical_protein	6zjv-assembly1.cif.gz_A	LOKIASV2_0167_ESMFold_hypothetical_protein	6zjv-assembly1.cif.gz_A Cold-adapted beta-D-galactosidase from Arthrobacter sp. 32cB mutant D207A	0.094	227	195	5	220	585	811	5.176E+00	8
